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ABSTRACT 
 
Autism Spectrum Disorders (ASD) genetic testing has been recommended to 
children diagnosed with ASD for the evaluation of genetic etiology by leading medical 
organizations in the U.S. Yet, the utilization of ASD genetic testing for children with 
ASD is low. Although several studies have investigated factors associated with the 
underutilization of ASD genetic testing, parents’ perspective regarding this testing has 
been overlooked. To address such issue, through four research studies, this dissertation 
seeks to examine parents’ perception, intention, experience, and education needs related 
to ASD genetic testing. 
 The first study focuses on the development and psychometric testing of a theory-
based survey which measured parents’ intention in taking their affected children for 
ASD genetic testing and related psychosocial factors. Findings of this study showed that 
the survey is reliable and valid in assessing parents’ intention as well as associated 
factors. The second study examines the relationships among psychosocial factors 
associated with parents’ test-taking intention. Data were analyzed using structural 
equation modeling. This study demonstrated that parental test-taking intention was 
significantly associated with the constructs proposed in the model. The third study 
investigates parents’ utilization of ASD genetic testing as well as their testing 
experience. Results indicated that most parents have not had their affected children 
undergo ASD genetic testing. For parents had their affected children tested, most of 
them were satisfied with the testing and would recommend it to other parents of children 
 iii 
 
with ASD. The fourth study explores parents’ education needs regarding ASD genetic 
testing. Results showed that most parents were interested in receiving educational 
information about ASD genetic testing (e.g., accuracy, benefits, cost). Web-based 
approach was identified to be the most effective delivery method. 
The findings from the studies presented in this dissertation have direct 
implications for researchers and healthcare professionals. Specifically, it can potentially 
(1) assist researchers in examining factors associated with parents’ intention in ASD 
genetic testing, (2) help healthcare professionals provide tailored information to parents 
regarding ASD genetic testing, as well as (3) contribute to the development of theory- 
and evidence-based interventions to improve the unitization of ASD genetic testing 
among parents of children with ASD.  
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CHAPTER I  
INTRODUCTION 
 
Autism Spectrum Disorders (ASD) are prevalent neurodevelopmental 
disabilities. Individuals with ASD have limited abilities in social communication and 
interaction as well as demonstrate restricted, repetitive patterns of behavior (American 
Psychiatric Association, 2013). In addition, they also manifest great heterogeneity in 
adaptive function, cognitive and language abilities, and neurological comorbidities (Jeste 
& Geschwind, 2014). The fifth edition of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-V) excludes the previous subdiagnoses (e.g., autistic disorder, 
Asperger’s disorder, childhood disintegrative disorder, and pervasive developmental 
disorder not otherwise specified) and groups them under one umbrella term: ASD 
(American Psychiatric Association, 2013). The prevalence of ASD has doubled in the 
past decade (Centers for Disease Control and Prevention, 2016) and impacted one in 68 
children aged 8 years in the U.S. (Christensen, 2016). Gender difference can be seen 
among the diagnosed children; the estimated prevalence for boys is 4.5 times higher than 
that of girls (Christensen, 2016). The diagnosis of ASD is primarily based on the 
evaluation of clinical developmental history and assessment of behavioral characteristics 
(Centers for Disease Control and Prevention, 2015; Walsh, Elsabbagh, Bolton, & Singh, 
2011). Currently, behavior interventions are the major treatment options for most 
individuals with ASD (Kasari, Shire, Factor, & McCracken, 2014; Rogers et al., 2014).  
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While the etiology of ASD has not been fully understood, genetic components 
have found to be highly involved in the development of ASD (Betancur, 2011; Devlin & 
Scherer, 2012; Šestan, 2012). Hundreds of ASD-associated genes have been identified, 
which can be attributed to three major groups: de novo single-nucleotide variants 
(SNVs) (e.g., CHD8, DYRK1A), copy number variants (CNVs) (e.g., 16p11.2 
duplication, 16p11.2 deletion), and single-gene disorders (e.g., Fragile X, Tuberous 
sclerosis) (de la Torre-Ubieta, Won, Stein, & Geschwind, 2016). Moreover, because of 
these identified ASD-associated genes, utilizing genetic testing to detect the genetic 
etiology of ASD has become available in clinical practice. ASD genetic testing has been 
recommended as an evaluation tool for children diagnosed with ASD by the American 
College of Medical Genetics and Genomics and American Academy of Pediatrics 
(American Academy of Pediatrics, 2013; Barr & Millar, 2003; Hayeems, Babul-Hirji, 
Hoang, Weksberg, & Shuman, 2016; Schaefer & Mendelsohn, 2013). The first-tier test 
is the chromosomal microarray analysis (CMA) (Schaefer & Mendelsohn, 2013), which 
can identify the ASD-associated CNVs. Other methods of ASD genetic testing, such as 
Fragile X testing, whole exome sequencing, and whole genome sequencing, are also 
available for children with ASD (Jiang et al., 2013; Tammimies et al., 2015). 
Yet, due to the uncertainty of ASD susceptibility genes, the overall diagnostic 
yield of ASD genetic testing is below 40% (Miller et al., 2010; Roesser, 2011; Schaefer 
& Lutz, 2006; Schaefer & Mendelsohn, 2008, 2013; Shen et al., 2010). Debates also 
exist regarding the application and usefulness of ASD genetic testing among ASD 
professionals (Hens, Peeters, & Dierickx, 2016). Moreover, the uptake rate of ASD 
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genetic testing for children diagnosed with ASD is low in the U.S. (Cuccaro et al., 2014; 
Kiely, Vettam, & Adesman, 2016; Narcisa et al., 2013; Wydeven, Kwan, Hardan, & 
Bernstein, 2012). Studies also showed that parents lack awareness in and sufficient 
knowledge about ASD genetic testing (Chen, Xu, Huang, & Dhar, 2013). Furthermore, 
parents and their affected children have limited access to ASD genetic information and 
services (Cuccaro et al., 2014; Narcisa et al., 2013; Wydeven et al., 2012).. Although 
several studies have been conducted to examine factors associated with the 
underutilization of ASD genetic testing (Cuccaro et al., 2014; Narcisa et al., 2013; 
Wydeven et al., 2012), parents’ perspective regarding this testing was largely 
overlooked. To improve the affected children’s access to ASD genetic services, provide 
recommendations to healthcare providers to better serve parents in need, as well as 
develop tailored information regarding ASD genetic testing to address parents’ concerns 
and meet their needs, it is imperative to understand parents’ perspective regarding this 
testing. Thus, the purpose of this dissertation is to examine parents’ perception, 
intention, experience, and education needs related to ASD genetic testing. 
This dissertation consists of six chapters. Chapter I contains an overview of the 
dissertation, introducing the content that follows. Chapter II reports on the development 
and psychometric testing of a theoretically-based survey instrument designed to assess 
various factors associated with parents’ intention in taking their affected children for 
ASD genetic testing. Chapter III examines the psychosocial factors that influence 
parents’ intention in taking their children with ASD for ASD genetic testing. Chapter IV 
assesses the utilization of ASD genetic testing for children with ASD as well as parents’ 
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experience of taking their affected children for ASD genetic testing. Chapter V explores 
parents’ education needs regarding ASD genetic testing. Finally, chapter VI presents the 
conclusion of this dissertation based on the discussions in Chapter II, III, IV, and V. 
Moreover, seven appendices are also attached at the end of this dissertation, including 
Appendix A (pilot test information sheet), Appendix B (pilot test survey instrument), 
Appendix C (pilot test invitation email), Appendix D (formal test information sheet), 
Appendix E (formal test survey instrument), Appendix F (formal test invitation email), 
and Appendix G (dataset use agreement). 
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CHAPTER II 
PSYCHOMETRIC PROPERTIES OF THE PARENTS’ PERCEPTION OF 
AUTISM SPECTRUM DISORDERS GENETIC TESTING SURVEY 
 
Autism Spectrum Disorders (ASD) are prevalent neurodevelopmental disabilities 
(Gaugler et al., 2014). Individuals with ASD have limited abilities in social 
communication and interaction. While the etiology of ASD remains complex and 
unclear, with the advancement in genome-based microarray and sequencing 
technologies, hundreds of genes related with ASD have been identified (Betancur, 2011; 
Devlin & Scherer, 2012; Šestan, 2012). As genetic components play an important role in 
the development of ASD, genetics evaluation for children with ASD may help affected 
families get a specific genetic diagnosis and arrange future medical follow-up and 
treatment plans for the children with ASD. In clinical practice, ASD genetic testing has 
been recommended as an evaluation tool for children with ASD by the American 
College of Medical Genetics and Genomics and American Academy of Pediatrics 
(American Academy of Pediatrics, 2013; Barr & Millar, 2003; Hayeems et al., 2016; 
Schaefer & Mendelsohn, 2013), and the first-tier test is the chromosomal microarray 
analysis (CMA) (Schaefer & Mendelsohn, 2013).  
Despite the potential benefits offered by ASD genetic testing and 
recommendations from the leading organizations, studies had shown that ASD genetic 
testing was still underutilized among children with ASD in the U.S. (Cuccaro et al., 
2014; Narcisa et al., 2013; Wydeven et al., 2012). Although several factors that 
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contributed to the low utilization of ASD genetic testing had been identified (e.g., 
parents’ low awareness of ASD genetic testing, limited knowledge of ASD genetic 
testing, financial burden, health care provider’s role) (Chen et al., 2013; Wydeven et al., 
2012), no further quantitative studies have been conducted to predict parents’ intention 
or behavior in taking their children with ASD for ASD genetic testing. As intention is a 
strong predictor of behavior (Cooke & French, 2008; Sheeran, 2002; Sheeran & Webb, 
2016; Webb & Sheeran, 2006), in order to understand what motivates parents to take 
their children with ASD for ASD genetic testing, it is necessary to examine the 
psychosocial factors that influence parental intention in taking their children with ASD 
for testing. 
In previous research (Bunn, Bosompra, Ashikaga, Flynn, & Worden, 2002; 
Doukas, Localio, & Li, 2004; Gooding, Organista, Burack, & Biesecker, 2006; Lagos et 
al., 2008; Levine et al., 2010; Miller, Shoda, & Hurley, 1996; Sagi, Shiloh, & Cohen, 
1992; Vainio & Miller, 2003) that studied the factors associated with one’s test-taking in 
genetic testing, three health behavior models/theories were identified: Health Belief 
Model (Janz & Becker, 1984; Rosenstock, Strecher, & Becker, 1988), Theory of Planned 
Behavior (Ajzen, 1991; Ajzen, Lange, Kruglanski, & Higgins, 2012), and Social 
Cognitive Theory (Bandura, 1986, 2011; Glanz, Rimer, & Viswanath, 2008; 
Luszczynska & Schwarzer, 2005). While these three models/theories have been used 
extensively to explain determinants of test-taking intention (Bunn et al., 2002; Doukas et 
al., 2004; Gooding et al., 2006; Lagos et al., 2008; Levine et al., 2010; Miller et al., 
1996; Sagi et al., 1992; Vainio & Miller, 2003), they had often been used and examined 
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separately; limited studies have been conducted in combining these three models to 
predict health behavior in genetic testing. As a single-theory model may lack the 
capability to explore all the aspects of health behavior, an integrated, multi-theoretical 
model is needed (Armitage & Conner, 2000; Godin, Gagnon, Alary, Noel, & Morissette, 
2001). In particular, the integration of these models allows for a fuller understanding of 
how parental test-taking intention were influenced through the theoretical constructs 
from these social behavior theories. 
In this integrated theoretical framework, parental intention in taking their 
affected children for testing may be influenced by their attitudes towards ASD genetic 
testing, self-efficacy and subjective norms. Their attitudes towards ASD genetic testing 
may be associated by their perceived genetic cause of ASD, perceived benefits of ASD 
genetic testing, perceived barriers of ASD genetic testing, and perceived severity of 
ASD. The perceived severity level of affected children, the perceived benefits of ASD 
genetic testing, and the perceived barriers to taking affected children for ASD genetic 
testing were adopted from the Health Belief Model. Perceived genetic cause of ASD was 
added in this integrated model based on previous literature (Ashtiani, Makela, Carrion, 
& Austin, 2014; Barr & Millar, 2003; Chen et al., 2013; Hayeems et al., 2016). Attitudes 
toward ASD genetic testing, subjective norms, and intention in taking affected children 
for ASD genetic testing were adopted from the Theory of Planned Behavior, whereas 
self-efficacy derived from the Social Cognitive theory. 
As there existed no survey instruments that focused on parental intention and 
psychosocial factors that related to ASD genetic testing, we developed a new survey 
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instrument: Perception of ASD Genetic Testing Survey (POAGTS) guided by the 
proposed theoretical framework. Each subscale of the POAGTS was developed based on 
the abovementioned theoretical construct. As the POAGTS is the first instrument (to the 
best of our knowledge) in examining factors associated with parental intention in having 
their affected children for ASD genetic testing, it is important to test its reliability and 
validity. Thus, the primary purpose of this study is to examine the psychometric 
properties of the POAGTS among parents of children with ASD. 
Methods 
Measurement 
Perceived genetic cause of ASD scale. This scale included four items regarding 
whether or not parents believe that their children’s ASD were caused by genes. The 
items are rated on a four-point Likert-type scale ranging from strongly disagree, 
disagree, agree, to strongly agree. 
Perceived severity level of affected children scale: The perceived severity 
dimension contained six items that assess parents’ feelings about potential 
manifestations or consequences of their children’s ASD diagnoses using a four-point 
Likert-type scale (from strongly disagree, disagree, agree, to strongly agree).  
Perceived benefits of ASD genetic testing scale. This scale consists of six four-
point Likert-type items, from strongly disagree, disagree, agree, to strongly agree, that 
examine parents’ beliefs in the value of taking their children for ASD genetic testing. 
Perceived barriers to ASD genetic testing scale. Nine items with a four-point 
Likert-type scale (from strongly disagree to strongly agree) were used to study potential 
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barriers or obstacles that might prevent parents from taking their children for ASD 
genetic testing. 
Attitudes toward ASD genetic testing scale. We measured both the beliefs and 
values dimensions of parents’ attitudes toward taking their children with ASD for 
genetic testing. Each dimension was measured using five items. The belief subscale uses 
a four-point Likert-type rating on one’s agreement levels ranging from strongly disagree 
to strongly agree, whereas the value subscale consists of a four-point Likert-type rating 
on the levels of importance (from not important at all to extremely important). Each 
belief item had a corresponding value item, and their respective scores were multiplied, 
creating five composite attitudes scores. 
Subjective norms scale. It refers to an individual's perception of what significant 
others think about him/her in performing the behavior (normative beliefs) and his/her 
motivation to comply with significant others’ beliefs concerning performing that 
behavior (Ajzen, 1991; Glanz et al., 2008). Each of these two scales was measured using 
nine items in this study. Normative beliefs were collected by asking parents their 
likelihood of compliance if their significant others suggested taking their affected 
children for ASD genetic testing; it was rated on a four-point Likert-type scale ranging 
from extremely unlikely to extremely likely. Motivation to comply was assessed by 
asking parents the extent to which they care about whether or not their significant others 
think they should take their affected children for ASD genetic testing. It was rated on a 
four-point Likert-type scale ranging from not at all to very much. Each subjective norm 
score was calculated by multiplying the total scores for an individual’s normative beliefs 
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by the total score for his/her motivation to comply, creating nine subjective norms 
composite scores. 
Self-efficacy scale. The six-item self-efficacy dimension of the POAGTS 
assesses parents’ confidence in taking their affected children for ASD genetic testing. 
Response options range from 0% (I am not confident at all) to 100% (I am 100% 
confident). 
Intention scale. Intention is an important predictor of a person’s motivation to 
perform a particular behavior. Specifically, in this study, we examined the parents’ 
intention to take their children with ASD for ASD genetic testing. This six-item scales 
used a four-point Likert-type rating ranging from extremely unlikely to extremely likely. 
Pretesting Phases of POAGTS 
In order to conduct an initial testing for the POAGTS, we adopted the procedures 
recommended by Dillman (Dillman, 2011) and DeVellis (DeVellis, 2016). We recruited 
participants from the Bryan/College Station area in Texas for the pilot study. A panel of 
seven (n = 7) experts, including a geneticist, an ASD behavior analyst, two social 
behavior specialists, two special education experts and one education psychologist, 
reviewed the preliminary version of the POAGTS and evaluated five aspects of the 
instrument: (1) whether the survey items were applicable to parents of children with 
ASD in the U.S.; (2) whether the survey items assessed the constructs of interest; (3) 
whether any survey items were redundant or should be eliminated; (4) whether any new 
survey items should be added; and (5) whether the overall design of the survey should be 
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improved. Only a few changes (i.e., content and format) were made based on these 
experts’ suggestions.  
To evaluate the cognitive and retrospective qualities of the POAGTS, we 
conducted seven cognitive interviews and five retrospective interviews in the 
Bryan/College Station area. The cognitive and retrospective interviews aimed to 
examine how participants perceive, understand, and interpret the survey questions 
(Dillman, 2011). A total of 12 items were reworded based on the participants’ comments 
and suggestions. Then, the POAGTS was administered to a small group of people, which 
allowed us to evaluate the survey instrument and procedure as well as identify any 
potential problems or difficulties (Dillman, 2011). Additionally, the pilot study helped us 
identify the patterns of missing data, examine the scales for their ability to measure the 
intended theoretical-based constructs, and determine whether particular items should be 
eliminated in the formal testing. Around 300 parents of children with ASD were invited 
by the Autism clinics or organization in Bryan/College Station for the pilot test, and 52 
of them completed the pilot survey. The final phase of pretesting involved evaluating 
each construct in the POAGTS to assess its validity and reliability. This evaluation 
contained examination of missing pattern, data distribution, internal consistency, and 
factor analysis. 
Participants 
Participants were recruited from the Interactive Autism Network (IAN; 
http://www.iancommunity.org), an online autism-focused longitudinal database and 
research registry with over 22,000 registered parents of children with ASD (Interactive 
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Autism Network, 2016). The diagnosis of ASD in the IAN database has been clinically 
validated and verified by medical records. Parents in the IAN database were selected 
using a random sampling method in STATA (StataCorp, 2009), and 4,673 parents were 
invited to participate in this study. One invitation email and three reminder emails were 
sent out to these parents. Each participant received a $10 Amazon electronic gift card 
once they completed the online survey. Qualtrics (http://www.qualtrics.com), a web-
based survey platform, was used to host the POAGTS online. All the research protocols 
for this study were approved by the Institutional Review Board (IRB) at Texas A&M 
University.    
The sample of the formal test consisted of 500 participants (response rate: 
10.70%). The data collection and analysis procedures for the formal test were in line 
with the pilot testing. Moreover, because (1) only a few changes were made to the 
formal test instrument based on the pilot test results, and (2) no statistically significant 
differences existed in the demographic characteristics and outcome measures between 
the pilot and formal tests, the samples for the pilot and formal tests were combined for 
data analysis, yielding a sample of 552 parents of children with ASD (52 from the pilot 
test + 500 from the formal test). Furthermore, 153 parents were excluded from the data 
analysis because (1) they have already taken their children for ASD genetic testing or (2) 
they did not indicate whether they have taken their children for ASD genetic testing or 
not. Therefore, the final sample size used in the following data analyses is 411.  
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Statistical Analysis 
Descriptive statistics (means, standard deviations, frequencies, and percentages) 
showed the data distribution. Internal consistencies (i.e., reliabilities) were evaluated 
using Cronbach’s alpha (α). A value of 0.7 or above was considered as adequate (Field, 
2009; Nunnally & Bernstein, 1978). The underlying factor of each scale was first 
examined by exploratory factor analysis (EFA). Oblique promax rotation method was 
used (Hendrickson & White, 1964). Only factors with eigenvalues larger than 1.25 were 
retained (Henson & Roberts, 2006). The factor loadings were considered as moderately 
high if they were larger than 0.30 and high if they were over 0.60 (Kline, 2014). Both 
reliabilities and EFA were performed in SPSS 22.0 (SPSS Inc., Chicago, IL). 
Confirmatory factor analysis (CFA) with the maximum likelihood estimation method 
with robust estimate (Muthén, 2010) was performed to check the construct validity by 
using Mplus 8.0 (Muthén & Muthén, Los Angeles, CA). The fit statistics of the models 
in the CFA were expressed in chi-square (χ2), root mean square error of approximation 
(RMSEA), comparative fit index (CFI), and standardized root mean square residual 
(SRMR). A CFI level above 0.95, a RMSEA value less than 0.06, and a SRMR smaller 
than 0.08 are recommended for a good fit (Hu & Bentler, 1999).  
Results 
Sample Characteristics 
Most of our participants were mothers (92.2%) and married (86.1%) with an 
average age of 44.0 years old (SD = 8.00). In term of race/ethnicity, respondents were 
predominately White/Caucasian (86.4%), 5.8% were Hispanic/Latino, 4.1% were 
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African American, 2.2% were Asian and the remaining were Multiple races. Over one-
fourth of parents (25.1%) had some college or technical school, and more than two-
thirds of the participants’ educational level was college graduate (42.8%) or advanced 
graduate degree (25.8%). For religious belief, 40.9% of parents were Non-Catholic 
Christian, 22.9% were Catholic, 26.8% were unaffiliated or nonbelievers, and 9.5% 
practiced other religions. More than half (58.6%) of parents’ annual income was more 
than $75,000. Regarding employment status, 62.5% of participants were employed, and 
27.3% were homemaker, and the remaining (10.2%) were other. Among their children 
with ASD, 404 (84.5%) were male, and 74 (15.5%) were female. The majority of 
children with ASD (74.5%) had private health insurance. For the type of ASD based on 
the text revision of the fourth edition of Diagnostic and Statistical Manual of Mental 
Disorders, 44.4% of these children had Autistic disorder, 29.5% had Pervasive 
Developmental Disorder-Not Otherwise Specified (PPD-NOS), 21.8% had Asperger 
syndrome, and the remaining 4.4% of these children had unknown diagnosis of ASD. 
The average age of diagnosis of children with ASD was 53.8 months (SD = 35.14).  
Reliability 
The internal consistencies of the scales within the POAGTS were tested utilizing 
the Cronbach’s α coefficients. Results showed Cronbach’s α coefficients ranged from 
0.73 (Perceived Barriers to ASD Genetic Testing) to 0.90 (Intention), suggesting strong 
internal consistencies (reliabilities) for the constructs/scales. Table 1 details the means, 
standard deviations, corrected item–total correlations, and Cronbach’s α for each 
construct as well as its corresponding items. 
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Table 1.1 Means, standard deviations, item-total correlations, and Cronbach’s alpha (α) coefficients for scales within the 
POAGTS 
 
Item Mean SD Item Total r 
Perceived Genetic Cause of ASD Scale (4 items) N = 411    
Response Scale: (1) Strongly Disagree, (2) Disagree, (3) Agree, (4) Strongly Agree    
How much do you agree or disagree with the following statements?    
1. ASD has a genetic factor 3.30 0.62 0.55 
2. ASD is caused by genes 2.90 0.67 0.68 
3. ASD is associated with family history 2.93 0.64 0.69 
4. ASD is an inherited disorder 2.76 0.69 0.69 
Scale (total score) 11.88 2.12  
Internal Consistency (Cronbach’s α) 0.83   
Perceived Severity Scale (6 items) N = 411    
Response Scale: (1) Strongly Disagree, (2) Disagree, (3) Agree, (4) Strongly Agree    
How much do you agree or disagree with the following statements?    
1. ASD is a severe disorder 3.02 0.79 0.49 
2. Individuals with ASD have problems living independently   3.03 0.71 0.59 
3. The public discriminates against individuals with ASD 3.21 0.68 0.42 
4. Individuals with ASD have fewer job opportunities 3.46 0.65 0.49 
5. Compared to a child without ASD, it’s hard to raise a child with ASD 3.48 0.68 0.49 
6. Health problems associated with ASD are severe 2.53 0.78 0.41 
Scale (total score) 18.73 2.84  
Internal Consistency (Cronbach’s α) 0.74   
Perceived Benefits of ASD Genetic Testing Scale (6 items) N = 411    
Response Scale: (1) Strongly Disagree, (2) Disagree, (3) Agree, (4) Strongly Agree
  
   
How much do you agree or disagree with the following statements?    
1. ASD genetic testing identifies the cause of children’s ASD 2.38 0.69 0.35 
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Table 1.1 
Continued 
 
Item Mean SD Item Total r 
2. ASD genetic testing promotes early detection and intervention for children with 
ASD 
2.92 0.65 0.68 
3. ASD genetic testing helps develop treatment plans targeting ASD-associated 
medical conditions for affected children 
2.88 0.66 0.67 
4. ASD genetic testing helps children with ASD make informed family planning 
decisions 
2.81 0.70 0.58 
5. ASD genetic testing helps children with ASD get more social support 2.55 0.78 0.57 
6. Taking children with ASD to undergo ASD genetic testing contributes to ASD 
research 
3.36 0.57 0.30 
Scale (total score) 16.90 2.80  
Internal Consistency (Cronbach’s α) 0.78   
Perceived Barriers of ASD Genetic Testing Scale (9 items) N = 411    
Response Scale: (1) Strongly Disagree, (2) Disagree, (3) Agree, (4) Strongly Agree
  
   
How much do you agree or disagree with the following statements?    
1. ASD is not caused by genes 1.98 0.65 0.11 
2. ASD genetic testing cannot improve the current situation of my child(ren) 
diagnosed with ASD 
2.49 0.82 0.33 
3. My child(ren) has/have already been diagnosed with ASD, so there’s no need to 
undergo this testing 
2.07 0.73 0.53 
4. Taking my child(ren) with ASD to undergo ASD genetic testing contradicts 
with my religious or cultural beliefs. 
1.33 0.49 0.29 
5. ASD genetic testing does more harm than good 1.59 0.62 0.58 
6. ASD genetic testing can cause family conflicts 2.05 0.81 0.48 
7. The procedure of undergoing ASD genetic testing is uncomfortable for my 
child (i.e., drawing blood) 
2.73 0.93 0.30 
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Table 1.1 
Continued 
 
Item Mean SD Item Total r 
8. The results of ASD genetic testing can cause public discrimination against my 
child(ren) with ASD 
1.96 0.77 0.58 
9. The results of ASD genetic testing can put the health insurance status of my 
child(ren) with ASD in jeopardy 
2.19 0.88 0.48 
Scale (total score) 18.38 3.81  
Internal Consistency (Cronbach’s α) 0.73   
Attitudes Toward ASD Genetic Testing Scale – Product of Belief and Value     
1.Taking a child with ASD to undergo ASD genetic testing is a good thing 8.93 3.56 0.79 
2.Taking a child with ASD to undergo ASD genetic testing is beneficial 9.28 3.48 0.77 
3.Taking a child with ASD to undergo ASD genetic testing is necessary 6.18 3.83 0.84 
4.All children diagnosed with ASD should undergo ASD genetic testing 6.29 3.91 0.86 
5.All children with ASD characteristics or traits should undergo ASD genetic 
testing 
6.24 3.81 0.82 
Scale (total score) 36.91 16.43  
Internal Consistency (Cronbach’s α) 0.93   
Subjective Norms Scale – Product of Normative Belief and Motivation to Comply     
1.  Spouse   6.21 4.44 0.53 
2.  Your family members on your side 4.64 3.67 0.71 
3.  Your family members on your spouse’s side  3.25 2.82 0.63 
4.  Physicians 6.41 3.85 0.72 
5.  Health care professionals other than physicians (e.g., nurses, social workers,  
     occupational/ physical/ speech therapists, psychologists) 
6.04 3.82 0.74 
6.  School teachers  4.02 3.38 0.72 
7.  Your friends 3.47 2.93 0.73 
8.  Other parents of children with ASD 5.31 3.71 0.64 
9.  General public 2.84 2.43 0.60 
Scale (total score) 42.19 23.22  
Internal Consistency (Cronbach’s α) 0.90   
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Table 1.1 
Continued 
 
Item Mean SD Item Total r 
Self-Efficacy Scale (6 items) N = 411    
Response Scale: From 0% (I am not confident at all) to 100% (I am 100% confident)    
How confident are you…    
1. in finding a time to take your child(ren) with ASD for ASD genetic testing? 6.58 3.14 0.52 
2. that you can afford to take your child(ren) with ASD for ASD genetic testing?   3.88 3.39 0.56 
3. in finding a suitable hospital or doctor to take your child(ren) with ASD for 
ASD genetic testing?   
5.37 3.25 0.73 
4. that you can make an appointment with an ASD genetic testing provider to take 
your child(ren) with ASD for ASD genetic testing? 
5.20 3.29 0.78 
5. that you can figure out the health insurance for ASD genetic testing 4.00 3.37 0.70 
6. that your family members will support you in taking your child(ren) with ASD 
to undergo genetic testing for ASD?   
6.79 2.96 0.49 
Scale (total score) 31.83 14.61  
Internal consistency (Cronbach’s α) 0.85   
Intention Scale (6 items) N = 411    
Response Scale: (1) Extremely unlikely, (2) Unlikely, (3) Likely, (4) Extremely likely    
How likely are you to…    
1. organize your time to take your child(ren) with ASD to undergo ASD genetic 
testing? 
2.73 0.96 0.84 
2. pay out-of-pocket for ASD genetic testing for your child(ren) with ASD? 1.83 0.88 0.56 
3. make an appointment with an ASD genetic testing provider to take your 
child(ren) with ASD for ASD genetic testing? 
2.45 0.91 0.83 
4. contact the health insurance company about the cost of ASD genetic testing for 
your child(ren) with ASD? 
2.46 1.01 0.75 
5. obtain your family members’ support to take your child(ren) with ASD to 
undergo ASD genetic testing? 
2.32 0.97 0.60 
6. take your child(ren) with ASD to undergo ASD genetic testing? 2.49 0.91 0.85 
Scale (total score) 14.28 4.62  
Internal Consistency (Cronbach’s α) 0.90   
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Exploratory Factory Analysis (EFA) 
The Kaiser-Meyer-Olkin (KMO) analysis was conducted to examine the criteria 
of EFA for identifying the factor structure, The KMO index of these scale were ranging  
from 0.719 to 0.904, which is larger than 0.50 (Field, 2009; Hutcheson & Sofroniou, 
1999), indicating that the data set is suitable for EFA. The Bartlett’s test of sphericity 
was carried out to determine if there existed correlation among the items. All scales were 
found to be statistically significant (p < 0.001), indicated that the items correlation in 
each scale existed. Table 2 presented the items and factor loading for each scale. 
Perceived genetic cause of ASD scale. This scale consisted of four items, and 
all of them loaded onto a single factor. These four items accounted for 67.3% of the 
variance. The factor loadings were high and ranged from 0.732 to 0.843. As only one 
factor emerged, the rotation was not necessary. 
Perceived severity level of affected children scale. All of these six items loaded 
positively onto a single factor. The six perceived severity items accounted for 44.5% of 
the variance. The item of “The public discriminates against individuals with ASD” is a 
poor measure as its factor loading was 0.295. The factor loading of other five items 
ranged from 0.392 to 0.812. 
Perceived benefits of ASD genetic testing scale. The six items presented in this 
scale loaded onto one factor, which accounted for 48.6% of the total variance. The 
coefficients of the items in this single factor ranged from 0.442 to 0.831. 
Perceived barriers to ASD genetic testing scale. Two factors emerged from 
these nine items, accounting for 48.6% of the total variance. The first barriers subscale 
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Table 1.2 Factor loadings for exploratory factory analysis 
 
Item Factor 1 Factor 2 
Perceived Genetic Cause of ASD Scale (4 items) N = 411   
1. ASD has a genetic factor 0.732  
2. ASD is caused by genes 0.829  
3. ASD is associated with family history 0.839  
4. ASD is an inherited disorder 0.843  
Total variance explained = 65.94% 65.94%  
Perceived Severity Scale (6 items) N = 411   
1. ASD is a severe disorder 0.812  
2. Individuals with ASD have problems living independently   0.744  
3. The public discriminates against individuals with ASD 0.295  
4. Individuals with ASD have fewer job opportunities 0.392  
5. Compared to a child without ASD, it’s hard to raise a child with ASD 0.650  
6. Health problems associated with ASD are severe 0.686  
Total variance explained = 61.27% 44.25%  
Perceived Benefits of ASD Genetic Testing Scale (6 items) N = 411   
1. ASD genetic testing identifies the cause of children’s ASD 0.495  
2. ASD genetic testing promotes early detection and intervention for children with ASD 0.830  
3. ASD genetic testing helps develop treatment plans targeting ASD-associated medical conditions 
for affected children 
0.831  
4. ASD genetic testing helps children with ASD make informed family planning decisions 0.754  
5. ASD genetic testing helps children with ASD get more social support 0.726  
6. Taking children with ASD to undergo ASD genetic testing contributes to ASD research 0.442  
Total variance explained = 48.61%  48.61%  
Perceived Barriers of ASD Genetic Testing Scale (9 items) N = 411   
1. ASD is not caused by genes - 0.383 
2. ASD genetic testing cannot improve the current situation of my child(ren) diagnosed with ASD - 0.893 
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Table 1.2 
Continued 
 
Item Factor 1 Factor 2 
3. My child(ren) has/have already been diagnosed with ASD, so there’s no need to undergo this 
testing 
- 0.817 
4. Taking my child(ren) with ASD to undergo ASD genetic testing contradicts with my religious or 
cultural beliefs. 
0.304 - 
5. ASD genetic testing does more harm than good 0.618 - 
6. ASD genetic testing can cause family conflicts 0.693 - 
7. The procedure of undergoing ASD genetic testing is uncomfortable for my child (i.e., drawing 
blood) 
0.591 - 
8. The results of ASD genetic testing can cause public discrimination against my child(ren) with 
ASD 
0.794 - 
9. The results of ASD genetic testing can put the health insurance status of my child(ren) with 
ASD in jeopardy 
0.699 - 
Total variance explained = 48.58% 34.02% 14.56% 
Attitudes Toward ASD Genetic Testing Scale (5 items) N = 411   
1. Taking a child with ASD to undergo ASD genetic testing is a good thing 0.871  
2. Taking a child with ASD to undergo ASD genetic testing is beneficial 0.851  
3. Taking a child with ASD to undergo ASD genetic testing is necessary 0.897  
4. All children diagnosed with ASD should undergo ASD genetic testing 0.910  
5. All children with ASD characteristics or traits should undergo ASD genetic testing 0.888  
Total variance explained = 78.09% 78.09%  
Subjective Norms Scale – (9 items) N = 411   
1-1.  Spouse   0.615  
1-2.  My family members on my side 0.788  
1-3.  My family members on my spouse’s side  0.710  
1-4.  Physicians 0.781  
1-5.  Health care professionals other than physicians (e.g., nurses, social workers, occupational/ 
physical/ speech therapists, psychologists) 
0.805  
1-6.  School teachers  0.796  
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Table 1.2 
Continued 
 
Item Factor 1 Factor 2 
1-7.  My friends 0.808  
1-8.  Other parents of children with ASD 0.730  
1-9.  General public 0.692  
Total variance explained = 56.24% 56.24%  
Self-Efficacy Scale (6 items) N = 411   
7. in finding a time to take your child(ren) with ASD for ASD genetic testing? 0.650  
8. that you are able to afford to take your child(ren) with ASD for ASD genetic testing?   0.694  
9. in finding a suitable hospital or doctor to take your child(ren) with ASD for ASD genetic 
testing?   
0.841  
10. that you can make an appointment with an ASD genetic testing provider to take your child(ren) 
with ASD for ASD genetic testing? 
0.876  
11. that you can figure out the health insurance for ASD genetic testing 0.816  
12. that your family members will support you in taking your child(ren) with ASD to undergo 
genetic testing for ASD?   
0.618  
Total variance explained = 57.11% 57.11%  
Intention Scale (6 items) N = 411   
7. organize your time to take your child(ren) with ASD to undergo ASD genetic testing? 0.903  
8. pay out-of-pocket for ASD genetic testing for your child(ren) with ASD? 0.670  
9. make an appointment with an ASD genetic testing provider to take your child(ren) with ASD for 
ASD genetic testing? 
0.897  
10. contact the health insurance company about the cost of ASD genetic testing for your child(ren) 
with ASD? 
0.835  
11. obtain your family members’ support to take your child(ren) with ASD to undergo ASD genetic 
testing? 
0.702  
12. take your child(ren) with ASD to undergo ASD genetic testing? 0.910  
Total variance explained = 68.10% 68.10%  
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accounted for 34.0% of the total variance. Specifically, six of the nine items loaded 
positively onto this factor, exhibiting coefficients of .588 or higher, and measured 
potential harms that cause by ASD genetic testing. The remaining three items were 
found to relate to the second factor and accounted for approximately 14.6% of the total 
variance. These items addressed personal barriers that would inhibit one from taking 
their children for ASD genetic testing.   
Attitudes toward ASD genetic testing scale. The five items on the attitude scale 
loaded onto a single factor, accounting for 78.1% of the variance. The coefficient of each 
item was above 0.851. 
Subjective norms scale. A single factor emerged from the nine items on the 
subjective norm scale, accounting for 56.2% of the variance. All items displayed 
pattern/structure coefficients of 0.615 or higher. 
Self-efficacy scale. The six items presented in the self-efficacy scale merged into 
one component, and accounted for 57.1% of the total variance. The coefficients of the 
items were ranged from 0.618 to 0.876, indicating high factor loading. 
Intention scale. Six items in the intention scale loaded onto one component and 
accounted for 68.1% of the total variance.  The factor loadings were regarded as high, 
and ranged from 0.670 to 0.910. 
Confirmatory Factor Analysis (CFA) 
Perceived genetic cause of ASD scale. The original four items in the Perceived 
Genetic Cause Scale only yield a mediocre model fit (χ2 = 29.26, df = 2, p < 0.001, 
RMSEA = 0.18, CFI = 0.96, and SRMR = 0.032). The modification indexes indicated 
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that correlations existed between the error terms of item 1 (ASD has a genetic factor) 
and item 4 (ASD is an inherited disorder). We assume that these correlations reflected 
non-random measurement errors due to the overlap of content. The finalized model fit 
improved (χ2 = 1.07, df = 1, p = 0.30. RMSEA = 0.013, CFI = 1.00, and SRMR = 0.007). 
The standardized factor loadings ranged from 0.69 to 0.88. 
Perceived severity level of affected children scale. The original six-item model 
did not fit the specified factor model well (χ2 = 90.36, df = 9, p < 0.001, RMSEA = 0.15, 
CFI = 0.84, and SRMR = 0.061). According to the modification indices, two 
measurement error covariances were added in the factor model. Item 3 (The public 
discriminates against individuals with ASD) was correlated with item 4 (Individuals with 
ASD have fewer job opportunities), and Item 2 (Individuals with ASD have problems 
living independently) was correlated with item 5 (Compared to a child without ASD, it is 
hard to raise a child with ASD). Item 3 and item 4 reflected the negative effect of having 
ASD in the society, item 2 and item 5 reflected the hardship of raising children with 
ASD. Thus, we considered these correlated measurement errors represented the content 
overlap. The added measurement error covariances improved the one-factor model fit 
(χ2 = 14.25, df = 7, p = 0.047, RMSEA = 0.050, CFI = 0.99, and SRMR = 0.026). The 
standardized factor loadings were statistically significant, ranging between 0.38 and 
0.86.  
Perceived benefits of ASD genetic testing scale. The original six-item model of 
the Perceived Benefits Scale fits the one-factor model well (χ2 = 21.17, df = 9, p = 0.012, 
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RMSEA = 0.057, CFI = 0.98, and SRMR = 0.030). The standardized factor loadings 
were statistically significant, ranging between 0.35 and 0.82.  
Perceived barriers to ASD genetic testing scale. The original nine items in the 
Perceived Barriers Scale were not compatible with the two-factor model (χ2 = 155.11, df 
= 26, p < 0.001, RMSEA = 0.11, CFI = 0.82, and SRMR = 0.06). Two measurement 
error covariances were added in the specified model based on the modification indices: 
(1) item 4 (Taking my child(ren) with ASD to undergo ASD genetic testing contradicts 
with my religious or cultural beliefs.) was correlated with item 5 (ASD genetic testing 
does more harm than good); and (2) item 8 (The results of ASD genetic testing can cause 
public discrimination against my child(ren) with ASD) was correlated with item 9 (The 
results of ASD genetic testing can put the health insurance status of my child(ren) with 
ASD in jeopardy). As both item 4 and item 5 represented the harmfulness of ASD 
genetic testing and both item 8 and item 9 represented the negative effect after 
undergoing ASD genetic testing, we believe that the correlations between the errors 
terms indicated these items shared common factors. The added measurement errors 
improved the model fit (χ2 = 61.43, df = 24, p < 0.001, RMSEA = 0.062, CFI = 0.96, and 
SRMR = 0.040). All the standardized factor loadings were statistically significant. 
Attitudes toward ASD genetic testing scale. The original Attitudes Scale did 
not have a good fit (χ2 = 440.86, df = 5, p < 0.001, RMSEA = 0.46, CFI = 0.0.79, and 
SRMR = 0.087). Based on the modification indexes, two measurement error covariances 
need to be added in the model. The measurement error of item1 (Taking a child with 
ASD to undergo ASD genetic testing is a good thing) was correlated with the 
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measurement error of item 2 (Taking a child with ASD to undergo ASD genetic testing 
is beneficial), the error of item 4 (All children diagnosed with ASD should undergo ASD 
genetic testing) was correlated with item 5 (All children with ASD characteristics or 
traits should undergo ASD genetic testing). We reviewed the scale and found that both 
item 1 and item2, item 4 and item5 have shared similarity in terms of the content. The 
revised factor had a good fit model (χ2 = 3.95, df = 3, p = 0.27, RMSEA = 0.028, CFI = 
1.00, and SRMR = 0.006). This construct had statistically significant standardized factor 
loadings from 0.71 to 0.92. 
Subjective norms scale. The original Subject Norms Scale did not yield a good 
model fit (χ2 = 204.44, df = 27, p < 0.001, RMSEA = 0.126, CFI = 0.849, and SRMR = 
0.62). The modification indices indicated that items (item 1–Spouse was correlated with 
item 2–my family members on my side; item 1–Spouse was correlated with item 3–my 
family members on my spouse’s side; item 2–my family members on my side was 
correlated with item 3–my family members on my spouse’s side; and item 4–physician 
was correlated with item 5–health care professionals other than physicians [e.g., nurses, 
social workers, occupational/ physical/ speech therapists, psychologists]). Item 1, 2 and 
3 reflected the subjective norms from family member, and item 4 and 5 reflected the 
subjective norms from health care professional. As there were overlapping in terms of 
wording among item 1, item2, and item3 and between item 4 and item 5, the correlations 
among these errors terms were considered as non-random. The revised model has a good 
fit (χ2 = 60.90, df = 23, p < 0.001, RMSEA = 0.063, CFI = 0.97, and SRMR is 0.038). 
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This construct had statistically significant standardized factor loadings ranging from 0.49 
to 0.82. 
Self-efficacy scale. The original six-item Self-Efficacy Scale only had a 
mediocre model fit (χ2 = 99.58, df = 9, p < 0.001, RMSEA = 0.16, CFI = 0.92, and 
SRMR = 0.056). The modification indices indicated that item 1 (How confident are you 
in finding a time to take your child(ren) with ASD for ASD genetic testing?) was 
correlated with item 5 (How confident are you that you can figure out the health 
insurance for ASD genetic testing?) and that item 2 (How confident are you that you are 
able to afford to take your child(ren) with ASD for ASD genetic testing?) was correlated 
with item 6 (How confident are you that your family members will support you in taking 
your child(ren) with ASD to undergo genetic testing for ASD? ). The added 
measurement error covariances improved the model fit (χ2 = 13.99, df = 7, p = 0.051, 
RMSEA = 0.049, CFI = 0.99, and SRMR = 0.017). The standardized factor loadings 
ranged from 0.44 to 0.93. 
Intention scale. The original six items indicated a good model fit (χ2 = 16.05, df 
= 9, p = 0.066, RMSEA = 0.044, CFI = 1.00, and SRMR = 0.016). The standardized 
factor loadings were statistically significant ranging from 0.59 to 0.91. 
Summary of CFA. The original six-item perceived benefits and intention 
constructs yielded a good model fit verifying their construct validity. The remaining 
constructs were refined based on the modification indices and the redundancies among 
the correlated items. The above CFA results indicated that all the scales fit the models 
well and verified the structural model for each construct.  
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Discussion 
Due to elevated prevalence of ASD in the U.S., there is an increased trend for 
children diagnosed with ASD to be referred to genetic evaluation and testing. As ASD 
genetic testing has the potential to identify the etiology of ASD and to aid in early 
diagnosis as well as early treatment, it is essential to study factors that influence parents’ 
likelihood of taking their affected children for ASD genetic testing. This is the first study 
(to the best of our knowledge) using a theory-based survey instrument in measuring 
parents’ intention in taking their children for ASD genetic testing as well as its 
associated psychosocial factors in the U.S.; thus, it is important to validate the scales 
with this particular group.  
The POAGTS is reliable and valid in measuring parents’ intention in taking their 
children for ASD genetic testing, as indicated by the high α coefficients, inter-item 
correlations, model fit statistics of CFA, and correlation coefficient. Therefore, not only 
can the POAGTS be used in future research to measure parents’ intention in taking their 
children for genetic testing, the POAGTS also has several potential implications in the 
health behavior field, such as theory-based health intervention programs that help 
parents make informed decisions regarding ASD genetic testing and potentially enhance 
health outcomes for families of children with ASD.  
Results from the CFA indicated that the eight scales within the POAGTS fit the 
one-factor models well and verified the construct validity of each scale. However, 
correlated measurement errors need to be added to improve the construct validity for six 
out of the eight scales: perceived cause of ASD, perceived severity of ASD, perceived 
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barriers to ASD genetic testing, attitudes towards ASD genetic testing, subjective norms, 
and self-efficacy. This indicated that the correlated items in each of the six constructs 
shared some commonality, although each of which represents a different latent construct. 
For example, in the Subjective Norms Scale, the first three items were correlated with 
each other, suggesting that combining them into a single item (e.g., my family members) 
may be more appropriate. In addition, for items 4 (physicians) and 5 (other health care 
professionals), one may combine these two items into health care professionals. 
Researchers may consider revise these items in future studies.  
Along with the validation of the POAGTS, some limitations should be addressed. 
First, as the participants were recruited through the IAN online database, the 
generalizability of the findings may be limited to parents who have access to the 
Internet. Additionally, because most of our participants were White/Caucasian with high 
annual incomes, our findings may not represent families with minority backgrounds or 
with low social economic status. Utilization and testing of the POAGTS with more 
diverse samples and varied geographical settings are needed in future research. Second, 
the response rate in this study was relatively low; however, this low response rate is 
consistent with other studies that used the IAN database (Farmer et al., 2014; Masino et 
al., 2011; Wydeven et al., 2012). Third, as there was no access to the medical records of 
the participating parents’ children with ASD, their severity level could not be examined 
in this study. Future studies may consider using the children’s medical records to verify 
the severity level of ASD. Fourth, although all the constructs demonstrated a decent 
reliability, based on CFA, some factors in the original scales did not yield a good fit. 
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Thus, we revised and refined the scales within the POAGTS. More research may be 
needed to further improve the validity of this survey.  
As there has been limited research in developing survey instruments for parents’ 
intention regarding ASD genetic testing and examining its psychometric properties, the 
comparisons between our findings and those of past literature were not conduct. 
Therefore, further studies may be needed. Moreover, as evaluating psychometric 
properties of a new instrument requires more testing before it can be widely accepted for 
practice and research, we strongly encourage health behavior researchers to consider 
using the POAGTS to measure parents’ intention in taking their children for ASD 
genetic testing. 
The POAGTS developed and tested in this study is the first (to the best of our 
knowledge) survey instrument, based on the Health Belief Model, Theory of Planned 
Behavior, and Social Cognitive Theory, in assessing parents’ intention in taking their 
children for ASD genetic testing in the U.S. Not only can the POAGTS help health 
educators and heath behavior researchers examine factors associated with parents’ 
intention in ASD genetic testing, it may also serve as a useful tool in the implantations of 
theory-based interventions in helping children with ASD gain more access to ASD 
genetic services and improve their health outcome. 
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CHAPTER III 
PARENTS’ INTENTION TO TAKE THEIR CHILDREN DIAGNOSED WITH 
AUTISM SPECTRUM DISORDERS (ASD) FOR GENETIC TESTING: A 
STRUCTURAL EQUATION MODEL 
 
According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-
5), Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder with two major 
diagnostic criteria: impaired social communication and interaction ,as well as, restricted, 
repetitive patterns of behavior (American Psychiatric Association, 2013). The prevalence 
of ASD has increased drastically over the last decade in the U.S. (Centers for Disease 
Control and Prevention, 2016), which has drawn much attention among healthcare 
professionals, researchers, policy-makers, and the lay public (Schaefer & Mendelsohn, 
2013). Although our understanding of ASD etiology is still limited, genetic factors 
appear highly-related to ASD. The estimated heritability of ASD ranges from 50%-90% 
based on familial studies (Ozonoff et al., 2011; Rosti, Sadek, Vaux, & Gleeson, 2014; 
Sandin et al., 2014). The identified genetic components that are related to ASD 
phenotypes can be attributed to de novo single-nucleotide variants (SNVs; e.g., CHD8, 
DYRK1A) (de la Torre-Ubieta et al., 2016; Ronemus, Iossifov, Levy, & Wigler, 2014), 
copy number variants (CNVs; e.g., 16p11.2 dup, 16p11.2 del) (de la Torre-Ubieta et al., 
2016; Schaefer & Mendelsohn, 2013), and single-gene disorders (e.g., Fragile X, 
Tuberous sclerosis) (de la Torre-Ubieta et al., 2016).  
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Currently, ASD genetic testing is a genetic evaluation tool (Baker & Jeste, 2015; 
Schaefer & Mendelsohn, 2013; Shen et al., 2010; Zachor & Curatolo, 2014) 
recommended for children diagnosed with ASD in the U.S. (American Academy of 
Pediatrics, 2013; Barr & Millar, 2003; Hayeems et al., 2016; Schaefer & Mendelsohn, 
2013). Different genetic testing methods have been used for ASD genetic testing, such as 
chromosomal microarray analysis (CMA), Fragile X testing, G-banded karyotyping, and 
massively parallel sequencing (Myers & Johnson, 2007; Schaefer & Mendelsohn, 2013; 
Shen et al., 2010). Due to the complex nature of ASD, the overall diagnostic yield of 
ASD genetic testing for affected children is less than 40% (Roesser, 2011; Schaefer & 
Mendelsohn, 2013; Schaefer, Mendelsohn, Practice, & Committee, 2008; Shen et al., 
2010), thus, findings from the testing results may be limited and inconclusive. 
Nevertheless, ASD genetic testing has the potential to (1) help identify the genetic cause 
of ASD; (2) confirm diagnosis and facilitate access to needed health services; (3) 
estimate comorbid conditions, as well as (4) provide risk evaluation for the parents in 
terms of future family planning (Schaefer, 2016; Walsh et al., 2011). 
With the increased prevalence of ASD in the U.S., there is a growing trend for 
children with ASD to undergo testing. As primary caregivers for children with ASD, 
parents are likely to encounter the decision regarding whether to have their children 
undergo ASD genetic testing. Yet, utilization of ASD genetic testing for affected 
children is low in the U.S. (Cuccaro et al., 2014; Kiely et al., 2016; Narcisa et al., 2013; 
Wydeven et al., 2012). There are studies examining factors that may be associated with 
underutilization of ASD genetic testing; however, parental intention to test is largely 
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unknown. Without knowing parental test-taking intention, and underlying psychosocial 
factors, healthcare providers will not be able to understand parents’ perspectives 
regarding ASD genetic testing; provide tailored support and education for this group; 
and, ultimately, improve health outcomes for affected children. Therefore, it is 
imperative to examine how parents of children with ASD perceive ASD genetic testing, 
as well as how psychosocial factors influence their test-taking intention.  
We adapted three health behavior models/theories in guiding this research study: 
(1) Health Belief Model (Janz & Becker, 1984; Rosenstock et al., 1988), (2) Theory of 
Planned Behavior (Ajzen, 1991; Ajzen et al., 2012), and (3) Social Cognitive Theory 
(Bandura, 1986, 2011; Glanz et al., 2008; Luszczynska & Schwarzer, 2005). These 
models/theories are useful theoretical frameworks for predicting and explaining 
determinants of health behavior in genetic testing (Bunn et al., 2002; Doukas et al., 
2004; Gooding et al., 2006; Lagos et al., 2008; Levine et al., 2010; Miller et al., 1996; 
Sagi et al., 1992; Sweeny, Ghane, Legg, Huynh, & Andrews, 2014; Vainio & Miller, 
2003). The purpose of this study, then, is to examine the psychosocial factors associated 
with parental intention to have their children diagnosed with ASD undergo genetic 
testing. 
Methods 
Survey Design 
Based on previous genetic testing literature utilizing the three selected health 
behavior models/theories (Bunn et al., 2002; Doukas et al., 2004; Gooding et al., 2006; 
Lagos et al., 2008; Levine et al., 2010; Miller et al., 1996; Sagi et al., 1992; Sweeny et 
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al., 2014; Vainio & Miller, 2003), we developed a web-based survey to assess 
psychosocial factors related to parental intention to take their affected children for ASD 
genetic testing. Once an initial draft was completed, a geneticist, an ASD behavior 
analyst, two social behavioral specialists, two special education experts and one 
educational psychologist reviewed the survey items for content validity. Based on these 
experts’ suggestions, the survey was revised and then pre-tested with a community-
based sample in the Bryan/College Station, Texas area. A total of 52 parents completed 
the pilot test. Participating parents’ feedback was incorporated into the final draft of the 
survey, which was deployed using Qualtrics, a web-based survey platform, as part of a 
formal test. Participants from the Interactive Autism Network completed the 20-minute 
survey anonymously. All the research protocols for this study were approved by the 
Institutional Review Board at Texas A&M University.    
Measurement 
The web-based survey contained subscales measuring: (1) perceived cause of 
ASD; (2) perceived severity of ASD; (3) perceived benefits of ASD genetic testing; (4) 
perceived barriers to ASD genetic testing; (5) parental intention to take affected children 
for ASD genetic testing; (6) parental attitudes towards ASD genetic testing; (7) parental 
subjective norms; (8) parental self-efficacy; (9) demographic information; and (10) 
covariates (i.e., knowledge of ASD genetic testing and family health history of ASD). 
The internal consistency and construct validity for each construct were examined using 
Cronbach’s alpha and confirmatory factor analysis, respectively. Cronbach’s alpha 
values larger than 0.7 indicated good reliability for each construct. For construct validity, 
 35 
 
a root mean square error of approximation (RMSEA) less than 0.08; comparative fit 
index (CFI) larger than 0.95; and standardized Root Mean Residual (SRMR) less than 
0.08 indicated a good model fit for each construct (Hu & Bentler, 1999). Table 1 
contains the Cronbach’s alpha values and model fit indices for each construct. 
Perceived genetic cause of ASD. This is a four-item scale that assesses whether 
parents believe the genetic etiology of ASD, in other words, their children’s ASD is 
caused by genes. We used a four-point Likert-type rating scale ranging from “strongly 
disagree” to “strongly agree.” The results of CFA emerged as a one-factor model and a 
composite score was calculated for this construct. 
Perceived severity level of affected children. We assessed parents’ perceptions 
of how harmful ASD is to their affected children and family using six items. These items 
were rated on a four-point Likert-type scale ranging from “strongly disagree” to 
“strongly agree.” A single-factor model emerged from CFA and a composite score was 
generated for this construct. 
Perceived benefits of ASD genetic testing. We evaluated parents’ appraisal of 
the value of taking their affected children for ASD genetic testing (e.g., early detection 
and intervention, family planning). Perceived benefits were evaluated using six items on 
a four-point Likert-type scale ranging from “strongly disagree” to “strongly agree.” The 
results of CFA indicated that these six items measured a unidimensional factor and a 
composite score was computed for the perceived benefits construct in the model 
analysis. 
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Table 2.1 Reliability and construct validity of constructs 
 
Constructs 
# of 
items 
Cronbach’s 
alpha 
χ2 df p RMSEA CFI SRMR 
Perceived Genetic Cause of ASD 4 0.83 1.07 1 0.30 0.013 1.00 0.007 
Perceived Severity Level of Affected 
Children  
6 0.74 14.25 7 0.047 0.050 0.99 0.026 
Perceived Benefits of ASD Genetic Testing 6 0.78 21.17 9 0.012 0.057 0.98 0.030 
Perceived Barriers from Parents’ Personal 
Belief 
3 0.56 
61.43 24 <0.0001 0.062 0.96 0.040 
Perceived Barriers due to Potential Harms 
Caused by ASD Genetic Testing 
6 0.72 
Attitudes toward ASD Genetic Testing 5 0.93 3.95 3 0.27 0.028 1.00 0.006 
Subjective Norms 9 0.90 60.90 23 <0.0001 0.063 0.97 0.038 
Self-Efficacy 6 0.85 13.99 7 0.051 0.049 0.99 0.017 
Intention in Taking Children with ASD for 
ASD Genetic Testing 
6 0.90 16.05 9 0.066 0.044 1.00 0.016 
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Perceived barriers to ASD genetic testing. We measured parental perceptions 
concerning potential obstacles to ASD genetic testing. The subscale contained nine 
items, and each item was rated on a four-point Likert-type scale ranging from “strongly 
disagree” to “strongly agree.” The nine items loaded onto two factors: (1) perceived 
barriers from parents’ personal beliefs (3 items, e.g., ASD genetic testing cannot 
improve the current situation of my child(ren) diagnosed with ASD) and (2) perceived 
barriers due to potential harms caused by ASD genetic testing (6 items, e.g., ASD 
genetic testing does more harm than good). Total scores were calculated for each factor 
of the perceived barriers construct. 
Attitudes toward ASD genetic testing. A person’s attitudes are a function of 
his/her beliefs about performing a particular behavior and his/her evaluation (values) 
concerning the behavior (Ajzen, 1991). The belief and value attitudinal dimensions were 
measured using five items each. The belief items (e.g., taking a child with ASD to 
undergo ASD genetic testing is necessary) were rated on a four-point Likert-type scale 
ranging from “strongly disagree” to “strongly agree,” whereas value items ranged from 
“not important at all” to “extremely important.” Each belief item had a corresponding 
value item, and their respective scores were multiplied, creating five composite attitude 
scores. CFA results suggested that the five composite attitude scores measured a one-
factor model. Thus, the attitudes variable utilized in further model analysis was created 
by summing the five composite attitude scores. 
Subjective norms. This construct refers to an individual's perception of what 
other people think about him/her in performing a behavior (normative beliefs) and 
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his/her motivation to comply with their assessment (Ajzen, 1991; Glanz et al., 2008). In 
this study, normative beliefs (nine items) were evaluated by asking parents the likelihood 
of their compliance if others (e.g., spouse, friends, physicians) suggested they take their 
affected children for ASD genetic testing. Motivation to comply (nine items) was 
assessed by asking parents how much they care about whether others think they should 
take their affected children for testing. Four-point Likert-type scales ranging from 
“extremely unlikely” to “extremely likely,” and from “not at all” to “very much” were 
used to rate the two subscales, respectively. Each item in the normative beliefs domain 
had a corresponding item in the motivation to comply domain. These respective scores 
were multiplied, creating nine composite subjective norms scores. The CFA results 
indicated that the nine composite subjective norms scores yielded a one-factor model. 
The sum of the nine composite scores was used as the subjective norms scores in further 
model analysis. 
Self-efficacy. In this study, self-efficacy refers to parents’ confidence in their 
ability to go through with taking their affected children for ASD genetic testing. This 
construct was measured by six items, and the response for each item ranged from 0 (0% 
or “not confident at all”) to 10 (100% confident). The CFA results showed that these six 
items measured a one-factor self-efficacy model. Accordingly, we used the sum of the 
scores on the six items as the self-efficacy variable in the model analysis. 
Intention in taking children with ASD for ASD genetic testing. Parents were 
asked to rate their likelihood for taking their children for ASD genetic testing. It was 
measured by six items on a four-point Likert-type scale ranging from “extremely 
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unlikely” to “extremely likely.” The CFA results supported a one-factor model. An 
intention score was computed by summing the six items. 
Participants 
We initially conducted a pilot of the web-based survey with a community-based 
sample of parents of children with ASD in the Bryan/College Station, Texas area (n=52). 
Participants were then recruited from the Interactive Autism Network (IAN), an online 
autism-focused longitudinal database and research registry with over 22,000 registered 
parents of children with ASD (Interactive Autism Network, 2016)  
(http://www.iancommunity.org). Families in the IAN database were selected using a 
random sampling method in STATA (StataCorp, 2009), and 4,673 parents were invited 
to participate. One invitation email and three reminder emails were sent out to these 
parents. Each participant received a $10 Amazon.com electronic gift card once they 
completed the online survey. A total of 500 participants responded to our online survey 
during the formal pilot (response rate = 10.7%). Pilot test sample data was combined 
with that of the formal test sample for data analysis because (1) only a few changes were 
made to the formal test instrument based on the informal pilot results, and (2) no 
statistically-significant differences existed in sociodemographic characteristics and 
outcome measures between these samples. Two groups of parents (n=153) were 
excluded from the data analysis: (1) parents whose children had previously received 
ASD genetic testing and (2) parents who did not indicate whether their children received 
ASD genetic testing at some time point (i.e., it was unclear whether their children had 
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previously undergone testing). Therefore, the final sample size for the aggregated data 
was 411 parents. 
Data Analysis 
Descriptive statistics were compiled using SPSS 22.0 (SPSS Inc., Chicago, IL) 
for the distributions of parent survey responses, as well as univariate and multivariate 
normality. We then utilized Mplus 8.0 (Muthén & Muthén, Los Angeles, CA) to develop 
a structural equation model (SEM), which applied a maximum likelihood estimation 
method with robust standard errors to examine relationships among factors associated 
with parental intention to take their affected children for ASD genetic testing. The 
dependent variables in the model (i.e., attitudes, self-efficacy, and intention) were 
adjusted using sociodemographic variables (i.e., parents’ race/ethnicity, annual income) 
and covariates (i.e., family health history of ASD and knowledge of ASD genetic 
testing) that were statistically- significantly correlated to them. The SEM model fit was 
evaluated using the chi-square fit statistics (χ2), CFI, RMSEA, and SRMR. Generally, a 
RMSEA less than 0.08, a CFI larger than 0.95, and a SRMR less than 0.08, indicate that 
the model fit the data well (Hu & Bentler, 1999). 
Results 
Sample Characteristics 
Tables 2 and 3 present detailed descriptive statistics for the sociodemographic 
variables of the 411 parents of children with ASD in the sample, as well as those of their 
children. Participants were predominantly mothers (92.2%) and married (83.2%) with an 
average age of 44.0 years (SD = 8.00 years). Most of the participants identified as  
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Table 2.2 Sociodemographic characteristics of participating parents of children with 
ASD (N=411) 
 
Variable N (%) 
Gender   
 Male 32 7.8% 
 Female 379 92.2% 
Race/Ethnicity     
 White/Caucasian 355 86.4% 
 Hispanic/Latino 24 5.8% 
 Black/African American 17 4.1% 
 Asian 9 2.2% 
 Multiple races 6 1.5% 
Education Level   
 High school graduate or below 26 6.3% 
 Some college or technical school 103 25.1% 
 College graduate 176 42.8% 
  Advanced graduate degree 106 25.8% 
Marital Status   
 Married/Living as married 342 83.2% 
 Divorced/Separated/Widowed 48 11.7% 
 Never been married/Single 21 5.1% 
Plan to Have Children     
 No 382 92.9% 
 Yes 29 7.1% 
Annual Income     
 < $20,000 26 6.3% 
 $20,000 to <$35,000 25 6.1% 
 $35,000 to <$50,000 42 10.2% 
 $50,000 to <$75,000 77 18.7% 
  $75,000 or more 241 58.6% 
Current Employment Status   
 Employed 257 62.5% 
 Homemaker 112 27.3% 
  Other 42 10.2% 
Religion     
 Non-Catholic Christian  168 40.9% 
 Catholic 94 22.9% 
 Unaffiliated/None 110 26.8% 
 Other 39 9.5% 
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Table 2.2 
Continued 
 
Variable N (%) 
Number of Children 
 One 73 17.8% 
 Two  209 50.9% 
 Three 81 19.7% 
  Four or more 48 11.7% 
Numbers of Children with ASD 
 One 351 85.4% 
 Two or more 60 14.6% 
Family History of ASD   
 No 268 65.2% 
  Yes 140 34.1% 
 Missing 3 0.7% 
  Mean (SD) Range 
Age 44.0 (8.00) 25-68 
 
Note. SD = standard deviation. 
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Table 2.3 Demographic characteristics of participating parents’ children with ASD 
(N=478) 
 
Variable N (%) 
Gender   
 Male 404 84.5% 
  Female 74 15.5% 
 Type of ASD   
 Autistic disorder 212 44.4% 
 PDD-NOS 141 29.5% 
 Asperger syndrome 104 21.8% 
 I don't know or I am not sure 21 4.4% 
Children's Health Insurance When Diagnosed   
 Private Health Insurance 370 77.4% 
 Medicaid 72 15.1% 
 Military 22 4.6% 
 State Children's Health Insurance 25 5.2% 
 Medicare 7 1.5% 
 The child(ren) did not have health insurance. 4 0.8% 
 Other 7 1.5% 
Children's Current Health Insurance   
 Private Health Insurance 356 74.5% 
 Medicaid 159 33.3% 
 Military 16 3.3% 
 State Children's Health Insurance 28 5.9% 
 Medicare 15 3.1% 
 Medigap 3 0.6% 
 The child(ren) does/do not have health insurance. 3 0.6% 
  Other 1 0.2% 
  Mean (SD) Range 
Mother’s Age at Child’s Birth (Year)  30.3 (5.54) 17-46 
Father’s Age at Child’s Birth (Year) 32.8 (6.73) 17-58 
Diagnosis Age for the Affected Children (Month) 53.8 (35.14) 11-264 
Current Age of Children with ASD 13.25 (5.48) 2-27 
 
Note. PDD-NOS = pervasive developmental disorder not otherwise specified; SD = 
standard deviation. 
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White/Caucasian (86.4%), 5.8% Hispanic/Latino, 4.1% African American, and 2.2% 
Asian; the remaining 1.5% were multi-racial. Parents’ annual income was categorized as 
less than $20,000 (6.3%); between $20,000 and less than $35,000 (6.1%); between 
$35,000 and less than $50,000 (10.2%); between $50,000 and less than $75,000 
(18.7%); and more than $75,000 (58.6%). More than one-third of parents (34.1%) 
reported family histories of ASD. The average age at diagnosis for their children with 
ASD was 53.8 months (SD = 35.14 months).  
Measurement Variables in the Model 
Table 4 presents the descriptive statistics, numbers of items, possible score 
ranges, and interpretations of the scores for each construct. In general, parents believed 
in a strong genetic etiology of ASD; perceived that their affected children had severe 
ASD; and considered ASD genetic testing to be beneficial. Their perceived barriers and 
self-efficacy in taking their children for ASD genetic testing were just above average, 
suggesting they experienced moderate barriers and had moderate confidence in having 
their affected children for testing. Their responses concerning their attitudes toward 
taking their children for ASD genetic testing and their subjective norms were below 
average, indicating that they tended to have negative attitudes towards ASD genetic 
testing and low subjective norms. Paradoxically, more than half (51.1%) of parents 
indicated that they were either “likely” (37.7%) or “extremely likely” (13.4%) to take 
their affected children for ASD genetic testing. 
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Table 2.4 Interpretation and measurement of variables in the structural model 
 
Variable Mean SD 
Possible 
Score Range 
No. of 
Items 
Interpretation 
Perceived Genetic Cause of ASD 11.88 2.12 4 - 16 4 Higher score = more perceived genetic cause of ASD 
Perceived Severity of ASD 18.73 2.84 6 - 24 6 Higher score = more perceived severity of ASD 
Perceived Benefits of ASD 
Genetic Testing 
16.91 2.79 6 - 24 6 Higher score = more perceived benefits of ASD 
genetic testing 
Perceived Barriers from Parents’ 
Personal Beliefs 
6.54 1.61 3 - 12 3 Higher score = more perceived barriers due to 
personal beliefs 
Perceived Barriers due to 
Potential Harms  
11.84 2.98 6-24 6 Higher score = more perceived barriers due to 
potential harms caused by ASD genetic testing 
Attitudes toward ASD Genetic 
Testing 
36.91 16.43 5 - 90 6 Higher score = more positive attitudes toward ASD 
genetic testing 
Subjective Norms  42.19 23.22 9 - 144 9 Higher score = more influence from significant others 
regarding taking their affected children for testing 
Self-efficacy  31.83 14.61 0 - 60 6 Higher score = more confidence in taking their 
children with ASD for ASD genetic testing 
Intention in Taking Children with 
ASD for ASD Genetic Testing 
14.28 4.62 6 - 24 6 Higher score = higher intention to take their children 
with ASD for ASD genetic testing 
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Factors Associated with Parents’ Intention: Findings from the SEM 
Figure 1 presents the final model regarding parental intention to take their 
children diagnosed with ASD for ASD genetic testing and associated factors (e.g., 
attitudes, subjective norms, self-efficacy, intention). Although the overall model chi-
square value was statistically significant (χ2[df = 7] = 22.48, p = 0.0021), the other fit 
indices (CFI = 0.971, RMSEA = 0.073, and SRMR = 0.014) suggest an adequate fit of 
the proposed model to the survey data. Furthermore, variables in the full model explain 
51.1% of the variance in parental intention in taking their children for ASD genetic 
testing.  
Parental attitudes towards taking their affected children for ASD genetic testing 
were significantly and positively influenced by perceived severity of their children’s 
ASD (B = 0.71, p < 0.05); perceived benefits of ASD genetic testing (B = 1.37, p < 
0.001); and subjective norms (B = 0.16, p < 0.001). In contrast, parental attitudes were 
significantly and negatively associated with perceived barriers due parents’ personal 
beliefs about testing (B = -2.72, p < 0.001) and perceived potential harms resulting from 
testing (B = -1.13, p < 0.001). Thus, parents who perceived that their children’s ASD 
was more severe; positive benefits from testing; and/or reported significant others who 
provided positive support for testing had more positive attitudes towards taking their 
affected children for testing. Those parents reporting negative attitudes towards ASD 
genetic testing had negative personal beliefs about testing and perceived greater potential 
harms from testing. Further, parental attitudes towards ASD genetic testing varied 
significantly by race/ethnicity. Specifically, Hispanic/Latino parents reported more
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Figure 2.1 Structural equation model for parents’ intention in taking their children with ASD for ASD genetic testing and 
associated factors (N = 411) 
 
Notes: Standardized parameter estimates of the path coefficients were identified with asterisks for statistical significance (*p < 
0.05, **p < 0.01, ***p < 0.001); socio-demographic variables were dummy-coded (family health history of ASD: No = 0, Yes = 
1; race/ethnicity: White/Caucasian = 0, Hispanic/Latino = 1) 
1.42* -0.68*** 
0.15*** 
-0.14* 
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positive attitudes towards ASD genetic testing (B = 5.38, p < 0.05) compared to their 
White/Caucasian counterparts. 
Parental knowledge of ASD genetic testing and annual income were significantly 
and positively associated with self-efficacy. Those parents with greater knowledge of 
ASD genetic testing (B = 1.81, p < 0.01) and higher incomes (B = 2.04, p < 0.001) 
reported stronger confidence in their ability to secure testing for their affected children. 
Parents who reported having supportive significant others were also more confident in 
their ability to secure ASD genetic testing (B = 0.15, p < 0.001). Additionally, parental 
race/ethnicity was significantly and highly-positively associated with parental self-
efficacy. Hispanic/Latino parents’ responses (B = 6.24, p < 0.05) indicated substantially 
higher confidence in their ability to secure testing for their affected children than 
White/Caucasian parents. In contrast, perceived potential harms due to ASD genetic 
testing were significantly and negatively associated with parental self-efficacy (B = -
1.18, p < 0.001). The perception that their affected children might be harmed by ASD 
genetic testing was a barrier to parents’ confidence that they could take their affected 
children for testing.  
SEM results indicated that parental intention was significantly and positively 
associated with their attitudes (B = 0.048, p < 0.001), subjective norms (B = 0.050, p < 
0.001), and self-efficacy (B = 0.090, p < 0.001). Parents who reported positive overall 
attitudes (values and beliefs), supportive significant others, and confidence in acquiring 
testing for their children had greater intention to take their affected children for ASD 
genetic testing. Conversely, parents who reported greater perceived barriers associated 
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with personal beliefs (B = -0.68, p < 0.001) and higher potential harms (B = -0.14, p < 
0.05) were significantly less likely to report intentions to test. SEM findings also 
revealed racial/ethnic differences in parental testing intention. Hispanic/Latino parents 
were more likely to take their children for ASD genetic testing (B = 1.41, p < 0.05) 
compared to White/Caucasian parents.  
Discussion 
To the best of our knowledge, this is the first study to examine parental intention 
to take children with ASD for ASD genetic testing and relationships among associated 
factors. SEM findings suggest a good model fit between our health behavior model and 
survey data. Our final model indicates that participants’ intention was significantly and 
positively associated with their attitudes, subjective norms, and self-efficacy. Their 
attitude towards ASD genetic testing was also correlated with their perceived severity of 
ASD, perceived benefits of ASD genetic testing, and subjective norms. Overall, we 
found significant associations among the key constructs from the three health behavior 
models/theories and our SEM had high predictability and accounted for a large amount 
of variance in parental intention to test.  
Our findings provide the underpinning for several recommendations for 
healthcare professionals and health behavior researchers in terms of counseling and 
educating parents about ASD genetic testing. First, parents’ subjective norms were 
positively correlated with their attitudes toward ASD genetic testing, self-efficacy, and 
intention to take their children diagnosed with ASD for testing. This finding provides 
evidence of the extent to which significant others influence parental attitudes, self-
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efficacy and intention regarding ASD genetic testing. Specifically, more than one-half of 
parents mentioned that they are “likely” or “extremely likely” to follow physicians’ 
recommendations regarding whether to have their children tested. Yet, previous studies 
revealed that most physicians did not refer parents to see genetic professionals 
(Wydeven et al., 2012), and lacked genomic competencies (Hayeems et al., 2016). As 
such, physicians need to understand their role in parents’ seeking genetic services for 
their affected children and provide the necessary recommendations or information on 
ASD genetic testing. 
Second, parents’ perceived barriers due to perceptions concerning potential 
harms caused by ASD genetic testing were significantly and negatively correlated with 
their attitudes, self-efficacy, and intention. The two major barriers under this domain 
were their perceptions that: (1) undergoing the ASD genetic testing procedure is 
uncomfortable for their children; and (2) ASD genetic testing results can place their 
children’s health insurance status in jeopardy. Additionally, parents’ perceived barriers 
from their personal beliefs were negatively related to their attitudes and intention. The 
major barrier under this domain related to parents’ belief that undergoing ASD genetic 
testing would not improve their children’s lives. To alleviate these barriers, genetic 
counselors and genetic testing providers should consider providing information about the 
procedures, health insurance coverage, limitations, and benefits of ASD genetic testing 
to parents and healthcare providers. Future health education and promotion interventions 
aimed at increasing utilization of ASD genetic testing can also target these three barriers. 
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Third, parents’ self-efficacy in taking their affected children for testing was 
positively associated with their knowledge of ASD genetic testing and annual income. 
Parents’ scores related to knowledge of ASD genetic testing were low, on average; yet, 
these same parents reported believing in a strong genetic etiology of ASD. Interestingly, 
this belief in a strong genetic etiology and their perceptions of a genetic cause of ASD 
do not appear to influence their attitudes towards ASD genetic testing. Researchers 
should consider examining the relationship between parental attitudes and perceived 
genetic causes of ASD, as well as the genetic literacy (Kindig, Panzer, & Nielsen-
Bohlman, 2004) of these parents. Genetic health education training programs are clearly 
needed to ensure that parents of children with ASD have better understanding of ASD 
genetic etiology and genetic testing. Such programs should consider tailoring their 
efforts so that they are culturally- and linguistically- appropriate, while also addressing 
any cultural or conceptual conceptions of ASD and ASD genetic testing that may impact 
intent and access to testing. Additional programs providing financial resources for ASD 
genetic testing may also be needed to prevent disparities in access to testing for low 
income families.  
While the current study provides the first health behavior model for parental 
intentions to take their children for ASD genetic testing, there are a few notable 
limitations. Like many research studies, generalizability of our results may be an issue. 
Many of our participants had moderately-high annual incomes and high educational 
attainment; thus, the results may be more representative for high socioeconomic status 
parents. Similarly, our sample was primarily comprised of mothers and parents who 
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identified as White/Caucasian, which may limit the generalizability of our study to 
fathers and minority parents. Future studies should consider targeted recruitment of 
fathers and minority participants, particularly minority males, to broaden our 
understanding of psychosocial and theoretical factors influencing their parental intention 
to take their children for ASD genetic testing and any differences in utilization of ASD 
genetic services. Additionally, the response rate for our online survey was 10.7%, which 
may be lower compared to that of mailed questionnaires (Kardia & Wang, 2005). 
However, our response rate was similar to that of other studies (Farmer et al., 2014; 
Masino et al., 2011; Wydeven et al., 2012) using the IAN online database.  
Our study has many strengths, particularly as a first theory-based investigation 
into factors associated with parental intention to have their children with ASD 
undergoing ASD genetic testing. Not only do our findings serve as an initial window to 
provide insights into parents’ intention to take their affected children for genetic testing, 
but they may also contribute to the development and evaluation of theory- and evidence-
based ASD genetic education interventions for parents of children with ASD. The result 
may be improved utilization of ASD genetic testing/services in the U.S. 
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CHAPTER IV 
UTILIZATION AND EXPERIENCES OF AUTISM SPECTRUM DISORDERS 
(ASD) GENETIC TESTING AMONG PARENTS OF CHILDREN WITH ASD 
 
Autism Spectrum Disorders (ASD) are neurodevelopmental disabilities 
characterized by difficulties in social, physical, and/or language skills/abilities (Gaugler 
et al., 2014). The prevalence of ASD in the United States (U.S.) has increased 120.6% 
since 2000 (Centers for Disease Control and Prevention, 2016) affecting about one in 68 
8-year-old children (Autism & Investigators, 2014; Christensen et al., 2016). Currently, 
the diagnosis of ASD is largely based on the evaluation of clinical developmental history 
and assessment of behavioral characteristics (Centers for Disease Control and 
Prevention, 2015; Walsh et al., 2011). Although the etiology of ASD is complex (Zachor 
& Curatolo, 2014) and still largely unknown, research has found multiple factors that 
may contribute to the development of ASD (Dawson & Rice, 2016; Hsiao, McBride, 
Chow, Mazmanian, & Patterson, 2012; Palmieri & Persico, 2010). One of which is 
genetic components (de la Torre-Ubieta et al., 2016; Gronborg, Schendel, & Parner, 
2013; Ronemus et al., 2014; Sandin et al., 2014), and hundreds of genes associated with 
ASD have been identified (Betancur, 2011; Devlin & Scherer, 2012; Tordjman et al., 
2014). As ASD genetic testing can identify certain ASD-associated genes, exclude other 
neurological conditions, identify co-morbid conditions, provide recurrence risk 
estimation and family planning (Walsh et al., 2011), it has been recommended as an 
evaluation tool after children’s diagnosis. The first-tier ASD genetic testing is 
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chromosomal microarray analysis (CMA) (Schaefer & Mendelsohn, 2013). Other 
methods of ASD genetic testing include but not limited to fragile X testing, G-banded 
karyotyping, and massively parallel sequencing (Myers & Johnson, 2007; Schaefer & 
Mendelsohn, 2013; Shen et al., 2010).  
With the increased prevalence of ASD in the U.S. as well as the advancement of 
genetics and genomic technology, the number of children with ASD who are referred to 
ASD genetic evaluation and testing can be expected to grow. Yet, the uptake rate of 
ASD genetic testing among children diagnosed with ASD is low in the US, ranging from 
27.8% - 41.2% based on previous studies (Cuccaro et al., 2014; Kiely et al., 2016; 
Narcisa et al., 2013; Wydeven et al., 2012). Several factors may be associated with the 
low utilization of ASD genetic testing for children with ASD, such as: (1) low 
recommendation or referral rate from health providers (Cuccaro et al., 2014; Wydeven et 
al., 2012); (2) lack of awareness in ASD genetic testing among parents (Wydeven et al., 
2012); (3) concerns about cost by parents (Cuccaro et al., 2014; Wydeven et al., 2012); 
and (4) lack of availability (Cuccaro et al., 2014). Yet, the findings of these studies were 
limited as they were generated from a convenience sample which focused only on the 
ASD population from several states in the US. Thus, there’s a need to re-examine the 
factors that associated with utilization of ASD genetic testing in a national sample. 
Moreover, as more parents take their ASD-affected children to undergo ASD 
genetic testing, parents’ experience with this testing may play a pivotal role in shaping 
their future perspectives and decisions regarding medical follow-ups and therapies for 
their children with ASD (Barr & Millar, 2003). While past literature (Cuccaro et al., 
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2014; Narcisa et al., 2013; Wydeven et al., 2012) has explored parents’ experience with 
ASD genetic testing in the U.S., these studies mainly focused on parents’ experiences 
receiving genetic referral from primary health care providers, and the type of ASD 
genetic testing their children received. None of the research in this area (to the best of 
our knowledge) has explored parents’ satisfaction with ASD genetic testing that their 
affected children received. Without such information, we may not be able to evaluate 
parents’ overall feelings regarding ASD genetic testing and provide feedback to ASD 
genetic testing providers. As a growing number of parents with affected children come 
into contact with genetic services, it is essential to have a clearer understanding of 
parents’ satisfaction with ASD genetic testing and to recognize the subsequent impacts. 
These insights may also assist ASD genetic testing healthcare providers in delivering 
more effective and timely support for families of children with ASD prior to, during, 
and/or after a genetic service appointment.  
Additionally, some ASD professionals were concerned about the usefulness of 
ASD genetic testing, and mentioned that ASD genetic testing may be useful only regard 
to familial ASD or ASD-related comorbidities (Hens et al., 2016). Although two 
previous qualitative studies (Giarelli & Reiff, 2015; Reiff et al., 2015) explored parents’ 
perceived usefulness of CMA, the findings of these two studies were limited as there 
was a lack of quantitative perspective and the studies overlooked parents’ perception of 
the usefulness on different types of ASD genetic testing. Parents’ perception of 
usefulness of ASD genetic testing may vary due to the different type of ASD genetic 
testing that their children received. The uncertainty of the cause of ASD for their 
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affected children as well as the low diagnosis yield of ASD genetic testing (Schaefer & 
Mendelsohn, 2013) may also have influenced parents’ perception of usefulness of ASD 
genetic testing. Thus, in this study, we also examine parents’ perception of usefulness of 
ASD genetic testing that their children received. 
To increase the utilization of ASD genetic testing, better serve parents of children 
with ASD in ASD genetic services as well as provide recommendations to ASD genetic 
testing health professionals in the U.S., it is imperative to examine the factors associated 
with the utilization of ASD genetic testing and explore parents’ experience regarding 
ASD genetic testing. Specifically, we seek to (1) examine whether parents’ and their 
children’s socio-demographic characteristics impact the uptake of ASD genetic testing, 
(2) report both parents’ satisfaction and perception of usefulness in taking their affected 
children to undergo ASD genetic testing, and (3) assess if socio-demographic 
characteristics and the covariates (i.e., type of testing their children received) influence 
parents’ satisfaction and perception of usefulness of ASD genetic testing. 
Methods 
Survey Instrument 
The Institutional Review Board (IRB) at Texas A&M University approved the 
research protocols for the present study, which is part of a larger research project that 
examined perceptions regarding ASD genetic testing among parents of children 
diagnosed with ASD in the U.S. In this study, we focused on parents’ experience 
regarding taking their children with ASD for ASD genetic testing. Participating parents’ 
experience with ASD genetic testing and socio-demographic information were collected 
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via online survey. The survey instrument was developed based on previous literature 
(Bunn et al., 2002; Doukas et al., 2004; Gooding et al., 2006; Lagos et al., 2008; Levine 
et al., 2010; Miller et al., 1996; Sagi et al., 1992; Vainio & Miller, 2003). To test the 
content validity, the survey was first reviewed by a geneticist, an ASD behavior analyst, 
a social behavioral specialist, as well as a special education expert and was revised based 
on their feedback. The pre-test for the revised survey took place in the Bryan/College 
Station area in Texas with seven parents of children with ASD for the cognitive 
interview and five parents for the retrospective interview. The survey was revised again 
based on the pre-test and then pilot tested online in the Bryan/College Station area with 
52 parents whose input was included in the final survey. Qualtrics, a web-based survey 
platform (http://www.qualtrics.com), was utilized to administer the online survey to 
participants in the pilot and formal tests. 
Participants 
We used the Interactive Autism Network (IAN; http://www.iancommunity.org) 
(Interactive Autism Network, 2016) to recruit prospective participants for the formal 
test, as the IAN consists of registry data from more than 22,000 parents of children with 
ASD diagnosis that has been clinically verified. A total of 4,673 parents in the IAN were 
selected and invited using a random sampling method in STATA (StataCorp, 2009). 
Five-hundred participants responded to our online survey (response rate = 10.7%, which 
is consistent with response rates reported in other studies that also utilized the IAN 
(Farmer et al., 2014; Masino et al., 2011; Wydeven et al., 2012)). The data from the pilot 
and formal tests were combined for data analysis as (1) there were no major differences 
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between the two versions of the survey instrument and (2) no statistical significance 
were found between the two tests in socio-demographic and outcome variables, yielding 
a final sample size of 552 parents of children with ASD.  
Data Analysis 
      Using descriptive statistics via SPSS 22.0 (SPSS Inc., Chicago, IL), the response 
distributions and univariate/multivariate normality were examined. Logistic regression 
analysis was used to assess the associations between the utilization of ASD genetic 
testing and parents’ and children’s social characteristics. The variables that were entered 
in the logistic regression were determined by examining the correlations between the 
outcome variable (utilization of ASD genetic testing) and the social demographic 
variables at P < 0.05. Pearson’s chi-square (χ2) tests were also conducted to assess the 
relationship (1) between parents’ satisfaction in their children’s ASD genetic testing and 
socio-demographic characteristics of the parents and their children as well as the type of 
testing their children received and (2) between parents’ perceived usefulness of ASD 
genetic testing toward their family and the covariates (the type of testing their children 
received) and socio-demographic characteristics (of parents and their children). Content 
analysis was utilized to explore the open-ended questions using NVivo 10 (QSR 
International, Victoria, AU). 
Results 
Socio-Demographic Characteristics 
The sample characteristics are shown in Table 1. Participants were residents in 
47 different states across the U.S., such as Texas (14.3%), California (7.2%), New York 
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Table 3.1 Sociodemographic characteristics of participating parents of children with 
ASD (N = 552) 
 
Variable N (%) 
Gender   
 Male 44 8.0% 
 Female 508 92.0% 
Race/Ethnicity     
 White/Caucasian 471 85.3% 
 Hispanic/Latino 33 6.0% 
 Black/African American 21 3.8% 
 Asian 13 2.4% 
 Multiple Races/Other 14 2.5% 
Education Status   
 High school graduate or below 32 5.8% 
 Some college or technical school 137 24.8% 
 College graduate 223 40.4% 
  Advanced graduate degree 160 29.0% 
Marital Status   
 Married/Living as married 450 81.5% 
 Divorced/Separated/Widowed 73 13.2% 
 Never married/Single/Other 29 5.3% 
Plan to Have Children     
 No 509 92.2% 
 Yes 43 7.8% 
Annual Income     
 < $20,000 36 6.5% 
 $20,000 to <$35,000 40 7.2% 
 $35,000 to <$50,000 54 9.8% 
 $50,000 to <$75,000 99 17.9% 
  $75,000 or more  323 58.5% 
Current Employment Status   
 Employed 347 62.9% 
 Homemaker 144 26.1% 
  Other 61 11.0% 
Religion     
 Non-Catholic Christian  229  41.5% 
 Catholic 123  22.3% 
 Unaffiliated/None 144 26.1% 
 Other 56 10.1% 
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Table 3.1 
Continued 
 
Variable N (%) 
Numbers of Children 
 One 103 18.7% 
 Two  275 49.8% 
 Three 116 21.0% 
  Four or more 58 10.5% 
Numbers of Children with ASD 
 One 467 84.6% 
 Two or more 85 15.4% 
Family history of ASD   
 No 361 65.4% 
  Yes 187 33.9% 
 Missing 4 0.7% 
Type of ASD in all the families   
 Asperger syndrome 120 21.7% 
 Autistic Disorder 264 47.8% 
 PPD-NOS 186 33.7% 
Awareness of ASD genetic testing   
 No 236 42.8% 
 Yes 301 54.5% 
 Missing 15 2.7% 
Heard ASD genetic testing from doctors   
 No 363 65.8% 
 Yes 189 34.2% 
Type of ASD genetic testing children received   
 Fragile X testing 49 39.5% 
 G-banded karyotype 4 3.2% 
 Chromosomal microarray analysis (CMA) 41 33.1% 
 Gene sequencing and deletion/duplication analysis 32 25.8% 
 Don't know or unsure 45 36.3% 
 Others 14 11.3% 
  Mean (SD) Range 
Age 43.8 (8.00) 25-68 
Knowledge of ASD genetic testing 2.50 (1.22) 0-6 
 
Note. SD = standard deviation. PDD-NOS = pervasive developmental disorder not 
otherwise specified
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(6.9%), Virginia (5.4%), Florida (4.9%), and Maryland (4.7%). The majority of 
participants were mothers (92.0%) and married (81.5%), with an average age of 43.8 
years old (SD = 8.00). In terms of race/ethnicity, most of the participants were 
White/Caucasian (85.3%), 6.0% were Hispanic/Latino, 3.8% were Black/African 
American, 2.4% were Asian and 2.5% were identified as multiple races or other race. 
Among the participating parents, 5.8% held high school diploma or below, 24.8% had 
some college degree, and the remaining 69.4% reported having a college degree or 
above. Over half of the parents (62.9%) were employed, and 26.1% were homemakers. 
In regards to annual income, 6.5% of the parents showed a family income of less than 
$20,000, 7.2% of the parents’ income ranged from $20,000 to $35,000, 9.8% of the 
parents’ income fell within the range of $35,000 – $50,000, 17.9% of the parents’ 
income was in the range of $50,000 – $75,000, and the remaining 58.5% were above 
$75,000. Almost two-thirds of the participating parents (63.8%) were either Catholic or 
Non-Catholic Christian, 26.1% were unaffiliated with any religion, and the remaining 
10.1% were other religions. Most parents (84.6%) only had one child with ASD. Table 2 
shows the socio-demographic characteristics of participating parents’ children with 
ASD. The majority (81.8%) were boys; 18.2% were girls. For the type of ASD, 44.9% of 
the children had Autistic disorder, 30.6% had pervasive developmental disorder not 
otherwise specified (PDD-NOS), and 19.7% reported Asperger syndrome. The average 
diagnosis age for the children with ASD was 52.8 months (SD = 34.80). 
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Table 3.2 Demographic characteristics of participating parents’ children with ASD 
(N=650) 
 
Variable N (%) 
Gender   
 Male 532 81.8% 
  Female 118 18.2% 
 Type of ASD   
 Autistic disorder 292 44.9% 
 PDD-NOS 199 30.6% 
 Asperger syndrome 128 19.7% 
 I don't know or I am not sure 31 4.8% 
Children's Health Insurance When Diagnosed   
 Private Health Insurance 502 77.2% 
 Medicaid 98 15.1% 
 Military 32 4.9% 
 State Children's Health Insurance 31 4.8% 
 Medicare 8 1.2% 
 The child(ren) did not have health insurance. 7 1.1% 
 Other 13 2.0% 
Children's Current Health Insurance   
 Private Health Insurance 481 74.0% 
 Medicaid 225 34.6% 
 Military 24 3.7% 
 State Children's Health Insurance 35 5.4% 
 Medicare 20 3.1% 
 Medigap 3 0.5% 
 The child(ren) does/do not have health insurance. 5 0.8% 
  Other 4 0.6% 
  Mean (SD) Range 
Mother’s Age at Child’s Birth (Year)  30.4(5.60) 17-56 
Father’s Age at Child’s Birth (Year) 32.7(6.68) 17-58 
Diagnosis Age for the Affected Children (Month) 52.8(34.80) 11-264 
Current Age of Children with ASD 13.10 (5.66) 1-30 
 
Note. PDD-NOS = pervasive developmental disorder not otherwise specified; SD = 
standard deviation. 
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Utilization of ASD Genetic Testing 
Our survey showed that 22.5% (n = 124) of the participating parents reported that 
their children had undergone ASD genetic testing. Among these participating parents, in 
regards to the type of ASD genetic testing the children received, 39.5% (n = 49) reported 
fragile X testing, 33.1% (n = 41) had taken their children for CMA, 25.8% (n = 32) was 
shown for gene sequencing and deletion/duplication analysis, 3.2% (n = 4) parents had 
taken their children undergone G-banded karyotype, and 36.3% of the parents (n = 45) 
were not sure which type of ASD genetic testing their children received. Some of the 
children had undergone more than one type of testing, and for parents with two or more 
affected children, their children may not have had the same type of testing. Thus, due to 
multiple selections, the cumulative frequency exceeds the number of parents who 
reported that they had taken their children to undergo ASD genetic testing (n = 124). We 
also asked parents’ awareness of ASD genetic testing, and 54.5% of them mentioned that 
they were aware of ASD genetic testing. About one -third (34.2%) of parents heard ASD 
genetic testing from their doctors. 
A multiple logistic regression analysis was used to assess the associations 
between the utilization of ASD genetic testing (no ASD genetic testing N = 428; any 
ASD genetic testing N = 124) and parents’ and children’s demographic characteristics. 
Based on the correlation table, parents’ age, knowledge of ASD genetic testing, 
awareness of ASD genetic testing, whether heard ASD genetic testing from doctor, and 
if parents had children with Asperger syndrome were selected in the logistic regression 
model. The Hosmer-Lemeshow test indicates that the model is an adequate fit for the 
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data (χ2 = 3.67, df = 8, p = 0.89). The model accounted for 25.20% of the variance in 
whether or not a parent had ever taken their children to undergo ASD genetic testing. 
Table 3 showed the logistic regression model. Parents who were aware of ASD genetic 
testing were more likely to take their children for testing (Odds ratio: 3.51; 95% CI: 1.98 
– 6.24; p <0.001). Parents who heard ASD genetic testing from doctors were more likely 
to take their children for testing (Odds ratio: 3.71; 95% CI: 2.31 – 5.98; p <0.001).  
Experiences of ASD Genetic Testing 
Satisfaction of ASD genetic testing. Parents who had taken their children for 
ASD genetic testing were either satisfied (56.0%) or very satisfied (6.4%) with the 
genetic testing that their children received. Figure 1 shows the underlying reasons 
reported by the participating parents. The reasons were listed by frequency as follows: 
(1) the ASD genetic testing results can contribute to scientific knowledge and research, 
which would eventually lead to benefits for other and my own child(ren) with ASD 
(61.8%); (2) the ASD genetic testing results played a potential role in future 
reproductive decisions of my child(ren) or other family members (19.1%); (3) the ASD 
genetic testing result informed medical care for our child(ren) with ASD (11.8%); (4) the 
ASD genetic testing result  helped me to explain to others (e.g., medical providers, 
teachers, caretakers, and relatives) that our child(ren)’s behavior was the result of a 
medical condition (10.3%); (5) the ASD genetic testing result helped me in treatment 
planning  for my child(ren) with ASD (10.3%); (6) the ASD genetic testing result 
offered an explanation for our child(ren)’s condition, which made me feel comforted 
(10.3%); (7) the ASD genetic testing results helped me rule out other biological causes
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Table 3.3 Multiple logistic regression analysis for utilization of ASD genetic testing among children diagnosed with ASD 
 
Variable B SE OR 95% CI p 
Parents’ Age -0.011 0.15 0.99 0.96, 1.02 0.45 
Parents’ knowledge of ASD genetic testing 0.13 0.095 1.13 0.94, 1.37 0.18 
Parents who had children with Asperger Syndrome      
 Noa      
 Yes -0.29 0.31 0.75 0.41, 1.36 0.34 
Awareness of ASD genetic testing      
 Noa      
 Yes 1.26 0.29 3.51 1.98, 6.24 <0.001 
Heard ASD genetic testing from doctors      
 Noa      
 Yes 1.31 0.24 3.71 2.31, 5.98 <0.001 
 
Note. a Reference group.  B, unstandardized regression weight; SE, standard error of B; OR, odds ratio; CI, confidence 
interval. 
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Figure 3.1 Reasons behind why parents were satisfied with the ASD genetic testing their children received 
 
 
 
2.9%
4.4%
7.4%
7.4%
8.8%
8.8%
8.8%
10.3%
10.3%
10.3%
11.8%
19.1%
61.8%
The ASD genetic testing results helped me abandon approaches that could be futile or harmful(e.g., avoiding
vaccinations and restrictive diets)
The ASD genetic testing results helped me get connected with other families with children with ASD, or with
ASD organizations
The ASD genetic testing result reduced our feelings of guilt for my child(ren) with ASD
The ASD genetic testing result helped me to access additional services or resources for my child(ren) with
ASD
The ASD genetic testing result helped me to examine our child(ren)’s problems, and enabled me to improve 
my understanding of my child(ren)’s behaviors, capabilities, potential
The ASD genetic testing result helped me gain a better understanding of my child(ren)’s strengths and 
weaknesses, and also helped me develop more realistic expectations for my child(ren) with ASD
The ASD genetic testing results helped me rule out other biological causes of my child(ren)'s ASD (e.g.,
Fragile X)
The ASD genetic testing result offered an explanation for our child(ren)’s condition, which made me feel 
comforted
The ASD genetic testing result helped me in treatment planning  for my child(ren) with ASD
The ASD genetic testing result  helped me to explain to others (e.g., medical providers, teachers, caretakers, 
and relatives) that our child(ren)’s behavior was the result of a medical condition
The ASD genetic testing result informed medical care for our child(ren) with ASD
The ASD genetic testing results played a potential role in future reproductive decisions of my child(ren) or
other family members
The ASD genetic testing results can contribute to scientific knowledge and research, which would eventually
lead to benefits for other and my own child(ren) with ASD
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of my child(ren)'s ASD (e.g., Fragile X) (8.8%); (8) the ASD genetic testing result 
helped me gain a better understanding of my child(ren)’s strengths and weaknesses, and 
also helped me develop more realistic expectations for my child(ren) with ASD (8.8%); 
(9) the ASD genetic testing result helped me to examine our child(ren)’s problems, and 
enabled me to improve my understanding of my child(ren)’s behaviors, capabilities, 
potential (8.8%); (10) the ASD genetic testing result helped me to access additional 
services or resources for my child(ren) with ASD (7.4%); (11) the ASD genetic testing 
result reduced our feelings of guilt for my child(ren) with ASD (7.4%); (12) the ASD 
genetic testing results helped me get connected with other families with children with 
ASD, or with ASD organizations (4.4%) and (13) the ASD genetic testing results helped 
me abandon approaches that could be futile or harmful(e.g., avoiding vaccinations and 
restrictive diets) (2.9%). Pearson’s chi-square tests were utilized to test the relationships 
of parents’ satisfaction of ASD genetic testing with socio-demographic characteristics 
(of parents and their children) and the type of testing their children received. Upon 
correction for the Type I error, no statistically significant associations were found. 
Figure 2 shows the underlying reasons for parents who were either unsatisfied 
(30.3%) or very unsatisfied (7.3%) with the ASD genetic testing that their children 
received. The underlying reasons were listed as follows: (1) the ASD genetic testing 
didn't provide any new treatment options that could improve my child(ren)'s condition 
(53.7%); (2) the ASD genetic testing didn't make any change to my family’s day-to-day 
experience (51.2%); and (3) the ASD genetic testing didn't provide any useful  
information (34.1%); (4) the ASD genetic testing providers could not explain the genetic 
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Figure 3.2 Reasons behind why parents were unsatisfied with the ASD genetic testing their children received 
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The ASD genetic testing result was inaccurate
The ASD genetic testing merely confirmed what I already knew to be true about my child(ren)
The ASD genetic testing was too hard for me to understand
The ASD genetic testing result made me confused
The process of ASD genetic testing took long time (e.g., long waiting time to receive genetic testing results, too
much paperwork to fill out)
The ASD genetic testing was too expensive
The ASD genetic testing providers were unfriendly
The ASD genetic testing providers could not explain the genetic testing results well to me
The ASD genetic testing didn't provide any useful information
The ASD genetic testing didn't make any change to my family’s day-to-day experience
The ASD genetic testing didn't provide any new treatment options that could improve my child(ren)'s condition
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testing results well to me” (26.8%); (5) the ASD genetic testing providers were 
unfriendly (12.2%); (6) the ASD genetic testing was too expensive (12.2%); (7) the 
process of ASD genetic testing took long time (e.g., long waiting time to receive genetic 
testing results, too much paperwork to fill out) (12.2%); (8) the ASD genetic testing 
result made me confused (9.8%); (9) the ASD genetic testing was too hard for me to 
understand (7.3%); (10) the ASD genetic testing merely confirmed what I already knew 
to be true about my child(ren) (7.3%); (11) the ASD genetic testing result was inaccurate 
(2.4%). Interestingly, none of these parents reported that the genetic testing was causing 
family conflicts, or making them feel guilty about their children.  
Perceived usefulness of ASD genetic testing for their family. Participants were 
asked to rate the usefulness of ASD genetic testing results for their families. Among 
participating parents who had taken their children for ASD genetic testing, 86.3 % of 
parents mentioned that it was not at all useful (45.0%) or just a little useful (41.3%). 
Pearson’s chi-square tests with Bonferroni’s correction was conducted were conducted 
to examine the relationships of parents’ perceived usefulness of ASD genetic testing 
with parents’ and children’s socio-demographic characteristics and the type of testing 
their children underwent. There was only one statistically significant finding: parents 
who took their children for CMA were more likely to consider ASD genetic testing as 
useful compared to those who had other methods of testing, χ2(1) = 9.46, p = 0.002.  
Whether to recommend ASD genetic testing to other parents of children 
with ASD. Among participating parents who had taken their children for ASD genetic 
testing, approximately half (50.5%) reported that they would recommend ASD genetic 
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testing to other parents of children with ASD, and 12.8% would not recommend it. A 
little over one-quarter of the parents (26.6%) were undecided, while the remaining 
(10.1%) were unsure. In order to understand the underlying reasons for each of the four 
responses, parents were asked to response to the open-ended questions regarding their 
preference. For parents who would recommend ASD genetic testing, the top three 
identified reasons were that ASD genetic testing (1) might be helpful for others, (2) 
helps parents better understand ASD, and (3) contributes to research in ASD. For parents 
who would not recommend this testing, the two most cited reasons were that ASD 
genetic testing is (1) unhelpful and (2) expensive. One parent summarized the two 
reasons simultaneously: “All results were normal which was unhelpful. Yielded no new 
information. Was expensive and inconvenient.” For parents who reported that their 
decisions may depend on other factors, the most common reasons cited were: (1) it is 
parents’ personal choice; (2) if it is offered in a research setting; (3) if the testing 
provides useful information; and (4) it depends on the testing results. Among parents 
who were unsure whether they would recommend ASD genetic testing to other parents 
of children with ASD, the main reason reported was not knowing the benefits of ASD 
genetic testing. Specifically, one parent mentioned that: “I honestly don't know what 
type of testing is available now and what benefits it may have. I am fully interested in 
participating if it will help with research. Not so sure at this point in time, how it could 
help my son.” 
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Discussion 
This is one of the few studies that contribute to the understanding of utilization of 
and experience with ASD genetic testing among parents of children with ASD. Although 
ASD genetic testing is recommended for children diagnosed with ASD in the U.S. 
(American Academy of Pediatrics, 2013; Barr & Millar, 2003; Hayeems et al., 2016; 
Schaefer & Mendelsohn, 2013), our data showed that only 22.5% of the participating 
parents had taken their children for ASD genetic testing. Yet, the percentage found in 
this study was less than those reported in the previous studies published in the U.S. 
(Cuccaro et al., 2014; Kiely et al., 2016; Narcisa et al., 2013; Wydeven et al., 2012) 
(41.2%, 27.8%, 32.0%, and 33.6%). Such discrepancy may be influenced by the 
differences in recruitment areas and sample sizes. Cuccaro et al.(Cuccaro et al., 2014) 
recruited participants only in the State of Florida, which may show different patterns of 
ASD genetic testing uptake compared to the data collected from 47 states in this study. 
Results of Narcisa et.al.(Narcisa et al., 2013) and Wydeven et al.(Wydeven et al., 2012) 
also may not be comparable as their sample sizes were smaller (n = 162 and n = 155). 
For Bridget’s study (Kiely et al., 2016); it included only the affected children whose age 
were between six to seventeen years old, which also limits its generalizability. 
Of note, parents’ and children’s sociodemographic characteristics were not 
associated with the utilization of ASD genetic testing. Parents who were aware of ASD 
genetic testing or who heard ASD genetic testing from doctors were more likely to have 
their children undergo ASD genetic testing. These findings indicated that health care 
professional may play an important role in the utilization of ASD genetic testing for 
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children with ASD. Yet, only one-third of parents of children with ASD heard about 
ASD genetic testing from their doctors, which indicated that parents received inadequate 
information regarding ASD genetic testing from health care professionals.  The possible 
explanation was that a large number of doctors have insufficient knowledge of ASD and 
genetics (Hayeems et al., 2016), which limit their ability to provide information regard 
ASD genetic testing for parents of children with ASD. Therefore, to increase parents’ 
awareness of ASD genetic testing as well as the utilization of ASD genetic testing for 
their affected children, training health professional about ASD genetic testing are 
imperatively needed. 
Among parents who had taken their children for ASD genetic testing, over half 
of them were satisfied with the testing that their children received mainly because of 
their perceived contribution to scientific knowledge and research of ASD as well as to 
family planning for children with ASD and other family members. Nevertheless, there 
were still more than one-third of the parents who were unsatisfied or very unsatisfied 
with the ASD genetic testing that their children received. Some parents reported that the 
testing was too difficult to understand and the results were confusing. Moreover, as 
parents of children with ASD showed low knowledge of ASD genetic testing (mean 
score of knowledge in ASD genetic testing was 2.50 out of 7), and genetic testing results 
are often complicated, health care providers offering ASD genetic testing need to use lay 
language and provide parents with more details or explanation on the ASD genetic 
testing results.  
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Furthermore, many of these parents questioned the usefulness of the ASD genetic 
testing results, and over one-fourth of them would not recommend this testing to other 
parents of children with ASD or were unsure about where they stand on this issue. These 
parents were mainly concerned with the limited treatment options available to their 
children with ASD, lack of perceived usefulness to their family, and unclear 
interpretation of the test results from their healthcare providers. When taking their 
children to undergo ASD genetic testing, parents expected this testing can provide 
answers related to the underlying causes of their children’s ASD and hope this 
information can provide them with a prognosis and with some direction in managing, 
treating, or caring for their children (Ashtiani et al., 2014; Hayeems et al., 2016). 
However, the overall diagnostic yield of ASD genetic testing is still relatively low 
(Miller et al., 2010; Roesser, 2011; Schaefer & Lutz, 2006; Schaefer & Mendelsohn, 
2008, 2013; Shen et al., 2010), and inevitably, parents may receive inconclusive results 
or limited information. In order to help the affected families increase their knowledge 
and awareness in this area, it is crucial to provide education to parents, particularly on 
the role of genetics in ASD as well as the values and benefits of ASD genetic testing.  
A few limitations should be noted for this study. Frist, as parents were asked to 
recall if their children had undergone ASD genetic testing, data regarding the parents’ 
experience of ASD genetic testing may be influenced by recall bias. Future studies may 
consider gaining access to children’s medical records to confirm whether their children 
have undergone ASD genetic testing. Second, similar to previous studies (Narcisa et al., 
2013), most of our survey respondents were mothers, which may not realistically reflect 
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fathers’ experience regarding ASD genetic testing. It may be useful to motivate fathers 
to participate in future research. Third, our findings may also be more representative of 
those with high socioeconomic status as the majority of our participants reported high 
education level and annual household income.  Fourth, we didn’t ask parents whether 
their children’s doctors recommended or referred their children with ASD to see genetic 
professionals. As lack of referral to genetic professionals from doctors may contribute 
the lower utilization of ASD genetic testing (Wydeven et al., 2012), future studies are 
recommended to explore doctors’ specific roles in children’s utilization of ASD genetic 
testing. Fifth, parents’ experience with ASD genetic counselling was not explored in this 
study. As genetic counseling may impact parents’ experience in ASD genetic testing for 
their affected children (Collins, Halliday, Kahler, & Williamson, 2001; Tluczek et al., 
2006), future researchers may need to explore such genetic counselling experience. 
Despite the limitations, this study is one of the few that provides insights into the 
utilization and experiences of ASD genetic testing among parents of children with ASD. 
Findings showed a low uptake of childhood ASD genetic testing. Furthermore, for 
parents who had already taken their children with ASD for testing, most of them 
questioned the usefulness of ASD genetic testing, although approximately half of these 
parent would recommend this testing to other parents of children with ASD. To address 
these issues, more education regarding ASD genetic testing is needed for parents of 
children with ASD. Healthcare providers also need to explain various aspects of the 
ASD genetic testing (e.g., values, benefits, accuracy, limitations) to parents before 
offering it. Furthermore, findings in this study can be utilized by other health 
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professionals to address parents’ concerns as well as needs and ultimately improve 
services related to ASD genetic testing for families affected by ASD.  
 
 
 
 
 76 
 
CHAPTER V 
NEEDS ASSESSMENT IN AUTISM SPECTRUM DISORDERS (ASD) GENETIC 
TESTING: A SURVEY OF PARENTS OF CHILDREN WITH ASD IN THE U.S. 
 
The prevalence of Autism Spectrum Disorder (ASD) diagnoses has surged in the 
past decades (Centers for Disease Control and Prevention, 2016), leading to increased 
attention within the research community. Currently, ASD diagnoses primarily rely on 
clinical observation and evaluation of individuals’ behavioral and developmental 
characteristics (e.g., assessments of speech, language and intellectual abilities, and of 
educational or vocational attainment) (Centers for Disease Control and Prevention, 2015; 
Walsh et al., 2011). Yet, there is evidence of a strong genetic basis for ASD. Because of 
advances in genetic and genomic technology, our understanding of the genetic basis of 
ASD has increased substantially and many ASD-associated genetic variants have been 
identified (de la Torre-Ubieta et al., 2016; Schaefer, 2016). These identified ASD-
associated genes have provided a platform for finding the causal chains that resulted in 
ASD (de la Torre-Ubieta et al., 2016). 
ASD genetic testing, which includes chromosomal microarray analysis, whole 
exome sequencing, and whole genome sequencing, has been applied as an investigation 
tool in evaluating the genetic etiology of children diagnosed with ASD (Jiang et al., 
2013; Tammimies et al., 2015). However, due to the complex nature of the etiology of 
ASD and uncertainty of the diagnostic biomarkers, the overall diagnostic yield of ASD 
genetic testing is still low (Miller et al., 2010; Roesser, 2011; Schaefer & Lutz, 2006; 
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Schaefer & Mendelsohn, 2008, 2013; Shen et al., 2010), findings from this testing may 
be limited and inconclusive. Additionally, ethical, legal, and social concerns have been 
raised by practitioners and researchers about ASD genetic testing (e.g., eugenics, 
labelling, stigmatization, genetic discrimination, conflicting family values concerning 
testing) (Chen et al., 2015; Chen et al., 2013; Marchant & Robert, 2008; Walsh et al., 
2011). Moreover, there are concerns regarding the perceived utility of ASD genetic 
testing (Hens et al., 2016). Despite these limitations and concerns, ASD genetic testing 
may identify the genetic basis of children’s ASD; exclude other neurological conditions; 
help affected families understand their children’s prognosis and parental risk for having 
other children with ASD; estimate the related co-morbid medical conditions; and provide 
potential tailored ASD treatment for affected children (Schaefer, 2016; Walsh et al., 
2011). 
Even so, recent studies indicate that parents are generally unaware of ASD 
genetic testing and its uptake rate is low (27.8%-41.2%) (Cuccaro et al., 2014; Kiely et 
al., 2016; Narcisa et al., 2013; Wydeven et al., 2012). While doctors can be important 
sources of ASD genetic testing information for the affected families, these studies reveal 
that the majority of parents of children diagnosed with ASD did not receive referrals for 
genetic services from their physicians (Wydeven et al., 2012). Low rates of awareness-
building and information provision about ASD genetic testing from doctors likely has a 
direct effect on parental awareness and understanding of ASD and related genetic 
testing. Without adequate information about ASD genetic testing, parents may not be 
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able to make certain types of informed decisions, including accessing ASD genetic 
services and appropriate medical follow-up for their children with ASD. 
Several studies have examined parental attitudes, intentions, and utilization of 
ASD genetic testing in the U.S. (Cuccaro et al., 2014; Kiely et al., 2016; Narcisa et al., 
2013; Wydeven et al., 2012), yet, their preferred topics and educational delivery 
methods have been generally overlooked by researchers. In the U.S., only one qualitative 
study (Li et al., 2016) has assessed parents’ informational needs regarding ASD genetic 
testing. Study findings indicate that parents are very interested in learning more about 
ASD genetic testing and may provide an initial window for understanding their 
educational needs in this area. Its generalizability may be limited in terms of developing 
and disseminating genetic health education to parents about ASD genetic testing 
However, its findings were limited due to small sample sizes and lack of quantitative 
perspectives. Additionally, parents’ most desired topics and educational delivery 
methods were not identified.  Understanding parents’ informational needs for ASD 
genetic testing is very important for developing tailored, evidence-based health 
education materials for clinical use and assisting these parents in making informed 
decisions related to testing.  
To address these concerns, we designed and administrated an online survey to 
examine health educational needs regarding ASD genetic testing among a nationwide 
sample of U.S. parents of children with ASD. We aim to answer the following two 
questions: (1) What are parents’ sources of information regarding ASD genetic testing 
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and their levels of awareness about this testing? 2) What kinds of health education 
information and delivery method(s) do parents want to learn about ASD genetic testing?  
Methods 
Survey Instrument 
The current study is part of a larger research project that examined perceptions 
regarding ASD genetic testing among U.S. parents of children diagnosed with ASD. In 
this study, we focused on needs assessment concerning ASD genetic testing among 
parents of affected children. The survey instrument was developed in Qualtrics 
(http://www.qualtrics.com) based on previous literature (Bunn et al., 2002; Doukas et al., 
2004; Gooding et al., 2006; Lagos et al., 2008; Levine et al., 2010; Miller et al., 1996; 
Sagi et al., 1992; Vainio & Miller, 2003). To ensure content validity of the survey, a 
geneticist, an ASD behavior analyst, two social behavioral specialists, two special 
education experts and one educational psychologist were invited to review the survey. 
Subsequently, seven parents of children with ASD were invited for cognitive interviews 
and five parents were invited for retrospective interviews. The Qualtrics survey was then 
revised and pilot tested online in a rural area in Southeast Texas; 52 participants 
completed the pilot test. After additional minor revisions, the final version of the 
Qualtrics survey included 25 pages and 14 sections. This study has been approved by the 
Institutional Review Board (IRB) at Texas A&M University. 
Participants 
A total of 4,673 parents of children with ASD from Interactive Autism Network 
(IAN; http://www.iancommunity.org) (Interactive Autism Network, 2016) were invited 
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to participate in the formal test of the online survey using one invitation email and three 
reminder emails. Among the invited participants, 500 of responded our survey (formal 
test response rate=10.7%). Each participant who completed the survey received a $10 
Amazon.com electronic gift card. There were only minor wording changes between the 
informal and formal survey pilot versions. No statistically-significant differences were 
found in sociodemographic characteristics and outcome variables among participants. 
Therefore, we combined the datasets for the informal and formal survey tests, yielding a 
final sample size of 552 parents of children with ASD.  
Data Analysis 
Parents whose responses indicated that they were “somewhat aware” or “very 
much aware” of ASD genetic testing were categorized to an “awareness group” (56.1%) 
and those who were “very little aware” or “not at all aware” of ASD genetic testing were 
assigned to an “unawareness group” (43.9%). Initial bivariate differences by these two 
groups were evaluated by using chi-square analysis for categorical social demographic 
variables (i.e., parents’ gender, education level, employment status, race/ethnicity, 
marital status, children’s insurance type, children’s gender, type of ASD) and 
independent sample t-test for continuous social demographic variables (i.e., parents’ age, 
knowledge of ASD genetic testing, children’s age). Only the variables with statistically 
significant association (p < 0.05) with the parents’ awareness of ASD genetic testing 
were selected in the final logistic regression model. Based on the bivariate correlation 
between parents’ awareness of ASD genetic testing and their social demographic 
variables, parents’ knowledge of ASD genetic testing, source of information about ASD 
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genetic testing, and number of children with ASD were selected in the logistic regression 
model. 
Parents who responded “yes” to receiving health education regarding ASD 
genetic testing were classified as “desired education group” (73.7%), whereas those who 
answered “no” were assigned to “undesired education group” (26.3%). Initial bivariate 
analysis was performed by using chi-square analysis for categorical social demographic 
variables and independent sample t-test for continuous social demographic variables. 
The variables with a statistically significant association (p < 0.05) with the outcome 
were included in the multiple logistic regression analysis. Based on the correlation 
between parents’ interest in receiving health education about ASD genetic testing and 
their sociodemographic information, parents’ education level, race/ethnicity, awareness 
of ASD genetic testing were selected in the logistic regression model. All analyses were 
conducted using SPSS 22.0 (SPSS Inc., Chicago, IL). 
Results 
Sample Characteristics 
Most survey respondents were female (92.0%) and married (81.5%). The average 
age of participating parents was 43.8 years (SD = 8.00 years). Participants were 
predominantly White/Caucasian (85.3%), 6.0% Hispanic/Latino, 3.8% Black/African 
American, and 2.4% Asian; 2.5% indicated multiple races or other race. In terms of 
educational background, 5.8% of parents surveyed completed a High School Diploma or 
lower level K-12 grades; 24.8% completed college coursework or an Associate’s degree; 
40.4% were college graduates (i.e., Bachelor’s degrees), and the remaining 29.0% 
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completed advanced graduate degrees. Nearly two-third of the parents (62.9%) were 
employed and 26.1% indicated that they were “homemakers.” In regards to annual 
income, 6.5% of parents reported their annual income as less than $20,000; 7.2% of 
parents’ income ranged from $20,000 to $35,000; 9.8% of annual incomes fell within the 
range of $50,000–$75,000; and the remaining 58.5% of annual incomes were at or above 
$75,000. Almost two-third of the participating parents (63.8%) indicated they were 
Catholic or Christian, and 26.1% were unaffiliated with any religion. Most parents 
(84.6%) reported only having one child with an ASD diagnosis. The majority (81.8%) 
were boys. In terms of the type of ASD diagnoses based on fourth edition of Diagnostic 
and Statistical Manual of Mental Disorders (DSM-IV-TR), 44.9% of the children were 
diagnosed with Autistic Disorder; 30.6% had Pervasive Developmental Disorder, not 
otherwise specified (PDD-NOS); and 19.7% reported Asperger Syndrome. Their average 
age at ASD diagnosis was 52.8 months (SD = 34.80 months). 
Parents’ Source of Information and Awareness of ASD Genetic Testing 
Among the parents who completed the online survey, 78.1% reported hearing 
about ASD genetic testing (see Figure 1). The five most cited information sources were 
Internet (45.7%), ASD organization or supporting groups (42.9%), physicians (35.3%), 
research articles/studies (24.6%), and other parents of children with ASD. We also 
queried parents about their awareness of ASD genetic testing. Almost one-half of parents 
surveyed indicated they were either “not at all aware” (10.1%) or “very little aware” 
(33.9%) of ASD genetic testing. The remainder of parents were either “somewhat 
aware” (41.9%) or “very much aware” (14.2%) of ASD genetic testing.  
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Figure 4.1 Sources that parents learned about ASD genetic testing 
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Logistic regression analysis was used to assess associations between parents’ 
awareness of ASD genetic testing (the unawareness group verse the awareness group) 
and sociodemographic characteristics of parents and children with ASD. Table 1 shows 
the logistic regression model. Specifically, parents who had higher knowledge score 
regarding ASD genetic testing (Odds ratio: 1.42; 95% CI: 1.16 – 1.74; p = 0.001) or who 
had two or more children with ASD (Odds ratio: 3.57; 95% CI: 1.56 – 8.18; p = 0.003) 
were more likely to be aware of ASD genetic testing than those with lower ASD genetic 
testing knowledge or had only one child with ASD. Parents who heard about ASD 
genetic testing from ASD organization or supporting groups (Odds ratio: 0.33; 95% CI: 
0.14 – 0.82; p = 0.016), Internet (Odds ratio: 0.25; 95% CI: 0.10 – 0.59; p = 0.002) or 
other parents of children with ASD (Odds ratio: 0.11; 95% CI: 0.017 – 0.67; p = 0.017) 
were less likely to be aware of ASD genetic testing compared with those who obtained 
the information from physicians. 
Interests in Receiving Health Education about ASD Genetic Testing  
The majority (73.7%) of our survey respondents indicated interest in receiving 
information about ASD genetic testing. As indicated in Table 2, the logistic regression 
model suggested that parents whose highest education degrees below college were more 
likely to be interested in receiving information about ASD genetic testing than those 
with above college degrees (Odds ratio: 2.13; 95% CI: 1.34 – 3.41; p = 0.002).  
Moreover, Parents who identified themselves as race/ethnicity minorities were more 
likely to be educated for ASD genetic testing than White parents (Odds ratio: 2.08; 95% 
CI: 1.08 – 4.00; p = 0.29). Additionally, parents who had low awareness of ASD genetic
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Table 4.1 Multiple logistic regression analysis for parents’ awareness of ASD genetic testing 
 
Variable B SE OR 95% CI p 
Parents’ knowledge of ASD genetic testing 0.35 0.10 1.42 1.16, 1.74 0.001 
Numbers of children with ASD      
 One childa      
 Two or above children  1.27 0.42 3.57 1.56, 8.18 0.003 
Source of information about ASD genetic testing      
 Physiciansa      
 ASD organizations or supporting groups -1.10 0.46 0.33 0.14, 0.82 0.016 
 Internet -1.41 0.45 0.25 0.10, 0.59 0.002 
 Research articles/studies 0.15 0.88 1.16 0.21, 6.46 0.86 
 Other parents of children with ASD -2.24 0.94 0.11 0.02, 0.67 0.017 
 Two or more sources of information 0.32 0.37 1.32 0.64, 2.73 0.46 
 
Note. a Reference group.  B, unstandardized regression weight; SE, standard error of B; OR, odds ratio; CI, confidence 
interval. 
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Table 4.2 Multiple logistic regression analysis for parents’ interest in receiving information about ASD genetic testing 
 
Variable B SE OR 95% CI p 
Education Level      
 College graduate or abovea      
 Below college  0.76 0.24 2.13 1.34, 3.41 0.002 
Race/Ethnicity      
 Whitea      
 No-White 0.73 0.34 2.08 1.08, 4.00 0.029 
Awareness of ASD genetic testing      
 Yesa      
 No 0.62 0.21 1.85 1.23, 2.79 0.003 
 
Note. a Reference group.  B, unstandardized regression weight; SE, standard error of B; OR, odds ratio; CI, confidence 
interval. 
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testing were more likely to express interest in having ASD genetic testing education 
(Odds ratio: 1.85; 95% CI: 1.23 – 2.79; p = 0.003).  
Preferred Topics and Delivery Methods in Health Education about ASD Genetic 
Testing 
Among parents who were in the “desired education training group,” their 
preferred topics included (1) accuracy of ASD genetic testing (n = 350, 88.4%); (2) cost 
of ASD genetic testing (n = 340, 85.9%); (3) benefits of ASD genetic testing (n = 332, 
83.8%); (4) procedure of undergoing ASD genetic testing (n = 308, 77.8%); (5) 
eligibility of ASD genetic testing (n = 247, 62.4%); (6) potential harm caused by ASD 
genetic testing (n = 222, 56.1%); (7) Previous utilization of ASD genetic testing by 
affected individuals (n = 201, 50.8%); and (8) confidentiality of ASD genetic testing 
results (n = 190, 48.0%).  The majority (n = 336, 84.8%) of parents completing the 
survey endorsed a web-based approach/education as their most preferred delivery 
method. They also supported brochures/flyers (n = 184, 46.5%); videos/CDs (n = 85, 
21.5%); and workshops/seminars (n = 79, 19.9%) as preferred methods. 
Discussion 
To the best of our knowledge, the current evaluation represents the first 
quantitative needs assessment study of parental preferred topics and educational delivery 
methods regarding ASD genetic testing among U.S. parents of children with ASD. 
Although 78.1% of parents reported hearing about ASD genetic testing, only 56.1% of 
them were “somewhat” or “very much” aware of ASD genetic testing. This discrepancy 
may be attributed to parents’ limited understanding of and exposure to ASD genetic 
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testing. Yet, the percentage of parents in our study who reported awareness of ASD 
genetic testing was higher than in previous studies (Chen, Min, Yeh, Huang, & Zhao, 
2018; Li et al., 2016). Additionally, higher numbers of the parents in our study reported 
obtaining this information from the Internet or Autism organization/supporting groups 
than from doctors.  
While physicians play an important role in helping parents receive information 
regarding genetic testing for ASD (Rhoades, Scarpa, & Salley, 2007), our study results 
demonstrate that most parents have not received adequate information about these tests 
from their physicians. Thus, these parents appear to have limited awareness and 
understanding of ASD genetic testing and access to ASD genetic services. This finding 
is consistent with previous studies reporting that the majority of parents of children 
diagnosed with ASD do not receive suggestions or referrals for genetic services from 
their doctors (Wydeven et al., 2012). Additionally, doctors may have limited knowledge 
about ASD and genetics (Hayeems et al., 2016), which also limits their ability to serve 
as information resources and referrals for ASD genetic testing. Education training 
programs, specifically focusing on ASD genetic testing, are needed to improve doctors’ 
genomic competencies in this area. Given their role as “front line” physicians, 
pediatricians may be a particularly appropriate target for such training programs.  
Of note, more than two-third of parents of children with ASD in the current study 
expressed interest in receiving information about genetic testing for ASD. This finding is 
comparable to that of a recent study conducted in Taiwan (Chen et al., 2018), yet, the 
percentages are lower than a previously-published qualitative study in the U.S.(Li et al., 
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2016). We also found that parents who identified as racial/ethnic minorities or who 
completed High School Diplomas or lower levels of education were more likely to seek 
information regarding ASD genetic testing. Given the well-documented barriers 
minorities face in accessing healthcare, future genetic health education programs, and 
specifically those related to ASD genetic testing, future education programs about ASD 
genetic testing should consider tailoring their efforts to focus on minorities.  
Due to qualitative nature of the previous study, our quantitative study may 
provide greater representation of parents’ informational preferences in genetic testing for 
ASD. For example, while the U.S.-based qualitative study identified that cost of ASD 
genetic testing was parents’ most preferred informational topic, our study findings reveal 
that most participants preferred the topic of accuracy of ASD genetic testing (Li et al., 
2016). In fact, the clinical diagnostic yield of ASD genetic testing varies a lot due to 
different testing methods (Rossi et al., 2017; Tammimies et al., 2015). For example, the 
diagnostic yield of CMA, fragile X, and exome sequencing were ranging from 9.3% to 
24%, 0.4% to 8%, and 8.4% - 25.8%, respectively (Rossi et al., 2017; Tammimies et al., 
2015).  It is particularly important to inform parents about the accuracy of genetic testing 
so that they can make informed decisions. Future education programs focused on genetic 
testing for ASD should be prepared to explain the different methods of ASD genetic 
testing and their corresponding diagnostic yield in culturally- and linguistically-
appropriate terms to parents of children with ASD.  Additionally, parents’ health literacy 
levels should be considered. 
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Additionally, our finding also highlighted parents’ preferred delivery methods for 
receiving health education regarding genetic testing for ASD. Our results show that most 
parents prefer a web-based approach. This finding is consist with a previous qualitative 
stud in the U.S. (Li et al., 2016). In contrast, the study (Chen et al., 2018) in Taiwan 
identified that parents preferred health education brochures. The possible explanation 
may be because of the differences in culture, medical practice, and parents’ familiarity 
with an online learning platform (Chen et al., 2018). 
While the current study has yielded results that support those of previous studies, 
it has several limitations that should be noted in order to interpret study findings. First, 
our survey participants were 43.8 years old, on average. Parents who are younger may 
have different preferred topics related to ASD genetic testing. Second, participants in our 
study tended to have higher income and educational attainment, which may limit the 
generalizability of our study findings. Future studies are encouraged to recruit 
participants with more diverse socioeconomic status. Third, the percentage of parents 
who have heard about ASD genetic testing may be higher, as some of our participants 
had participated in several research projects regarding ASD genetic testing through the 
Interactive Autism Network.  
Despite these limitations, this needs assessment study helps to advance the field of 
genetic health education and promotion by exploring the information needs in ASD 
genetic testing among U.S. parents of children with ASD from a quantitative 
perspective. Our study showed that most parents surveyed were interested in receiving 
information regarding ASD genetic testing; however, they generally used informal 
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sources such as the Internet and Autism organizations or supporting groups, rather than 
physicians. Only 35.1% of parents heard ASD genetic testing from their doctors. As 
such, there is a need for doctors to provide information regarding ASD genetic testing to 
parents of children with ASD, particularly in the aspect of accuracy, cost, benefits, and 
procedure of ASD genetic testing. By doing this, we can facilitate better physician-
parent communication regarding ASD genetic testing and ensure parents make informed 
decisions.  
Future education program of ASD genetic testing may consider a twin approach 
by training doctors and collaborating with Autism organizations and supporting groups 
to reach more parents of children with ASD. Parents’ preferred topics identified in this 
study can be utilized by health educators in designing evidence-based educational 
programs regarding ASD genetic testing for parents, physicians, and community 
advocates. Given that parents identified a web-based approach as the most effective 
delivery method for educational programs on ASD genetic testing, future education 
programs about ASD genetic testing should consider using online learning platforms.  
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CHAPTER VI 
CONCLUSIONS 
 
This dissertation aims to investigate parents’ perspective regarding ASD genetic 
testing through four separate studies. The first study evaluates the psychometric 
properties of a survey instrument (Perception of ASD Genetic Testing Survey 
[POAGTS]), which was developed based on the Health Belief Model, Theory of Planned 
Behavior, and Social Cognitive Theory. Eight distinct scales were found as proposed in 
the theoretical model. POAGTS was found to be reliable and valid. This study serves as 
a useful tool for health behavior researchers to measure parents’ intention in taking their 
children for ASD genetic testing and examine associated factors. 
The second study utilizes structural equation modeling to evaluate the proposed 
theoretical framework. Results show that the model fit the data well. Significant 
associations were found among the key constructs from the three social and health 
models/theories. Furthermore, our structural model had high predictability and 
accounted for a large amount of variance in parents’ intention in taking their children for 
testing. This study provides insights to understand parents’ intention to take their 
children with ASD for genetic testing.  
The third study shows that the uptake rate of ASD genetic testing is still low in 
the U.S. Parents who were aware of ASD genetic testing or who heard ASD genetic 
testing from doctors were more likely to have their children undergo ASD genetic 
testing. These findings indicated that healthcare professional may play an important role 
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in the utilization of ASD genetic testing for children with ASD. Therefore, to increase 
parents’ awareness in ASD genetic testing as well as the utilization of ASD genetic 
testing for their affected children, training health professional on ASD genetic testing is 
essential. Although most parents were satisfied with the testing their children received, 
many of them questioned the usefulness of the ASD genetic testing. To address such 
discrepancy, it is crucial to provide education to parents, particularly on the role of 
genetics in ASD as well as the values and benefits of ASD genetic testing. 
The fourth study demonstrated that most participating parents were interested in 
receiving information regarding ASD genetic testing; however, they generally used 
informal sources such as the Internet and Autism organizations or support groups, rather 
than physicians. As such, there is a need for doctors to provide information regarding 
ASD genetic testing to parents of children with ASD, particularly on the accuracy, cost, 
benefits, and procedure of ASD genetic testing as these were the topics of interest 
identified by the participating parents. Such practice can facilitate better physician-
parent communication regarding ASD genetic testing and ensure parents make informed 
decisions.  
Implications for Practice 
The results of this dissertation reveal several implications. First, the model 
identified in this dissertation may contribute to the development of theory- and evidence-
based health interventions for parents of children with ASD to improve their affected 
children’s access to ASD genetic testing. Second, as parents have limited knowledge of 
ASD genetic testing, ASD genetic testing providers need to explain the values, benefits, 
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accuracy, and limitations to parents before offering it. Third, the topics that the 
participating parents were interested to learn regarding ASD genetic testing can be 
utilized by health educators in designing evidence-based education programs for parents, 
physicians, and community advocates. Fourth, future education program of ASD genetic 
testing may consider a twin approach by training doctors and collaborating with Autism 
organizations and support groups to reach more parents of children with ASD. 
Furthermore, as the majority of the participating parents preferred the web-based 
approach to receive the information regarding ASD genetic testing, future education 
programs on ASD genetic testing should consider using online learning platforms. 
Limitations 
 There are some limitations in this research. First, as more than half of our 
participants had a moderately high annual income and high education level, the 
generalizability of the results may be limited. Second, the response rate of this 
anonymous online survey was lower compared to traditional mailed questionnaires 
(Kardia & Wang, 2005); however, it is similar to other studies that used Interactive 
Autism Network (IAN) (Farmer et al., 2014; Masino et al., 2011; Wydeven et al., 2012). 
Third, most of the survey respondents were mothers; thus, fathers’ perspective may not 
be fully represented in the studies. Future research may consider motivating fathers to 
participate and recruit more male participants. Fourth, due to the self-report nature of the 
survey, whether participating parents’ children actually received ASD genetic testing 
could not be verified. Fifth, parents’ experience of ASD genetic testing may be 
influenced by recall bias. Finally, the role of doctors’ genetic referral in the utilization of 
 95 
 
ASD genetic testing was not examined in this study. Lack of referral to genetic 
professionals from doctors may contribute to the lower utilization of ASD genetic 
testing; therefore, it may be beneficial to explore physician’ specific roles in the 
utilization of ASD genetic testing among children with ASD in future research. 
Future Research 
The findings of this dissertation have shed light on several areas that need more 
research. First, as the POAGTS in this dissertation is the first survey developed to 
measure parents’ intention in taking their affected children for testing as well as 
associated factors, more studies are needed to examine the psychometric properties of 
the survey items among different ASD groups or regions. Second, recruiting more 
parents with low social economic status as well as more male participants are needed to 
get a more representative sample. Third, as physicians’ role in genetic referral for ASD 
genetic testing has not been well researched, future studies are recommended to explore 
doctors’, particularly pediatricians’ specific roles in the utilization of ASD genetic 
testing among children with ASD as well as their genomic competencies.  
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APPENDIX A 
PILOT TEST INFORMATION SHEET 
 
Information Sheet 
  
Autism Spectrum Disorders (ASD) Genetic Testing: Perspectives 
among Parents of Children Diagnosed with ASD 
 
Why am I being asked to participate in this study? 
The purpose of this information sheet is to provide you (as a prospective research study 
participant) with information that may affect your decision as to whether or not to 
participate in this research. You are invited by the Interactive Autism Network (IAN) 
because you indicated a willingness to participate in research. You have been asked to 
participate in a research project that studies perspectives regarding ASD genetic testing 
among parents of children diagnosed with ASD. The purpose of this study is to 
understand the value of ASD genetic testing and help develop relevant laws and policies. 
You are selected to be a possible participant because you are the biological parents of 
children with ASD.  This study is being funded by Texas A&M University. 
 
What will I be asked to do? 
If you agree to participate in this study, you will be asked to complete an online survey 
that will assess the perspectives regarding ASD genetic testing among parents of 
children diagnosed with ASD. You will receive four e-mail solicitations within 23 days 
period, each with a link to the online survey. Once completed, subsequent e-mails will 
not be sent. Also, an “unsubscribe” option will be available with each e-mail, in case you 
do not wish to participate in the study. This study will take about 15 minutes. 
 
What are the risks involved in this study? 
The risks associated with participating in this study are minimal, and are not greater than 
risks ordinarily encountered in daily life. 
 
What are the possible benefits of this study? 
Your survey responses will help understand the value of ASD genetic testing and help 
develop relevant laws and policies in the future. 
 
Do I have to participate? 
No. Your participation is voluntary. You may decide not to participate or to withdraw at 
any time without your current or future relations with Texas A&M University being 
affected.  Moreover, the survey may contain questions of a sensitive nature. You do not 
have to answer any question(s) if you do not want to. 
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Will I be compensated? 
Yes. You will receive a $10 Amazon electronic gift card for your participation. 
 
Who will know about my participation in this research study? 
This is an anonymous study. All data will be electronically stored, password protected 
and only shared with the research team. Data from this study may be published in peer 
reviewed journals or presented at scientific meetings, but no identifiers linking you to 
this study will be included, as this is an anonymous survey.  
 
Whom do I contact with questions about the research? 
If you have questions regarding this study, you may contact the Principal Investigator, 
Dr. Lei-Shih Chen (lace@hlkn.tamu.edu, 979-862-2912) at the Department of Health & 
Kinesiology, Texas A&M University, College Station, Texas 77843-4243, or the 
Graduate Assistant, Shixi Zhao (shixizhao@tamu.edu, 979-422-7393) at the Department 
of Health & Kinesiology, Texas A&M University, College Station, Texas 77843-4243. 
 
Whom do I contact about my rights as a research participant?  
This research study has been reviewed by the Human Subjects’ Protection Program 
and/or the Institutional Review Board at Texas A&M University. For research related 
problems or questions regarding your rights as a research participant, you can contact 
these offices at (979) 458-4067 or irb@tamu.edu. 
 
Participation 
Please be sure to have read the above information, asked questions and received answers 
to your satisfaction. If you would like to be a part of the study, please print this page for 
your records and proceed to the survey.
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 APPENDIX B 
PILOT TEST SURVEY INSTRUMENT 
  
1. Which state do you currently live in? _________ 
2. Has your child(ren) been diagnosed with Autism Spectrum Disorders (ASD)?  
☐Yes  
☐No (If ‘No’, then you are not eligible to take this survey) 
3. Are you the biological parent of a child(ren) with Autism Spectrum Disorders 
(ASD)?  
☐Yes  
☐No (If ‘No’, then you are not eligible to take this survey) 
4. Have you ever heard or read about Autism Spectrum Disorders (ASD) genetic 
testing?  
☐Yes  
☐No (If ‘No’, please skip to Section I) 
4.1. From which of the following sources did you hear or read anything 
about Autism Spectrum Disorders (ASD) genetic testing?  (Please check all 
that apply) 
☐Doctors 
☐Autism organization or support groups (e.g., Autism speaks, Easter Seals 
East Texas Inc.) 
☐Other parents of children with ASD 
☐Internet 
☐Television 
☐Radio 
☐Magazine 
☐Research articles 
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☐Other (Please specify): 
________________________________________________________ 
                                                                                                                      
Section I Demographic Information 
 
Information about Your Child(ren) with Autism Spectrum Disorders (ASD) 
 
1. How many children do you have?  
2. How many of your children have been diagnosed with Autism Spectrum Disorders 
(ASD)?  
3. What’s the gender of your child with ASD: (Note: questions 3-10 will be repeated 
for each child with ASD, if needed) 
☐Male 
☐Female 
4. What’s the birth year and month of your child with ASD?  
    Year   Month 
5. Biological mother’s age at the time of the child’s birth:  
    
6. Biological father’s age at the time of the child’s birth:  
   
7. To the best of your knowledge, at what age was your child diagnosed with ASD:   
  Age (in years)   Month 
8. What health insurance did your child have when he/she was diagnosed with 
ASD? (Please check all that apply) 
☐Private Health Insurance (e.g., Blue Cross Blue Shield, Aetna, Cigna, Doctor’s, 
Generations, Optimum Choice, Partners, Coventry/Principal, QualChoice, 
Wellness Plan, United Healthcare, WellPath, Scott &White) 
☐State Children’s Health Insurance Plan (SCHIP) 
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☐Medicaid 
☐Medicare  
☐Military 
☐Indian Health Service 
☐Medigap (Medicare supplement insurance) 
☐Other (Please specify): 
____________________________________________________________ 
☐The child(ren) did not have health insurance 
9. What’s health insurance does your child with ASD have currently? (Please check all 
that apply) 
☐Private Health Insurance (e.g., Blue Cross Blue Shield, Aetna, Cigna, Doctor’s, 
Generations, Optimum Choice, Partners, Coventry/Principal, QualChoice, 
Wellness Plan, United Healthcare, WellPath, Scott &White) 
☐State Children’s Health Insurance Plan (SCHIP) 
☐Medicaid 
☐Medicare  
☐Military 
☐Indian Health Service 
☐Medigap (Medicare supplement insurance) 
☐Other (Please specify): 
____________________________________________________________ 
☐The child(ren) did not have health insurance 
10. There are five types of ASD. When your child was first diagnosed with ASD, which 
of the following types was your child diagnosed with? (Please choose only one 
answer) 
☐Autistic Disorder 
☐Asperger’s Syndrome 
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☐Rett Syndrome 
☐Pervasive development disorders-Not otherwise specified (PDD-NOS)  
☐Childhood disintegrative disorder  
☐I don’t know or I am not sure  
☐Other (Please specify): 
____________________________________________________________ 
 
Information about Yourself 
1. What is your gender?  
☐Male 
☐Female 
2. What is your current age:  
   
3. What is your race/ethnicity? One or more categories may be selected. (Please check 
all that apply) 
☐White/Caucasian  
☐Black/African American  
☐Hispanic/Latino  
☐Asian 
☐American Indian/Alaska Native  
☐Native Hawaiian/Pacific Islander 
☐Other (Please specify): 
____________________________________________________________ 
4. What is the highest grade or level of schooling you completed? 
☐Less than high school graduate 
☐High school graduate 
☐Some college or technical school 
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☐College graduate 
☐Advanced graduate degree 
☐Other (Please specify): 
____________________________________________________________ 
5. What is your current marital status? 
☐Married  
☐Living as married  
☐Divorced  
☐Widowed  
☐Separated  
☐Single, never been married  
☐Other (Please specify): 
____________________________________________________________ 
6. Do you plan to have any more children?  
☐Yes 
☐No 
7. Thinking about members of your family living in your household, what is your 
annual household income, meaning the total pre-tax income from all sources earned 
in the past year? 
☐$0 to $9,999 
☐$10,000 to $14,999 
☐$15,000 to $19,999 
☐$20,000 to $34,999 
☐$35,000 to $49,999 
☐$50,000 to $74,999 
☐$75,000 to $99,999  
☐$100,000 to $199,999 
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☐$200,000 or more 
8. What is your current occupational status? 
☐Employed  
☐Unemployed  
☐Homemaker  
☐Student  
☐Retired  
☐Other (Please specify): 
____________________________________________________________ 
9. Which of the following best describes your current religious affiliation? 
☐Catholic 
☐Non-Catholic Christian  
☐Mormon 
☐Jewish  
☐Muslim 
☐Buddhist 
☐Unaffiliated/None  
☐Other (Please specify): 
____________________________________________________________ 
10. To the best of your knowledge, other than your child with ASD, which of YOUR 
biological family members (including yourself) have any characteristics or traits 
of ASD? (Please check all that apply) 
☐Myself  
☐My child(ren) not diagnosed with ASD 
☐My mother  
☐My father 
☐My sibling(s) 
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☐My niece(s) and/or nephew(s)  
☐My uncle(s) and/or aunt(s)  
☐My cousin(s)  
☐My grandparent(s) on my mother's side 
☐My grandparent(s) on my father's side 
☐Other biological family member 
☐I don't have any biological family members with any characteristics or traits of 
ASD 
☐I don't know or I am unsure 
11. To the best of your knowledge, other than your child with ASD, which of YOUR 
biological family members (including yourself) been diagnosed with ASD? (Please 
check all that apply) 
☐Myself  
☐My child(ren) not diagnosed with ASD 
☐My mother  
☐My father 
☐My sibling(s) 
☐My niece(s) and/or nephew(s)  
☐My uncle(s) and/or aunt(s)  
☐My cousin(s)  
☐My grandparent(s) on my mother's side 
☐My grandparent(s) on my father's side 
☐Other biological family member 
☐I don't have any biological family members with any characteristics or traits of 
ASD 
☐I don't know or I am unsure 
 
 118 
 
Information about Your Spouse 
1. Is your current spouse the biological parent of your child(ren) with ASD?  
☐Yes  
☐No  
2. What is your spouse's current age?  
   
3. What is the highest grade or level of schooling your spouse completed? 
☐Less than high school graduate 
☐High school graduate 
☐Some college or technical school 
☐College graduate 
☐Advanced graduate degree 
☐Other (Please specify): 
____________________________________________________________ 
4. What is your spouse’s current occupational status? 
☐Employed  
☐Unemployed  
☐Homemaker  
☐Student  
☐Retired  
☐Other (Please specify): 
____________________________________________________________ 
5. Which of the following best describes your spouse’s religious affiliation? 
☐Catholic 
☐Non-Catholic Christian 
☐Mormon 
☐Jewish  
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☐Muslim 
☐Buddhist 
☐Unaffiliated/None  
☐Other (Please specify): 
____________________________________________________________ 
6. To the best of your knowledge, other than your child with ASD, which of YOUR 
SPOUSE'S biological family members (including your spouse) have any 
characteristics or traits of ASD? (Please check all that apply)   
☐My spouse 
☐My child(ren) not diagnosed with ASD 
☐My spouse’s mother  
☐My spouse’s father 
☐My spouse’s sibling(s) 
☐My spouse’s niece(s) and/or nephew(s)  
☐My spouse’s uncle(s) and/or aunt(s)  
☐My spouse’s cousin(s)  
☐My spouse’s grandparent(s) on his/her mother's side 
☐My spouse’s grandparent(s) on his/her father's side 
☐Other biological family member 
☐My spouse doesn't have any biological family members with any characteristics or 
traits of ASD 
☐I don't know or I am unsure 
7. To the best of your knowledge, other than your child with ASD, which of YOUR 
SPOUSE’S biological family members (including your spouse) been diagnosed 
with ASD? (Please check all that apply)   
☐My spouse 
☐My child(ren) not diagnosed with ASD 
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☐My spouse’s mother  
☐My spouse’s father 
☐My spouse’s sibling(s) 
☐My spouse’s niece(s) and/or nephew(s)  
☐My spouse’s uncle(s) and/or aunt(s)  
☐My spouse’s cousin(s)  
☐My spouse’s grandparent(s) on his/her mother's side 
☐My spouse’s grandparent(s) on his/her father's side 
☐Other biological family member 
☐My spouse doesn't have any biological family members with any characteristics or 
traits of ASD 
☐I don't know or I am unsure 
 
Section II Perceived Severity of Autism Spectrum Disorders 
(ASD) 
 
The following questions ask about your perspective about the severity of ASD. 
Please mark your answers in the appropriate boxes. 
How much do you agree or disagree with the 
following statements? 
Strongly 
Disagree 
Disagree Agree 
Strongly 
Agree 
1. ASD is a severe disorder     
2. Individuals with ASD have problems living 
independently   
    
3. The public discriminates against individuals with 
ASD 
    
4. Individuals with ASD have fewer job 
opportunities 
    
5.  Compared to a child without ASD, it’s hard to 
raise a child with ASD 
    
6. Health problems associated with ASD are severe     
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Section III Perceived Genetic Cause of Autism Spectrum 
Disorders (ASD) 
 
The following questions ask about your perspective about the cause of your 
child(ren)’s ASD. Please mark your answers in the appropriate boxes. 
How much do you agree or disagree with the 
following statements? 
Strongly 
Disagree 
Disagree Agree 
Strongly 
Agree 
1. ASD has a genetic factor     
2. ASD is caused by genes     
3. ASD is associated with family history     
4. ASD is an inherited disorder     
 
 
Section IV Perceived Benefits of Autism Spectrum Disorders 
(ASD) Genetic Testing 
 
The following questions ask you about the benefits of ASD genetic testing. 
Please mark your answers in the appropriate boxes. 
How much do you agree or disagree with the 
following statements? 
Strongly 
Disagree 
Disagree Agree 
Strongly 
Agree 
1. ASD genetic testing identifies the cause of 
children’s ASD 
    
2. ASD genetic testing promotes early detection and 
intervention for children with ASD 
    
3. ASD genetic testing helps develop treatment plans 
targeting ASD-associated medical conditions for 
affected children 
    
4. ASD genetic testing helps children with ASD 
make informed family planning decisions 
    
5. ASD genetic testing helps children with ASD get 
more social support 
    
6. Taking children with ASD to undergo ASD 
genetic testing contributes to ASD research 
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Section V Perceived Barriers in Taking Your Child(ren) with 
Autism Spectrum Disorders (ASD) to Undergo ASD Genetic 
Testing 
 
The following questions ask about your barriers that prevent you from taking your 
child(ren) with ASD to undergo ASD genetic testing.  
Please mark your answers in the appropriate boxes. 
How much do you agree or disagree with the 
following statements? 
Strongly 
Disagree 
Disagree Agree 
Strongly 
Agree 
1. ASD is not caused by genes     
2. ASD genetic testing cannot improve the current 
situation of my child(ren) diagnosed with ASD 
    
3. My child(ren) has/have already been diagnosed 
with ASD, so there’s no need to undergo this 
testing 
    
4. Taking my child(ren) with ASD to undergo ASD 
genetic testing contradicts with my religious or 
cultural beliefs. 
    
5. ASD genetic testing does more harm than good     
6. ASD genetic testing can cause family conflicts     
7. The procedure of undergoing ASD genetic testing 
is uncomfortable for my child (i.e., drawing 
blood) 
    
8. The results of ASD genetic testing can cause 
public discrimination against my child(ren) with 
ASD 
    
9. The results of ASD genetic testing can put the 
health insurance status of my child(ren) with ASD 
in jeopardy 
    
 
 
Section VI Previous Experience with Genetic Testing 
 
The following questions ask about your previous experience with genetic testing. 
Please mark your answer in the appropriate boxes. 
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1. Preconception testing is a genetic test that a couple undergo before becoming 
pregnant to help predict the chances of having a child with a genetic disorder [e.g., 
cystic fibrosis carrier testing, sickle cell testing, and Huntington's disease genetic 
testing]. Have you or your spouse ever undergone preconception testing? 
☐Yes 
☐No (If no, please skip to question 2) 
1.1. Your level of satisfaction with preconception testing: 
☐Very Unsatisfied  
☐Not Satisfied 
☐Satisfied  
☐Very Satisfied 
2. Have you or your spouse ever undergone non-invasive prenatal genetic 
testing (e.g., ultrasound, quad screen, NIPD/verifi) for any of your children?  
☐Yes  
☐No (If no, please skip to question 3) 
2.1. Your level of satisfaction with non-invasive prenatal genetic testing: 
☐Very Unsatisfied  
☐Not Satisfied  
☐Satisfied  
☐Very Satisfied 
3. Have you or your spouse ever undergone invasive prenatal genetic testing (e.g., 
amniocentesis, chorionic villus sampling [CVS]) for any of your children?  
☐Yes  
☐No (If no, please skip to question 4) 
3.1. Your level of satisfaction with invasive prenatal genetic testing: 
☐Very Unsatisfied 
☐Not Satisfied 
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☐Satisfied  
☐Very Satisfied 
4. Newborn screening begins within 24 to 48 hours of a child's birth when a few drops 
of blood are obtained from a heel stick. Have any of your children 
undergone newborn screening?  
☐Yes  
☐No (If no, please skip to question 5) 
4.1. Your level of satisfaction with newborn screening: 
☐Very Unsatisfied  
☐Not Satisfied  
☐Satisfied  
☐Very Satisfied 
5. Have you or your spouse ever undergone other types of genetic testing (e.g., 
BRCA1/2 genetic testing, Alzheimer's disease genetic testing) that are not mentioned 
above?   
☐Yes  
☐No (If no, please skip to Section VII) 
5.1. Your level of satisfaction with other types of genetic testing: 
☐Very Unsatisfied 
☐Not Satisfied  
☐Satisfied  
☐Very Satisfied 
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Section VII Attitudes toward Autism Spectrum Disorders 
(ASD) Genetic Testing 
 
The following questions ask about your attitudes toward ASD genetic testing. 
Please mark your answers in the appropriate boxes. 
How much do you agree or disagree with the 
following statements? 
Attitudes (Agreement) 
Strongly 
Disagree 
Disagree Agree 
Strongly 
Agree 
1. Taking a child with ASD to undergo ASD genetic 
testing is a good thing 
    
2. Taking a child with ASD to undergo ASD genetic 
testing is beneficial 
    
3. Taking a child with ASD to undergo ASD genetic 
testing is necessary 
    
4. All children diagnosed with ASD should undergo 
ASD genetic testing 
    
5. All children with ASD characteristics or traits 
should undergo ASD genetic testing 
    
 
 Please rate how important each statement is to 
you. 
Attitudes (Importance) 
Not 
Important 
At all 
Not 
Important 
Important 
Extremely 
Important 
1. Taking a child with ASD to undergo ASD 
genetic testing is a good thing 
    
2. Taking a child with ASD to undergo ASD 
genetic testing is beneficial 
    
3. Taking a child with ASD to undergo ASD 
genetic testing is necessary 
    
4. All children diagnosed with ASD should 
undergo ASD genetic testing 
    
5. All children with ASD characteristics or traits 
should undergo ASD genetic testing 
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Section VIII Subjective Norms 
 
The following questions ask about your subjective norms on Autism Spectrum 
Disorders (ASD) genetic testing. 
Please mark your answers in the appropriate boxes. 
 
1. How likely are the following people to suggest that I should take my child(ren) 
with ASD to undergo ASD genetic testing? 
 
Extremely  
unlikely 
Unlikely Likely 
Extremely 
likely 
1-1. Spouse       
1-2. My family members on my side     
1-3. My family members on my spouse’s side      
1-4. Physicians     
1-5. Health care professionals other than physicians 
(e.g., nurses, social workers, occupational/ 
physical/ speech therapists, psychologists) 
    
1-6. School teachers      
1-7. My friends     
1-8. Other parents of children with ASD     
1-9. General public     
 
2. Generally speaking, how much do you care if the following people think you 
should take your child(ren) with ASD to undergo ASD genetic testing? 
 Not at all 
Just a 
little 
Quite a 
bit 
Very 
much 
2-1. Spouse       
2-2. Your family members on your side     
2-3. Your family members on your spouse’s side      
2-4. Physicians     
2-5. Health care professionals other than physicians 
(e.g., nurses, social workers, occupational/ 
physical/ speech therapists, psychologists) 
    
2-6. School teachers      
2-7. Your friends     
2-8. Other parents of children with ASD     
2-9. General public     
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Section IX Self-Efficacy 
 
The following questions ask about your confidence in taking your child(ren) with 
Autism Spectrum Disorders (ASD) to undergo the genetic testing for ASD 
 
 
 
 
1. How confident are you in finding a time to take your child(ren) with ASD for 
ASD genetic testing?  
0 1 2 3 4 5 6 7 8 9 10 
2.  How confident are you that you are able to afford to take your child(ren) with 
ASD for ASD genetic testing?   
0 1 2 3 4 5 6 7 8 9 10 
3. How confident are you in finding a suitable hospital or doctor to take your 
child(ren) with ASD for ASD genetic testing?   
0 1 2 3 4 5 6 7 8 9 10 
4. How confident are you that you can make an appointment with an ASD genetic 
testing provider to take your child(ren) with ASD for ASD genetic testing?  
0 1 2 3 4 5 6 7 8 9 10 
5. How confident are you that you can figure out the health insurance for ASD 
genetic testing?   
0 1 2 3 4 5 6 7 8 9 10 
6. How confident are you that your family members will support you in taking 
your child(ren) with ASD to undergo genetic testing for ASD?   
0 1 2 3 4 5 6 7 8 9 10 
 
 
0 10 
“I am not confident at all” “I am 100% confident!” 
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Section X Intentions 
 
The following questions ask about your intentions to take your child(ren) with 
Autism Spectrum Disorders (ASD) to undergo ASD genetic testing 
How Likely do you think? 
Extremely 
Unlikely 
Unlikely Likely 
Extremely 
Likely 
1. How likely are you to organize your time to take 
your child(ren) with ASD to undergo ASD 
genetic testing? 
    
2. How likely are you to pay out-of-pocket for ASD 
genetic testing for your child(ren) with ASD? 
    
3. How likely are you to make an appointment with 
an ASD genetic testing provider to take your 
child(ren) with ASD for ASD genetic testing? 
    
4. How likely are you to contact the health insurance 
company about the cost of ASD genetic testing 
for your child(ren) with ASD? 
    
5. How likely are you to obtain your family 
members’ support to take your child(ren) with 
ASD to undergo ASD genetic testing? 
    
6. How likely are you to take your child(ren) with 
ASD to undergo ASD genetic testing? 
    
 
 
Part XI Behavior 
 
The following questions ask about your behavior regarding taking your child(ren) 
with Autism Spectrum Disorders (ASD) to undergo ASD genetic testing 
 
1. I have taken my child(ren) with ASD to undergo ASD genetic testing. 
☐Yes (If ‘Yes’, please continue this survey) 
☐No (If ‘No’, then you have completed this survey, and please return it to us. 
Thank you) 
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Part XII Perspectives about Prenatal Genetic Testing for 
Autism Spectrum Disorders (ASD) 
 
We would like to know your perspectives toward prenatal genetic testing for ASD 
in a hypothetical scenario. 
1. Suppose that you plan to have another child, the chance of having another child with 
ASD is _____%            (Percentage is from 1% – 100%) 
2. Compared to other parents (same age and gender as you) without children with 
ASD, your chance of having another child with ASD is: 
☐Much Lower  
☐Lower  
☐About the same  
☐Higher 
☐Much Higher 
3. Suppose that you plan to have another child, how likely are you or your spouse to 
undergo prenatal genetic testing for ASD to detect if the fetus might have ASD? 
☐Extremely unlikely  
☐Unlikely  
☐Likely  
☐Extremely likely  
☐It depends  
☐I prefer not to answer this question 
3.1 If you choose ‘Extremely unlikely’ or ‘Unlikely’, please state your reasons: 
(Please check all that apply) 
☐The test result would not make any difference in my decision to keep or abort 
the fetus 
☐Undergoing prenatal genetic testing for ASD is contradicted by my religion 
 130 
 
☐Undergoing prenatal genetic testing makes me anxious 
☐I am unsure about the value of prenatal genetic testing for ASD 
☐Other (Please specify): 
________________________________________________________ 
 
3.2 If you choose ‘Likely’ or ‘Extremely likely’, please state your reasons: (Please 
check all that apply) 
☐The test result would better prepare me for the birth of a child with ASD 
☐If my child has ASD, he/she will receive earlier and better medical treatment 
☐Undergoing prenatal genetic testing would allow me to abort the pregnancy 
☐Undergoing prenatal genetic testing for ASD contributes to research 
☐Curiosity about prenatal genetic testing for ASD 
☐Other (Please specify): 
________________________________________________________ 
3.3 If you choose ‘It depends’, please state your reasons: (Please check all that 
apply) 
☐My decision depends on the condition of pregnancy 
☐My decision depends on the month of pregnancy 
☐My decision depends on the cost of prenatal genetic testing for ASD 
☐My decision depends on the procedures involved in prenatal genetic testing for 
ASD 
☐My decision depends on the accuracy of prenatal genetic testing for ASD 
☐Other (Please specify): 
________________________________________________________ 
4. Suppose that you underwent prenatal genetic testing for ASD and the results indicate 
that you have a high risk of having another child with ASD. What would you plan to 
do? 
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☐Give birth to the child 
☐Terminate the pregnancy 
☐It depends 
☐I prefer not to answer this question 
4.1 If you choose ‘Give birth to the child’, please state your reasons: (Please check 
all that apply) 
☐The prenatal genetic testing for ASD would give me time to find resources and 
prepare for the birth of the child 
☐Bonding with the fetus during pregnancy 
☐Concerns about the limitations of prenatal genetic testing for ASD (e.g., low 
diagnosis rate of the test and the inability to identify the severity and types of 
ASD) 
☐Religious beliefs  
☐Fetus might have the high chance of having ASD, which does not mean she/he 
must develop this disease 
☐ASD is not a severe condition 
☐I already have the experience of raising a child with ASD 
☐A fetus is a living independent creature 
☐Other (Please specify): 
________________________________________________________ 
4.2 If you choose ‘Terminate the pregnancy’, please state your reasons: (Please 
check all that apply) 
☐The social stigma of ASD 
☐My family cannot afford to raise another child with ASD (e.g., money, time) 
☐ASD is a severe condition 
☐I do not want to give birth to another child with ASD 
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☐Other (Please specify): 
________________________________________________________ 
4.3 If you choose “It depends”, please state your reasons: (Please check all that 
apply) 
☐It depends on the doctor's recommendations  
☐It depends on the month of pregnancy 
☐Other (Please specify) 
________________________________________________________ 
 
Part XIII Autism Spectrum Disorders (ASD) Genetic Testing 
Education 
 
The following questions ask about the education needs regarding ASD genetic 
testing 
1. Are you interested in receiving information regarding ASD genetic testing? 
☐Yes  
☐No 
2. How much are you aware of ASD genetic testing? 
☐Not at all aware 
☐Very little aware  
☐Somewhat aware  
☐Very much aware 
3. What kind of information do you want to learn about ASD genetic testing? (Please 
check all that apply) 
☐ Cost of ASD genetic testing  
☐ Benefits of ASD genetic testing 
☐ Accuracy of ASD genetic testing 
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☐ Procedure of undergoing ASD genetic testing 
☐ Potential physical harm caused by ASD genetic testing 
☐ Confidentiality of ASD genetic testing results 
☐ Previous utilization of ASD genetic testing by affected individuals 
☐ Eligibility of ASD genetic testing 
☐Other (Please specify): 
____________________________________________________________ 
4. With what kind of delivery method would you prefer to receive information 
regarding ASD genetic testing? (Please check all that apply)   
☐Web-based approach/education (e.g., online courses, webinar, emails with 
links to online resources) 
☐Workshops/seminars 
☐Brochures/flyers 
☐Video/CD 
☐Other (Please specify): 
____________________________________________________________ 
 
Part XIV Knowledge 
 
The following questions ask about your knowledge of ASD genetic testing. 
Please circle the single best answer to the best of your knowledge. 
1. Among the following individuals, who can benefit from the ASD genetic testing? 
☐  A. Biological parents of children with ASD 
☐  B. Siblings of the children with ASD 
☐  C. Children with ASD themselves 
☐  D. All of the above 
☐  E. Don’t know or not sure  
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2. Which of the following is NOT a type of ASD genetic testing? 
☐  A. Fragile X  
☐  B. R-banded Karyotype 
☐  C. Chromosomal Microarray Analysis (CMA) 
☐  D. Gene Sequencing and Deletion/Duplication Analysis 
☐  E. Don’t know or not sure 
3. Which of the following is the diagnosis rate/yield of an individual ASD genetic test 
in a clinical setting? 
☐  A. <25% 
☐  B. 25% - 50% 
☐  C. 50% - 75% 
☐  D. 75% - 100% 
☐  E. Don’t know or not sure 
4. Which of the following is TRUE? 
☐  A. Undergoing ASD genetic testing can help identify the cause of ASD-affected 
children 
☐  B. Undergoing ASD genetic testing can help ASD-affected children get early 
diagnosis 
☐  C. Undergoing ASD genetic testing can help ASD-affected children get early 
treatment  
☐  D. All of the above 
☐  E. Don’t know or not sure 
5. Which of the following is FALSE? 
☐  A. Undergoing ASD genetic testing can help ASD-affected children make 
informed family planning decisions in the future 
☐  B. Undergoing ASD genetic testing can confirm ASD diagnosis for children who 
have been diagnosed with ASD 
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☐  C. Undergoing ASD genetic testing can prevent children with ASD from getting 
ASD 
☐  D. Undergoing ASD genetic testing can develop treatment plans targeting ASD-
associated medical conditions 
☐  E. Don’t know or not sure 
6. Which of the following is TRUE? 
☐  A. ASD genetic testing can identify the severity level of children’s ASD 
☐  B. ASD genetic testing can identify all genetic causes of children’s ASD 
☐  C. ASD genetic testing can identify the complications/disease related to ASD 
☐  D. All of the above 
☐  E. Don’t know or not sure 
7. Which of the following is FALSE? 
☐  A. It is illegal for health insurance providers to use or require genetic information 
to make decisions about ASD-affected children’s insurance eligibility or 
coverage 
☐  B. It is illegal for long-term disabilities providers to use or require genetic 
information to make decisions about ASD-affected children’s insurance 
eligibility or coverage  
☐  C. It is illegal for employers to use ASD-affected children’s genetic information 
when making decisions about hiring, promotion, and several other terms of 
employment 
☐  D. It is illegal for health insurance providers to ask or require that ASD-affected 
children have ASD genetic testing 
☐  E. Don’t know or not sure 
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Thank you very much! 
 
  
Thank you so much for participating in our Autism Spectrum Disorders (ASD) research. 
Your feedback is important and valuable for this study. In thanks for your participation, 
we would like to send you a $10 Amazon electronic gift card and a summary of study 
findings. You will be redirected to a separate web link below where you can fill out your 
name and preferred e-mail address. As this will be done through a separate web link, 
there will be no way to trace your responses and your identity. Please note that we will 
need both your name and email address to process the payment so that you can receive 
your $10 Amazon electronic gift card.  
 
   
 
Please click the 'Next Page' button below to enter your full name and email 
address. 
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APPENDIX C 
PILOT TEST INVITATION EMAIL 
 
Dear Parents of Children with Autism Spectrum Disorders (ASD), 
  
As a doctoral student in the Department of Health & Kinesiology at Texas A&M 
University, I am currently conducting an online study on perspectives regarding genetic 
testing for Autism Spectrum Disorders (ASD) among parents of children diagnosed with 
ASD. The purpose of this study is to understand the value of ASD genetic testing and 
help develop relevant laws and policies.  
 
Who qualifies? All biological parents of children with ASD are invited to participate. 
There are no age requirements for children with ASD. Participants should reside in the 
United States.  
 
What is involved? Biological parents of children with ASD are asked to complete an 
anonymous online survey regarding the views of ASD genetic testing. The survey takes 
about 20 minutes to complete and can be can be accessed using any computers and other 
smart devices (e.g., iPads, smart phones). 
 
Compensation: Study participants will be compensated for their time with a $10 
Amazon electronic gift card and a summary report of study findings.   
 
Questions? Please contact the Principal Investigator, Dr. Lei-Shih Chen, at 
lace@hlkn.tamu.edu 
or Graduate Assistant, Shixi Zhao, at shixizhao@tamu.edu 
  
Interested? Please click on the link or copy and paste the link into your Internet web 
browser when you are ready to start the 20-minute survey: https://goo.gl/XyMPxx 
 
Please fill out this online survey before 10/21/2015. Your feedback is very valuable to 
the ASD community.  Thank you very much for your support with this important 
research!!! 
  
Sincerely,  
 
Shixi Zhao, B.S. 
Doctoral Student in Health Education 
Department of Health & Kinesiology 
Texas A&M University 
4243 TAMU, College Station, Texas 77843-4243 
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Phone: 979-422-7393 
E-mail: shixizhao@tamu.edu
 139 
 
APPENDIX D 
FORMAL TEST INFORMATION SHEET 
 
Welcome to our research study! 
 
Autism Spectrum Disorders (ASD) Genetic Testing: Perspectives 
among Parents of Children Diagnosed with ASD 
 
Why am I being asked to participate in this study? 
Because you are a biological parent of one or more children with ASD. 
 
What will I be asked to do? 
You will be asked to complete an online survey that will assess the perspectives 
regarding ASD genetic testing among parents of children diagnosed with ASD. This 
study will take about 20 minutes. 
 
What are the risks involved in this study? 
The risks associated with participating in this study are minimal, and are not greater than 
risks ordinarily encountered in daily life. 
  
What are the possible benefits of this study? 
Your survey responses will help understand the value of ASD genetic testing and help 
develop relevant laws and policies in the future. 
 
Do I have to participate? 
No. Your participation is voluntary. You may decide not to participate or to withdraw at 
any time without your current or future relations with Texas A&M University being 
affected.  Moreover, the survey may contain questions of a sensitive nature. You do not 
have to answer any question(s) if you do not want to. 
 
Will I be compensated? 
Yes. You will receive a $10 Amazon electronic gift card for your participation. 
 
Who will know about my participation in this research study? 
This is an anonymous study. All data will be electronically stored, password protected 
and only shared with the research team. Data from this study may be published in peer 
reviewed journals or presented at scientific meetings, but no identifiers linking you to 
this study will be included, as this is an anonymous survey.  
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Whom do I contact with questions about the research? 
The Principal Investigator, Dr. Lei-Shih Chen (lace@hlkn.tamu.edu, 979-862-2912) or 
the Graduate Assistant, Shixi Zhao (shixizhao@tamu.edu, 979-422-7393). 
 
Whom do I contact about my rights as a research participant?  
This research study has been reviewed by the Human Subjects’ Protection Program 
and/or the Institutional Review Board at Texas A&M University. For research related 
problems or questions regarding your rights as a research participant, you can contact 
these offices at (979) 458-4067 or irb@tamu.edu. 
 
Participation 
Please be sure to have read the above information, asked questions and received answers 
to your satisfaction. If you would like to be a part of the study, please print this page for 
your records and proceed to the survey. 
 
This study is being funded by Texas A&M University. 
 
To continue to the survey, please click on the ‘Next Page’ button below.
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APPENDIX E 
FORMAL TEST SURVEY INSTRUMENT 
 
1. Which state or territory do you currently live in? _________ 
2. Has your child(ren) been diagnosed with Autism Spectrum Disorders (ASD)?  
☐Yes  
☐No (If ‘No’, then you are not eligible to take this survey) 
3. Are you the biological parent of a child(ren) with ASD?  
☐Yes  
☐No (If ‘No’, then you are not eligible to take this survey) 
4. Have you ever heard or read about ASD genetic testing?  
☐Yes  
☐No (If ‘No’, please skip to Section I) 
4.1. From which of the following sources did you hear or read anything about ASD 
genetic testing? (Please check all that apply) 
☐Doctors 
☐Autism organization or support groups (e.g., Autism speaks, Easter Seals 
East Texas Inc.) 
☐My friends 
☐My family members/relatives 
☐Other parents of children with ASD 
☐Internet 
☐Television 
☐Radio 
☐Magazine 
☐Research articles 
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☐Other (Please specify): 
________________________________________________________ 
 
Section I Demographic Information 
Information about Your Child(ren) with ASD 
 
1. How many children with ASD do you have?  
2. How many of your children has been diagnosed with ASD?  
3. What’s the gender of your child with ASD: (Note: questions 3-9 will be repeated for 
each child with ASD, if needed) 
☐Male 
☐Female 
4. What’s the birth year and month of your child with ASD? (For example, suppose 
your child was born on June 2010, then the year of birth would be 2010, and month 
of the birth would be 6)  
    Year   Month 
5. Biological mother’s age at the time of child’s birth (e.g., 26, 30, 35):  
   Years 
6. Biological father’s age at the time of child’s birth (e.g., 26, 30, 35):  
  Years 
7. To the best of your knowledge, at what age was your child diagnosed with 
ASD (For example, suppose your child was born on June 2010 and was diagnosed 
with ASD on August 2013. Then the age that your child was diagnosed with ASD was 
3 years 2 months):   
  Years old   Month 
8. What health insurance did your child have when he/she was diagnosed with 
ASD? (Please check all that apply) 
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☐Private Health Insurance (e.g., Blue Cross Blue Shield, Aetna, Cigna, Doctor’s, 
Generations, Optimum Choice, Partners, Coventry/Principal, QualChoice, 
Wellness Plan, United Healthcare, WellPath, Scott &White) 
☐State Children’s Health Insurance Plan (SCHIP) 
☐Medicaid 
☐Medicare  
☐Military 
☐Indian Health Service 
☐Medigap (Medicare supplement insurance) 
☐Other (Please specify): 
____________________________________________________________ 
☐The child(ren) did not have health insurance 
9. What’s health insurance does your child with ASD have currently? (Please check all 
that apply) 
☐Private Health Insurance (e.g., Blue Cross Blue Shield, Aetna, Cigna, Doctor’s, 
Generations, Optimum Choice, Partners, Coventry/Principal, QualChoice, 
Wellness Plan, United Healthcare, WellPath, Scott &White) 
☐State Children’s Health Insurance Plan (SCHIP) 
☐Medicaid 
☐Medicare  
☐Military 
☐Indian Health Service 
☐Medigap (Medicare supplement insurance) 
☐Other (Please specify): 
____________________________________________________________ 
☐The child(ren) did not have health insurance 
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10. There are five types of ASD. When your child received the first diagnosis, with 
which of the following types was your child diagnosed? (Please choose only one 
answer) 
☐Autistic Disorder 
☐Asperger’s Syndrome 
☐Rett Syndrome 
☐Pervasive development disorders-Not otherwise specified (PDD-NOS)  
☐Childhood disintegrative disorder  
☐I don’t know or I am not sure  
☐Other (Please specify): 
____________________________________________________________ 
 
Information about Yourself 
1. What is your gender?  
☐Male 
☐Female 
2. What is your current age:  
  Years 
3. What is your race/ethnicity?  
☐White/Caucasian  
☐Black/African American  
☐Hispanic/Latino  
☐Asian 
☐American Indian/Alaska Native  
☐Native Hawaiian/Pacific Islander 
☐Multiple Race 
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☐Other (Please specify): 
____________________________________________________________ 
4. What is the highest grade or level of schooling you completed? 
☐Less than high school graduate 
☐High school graduate 
☐Some college or technical school 
☐College graduate 
☐Advanced graduate degree 
☐Other (Please specify): 
____________________________________________________________ 
5. What is your current marital status? 
☐Married  
☐Living as married  
☐Divorced  
☐Widowed  
☐Separated  
☐Single, never been married  
☐Other (Please specify): 
____________________________________________________________ 
6. Do you plan to have any more children?  
☐Yes 
☐No 
7. Thinking about members of your family living in your household, what is your 
annual household income, meaning the total pre-tax income from all sources earned 
in the past year? 
☐$0 to $9,999 
☐$10,000 to $14,999 
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☐$15,000 to $19,999 
☐$20,000 to $34,999 
☐$35,000 to $49,999 
☐$50,000 to $74,999 
☐$75,000 to $99,999  
☐$100,000 to $199,999 
☐$200,000 or more 
8. What is your current occupational status? 
☐Employed  
☐Unemployed  
☐Homemaker  
☐Student  
☐Retired  
☐Other (Please specify): 
____________________________________________________________ 
9. Which of the following best describes your current religious affiliation? 
☐Catholic 
☐Non-Catholic Christian  
☐Mormon 
☐Jewish  
☐Muslim 
☐Buddhist 
☐Unaffiliated/None  
☐Other (Please specify): 
____________________________________________________________ 
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10. To the best of your knowledge, other than your child with ASD, which of YOUR 
biological family members (including yourself) have any characteristics or traits 
of ASD? (Please check all that apply) 
☐Myself  
☐My child(ren) not diagnosed with ASD 
☐My mother  
☐My father 
☐My sibling(s) 
☐My half sibling(s) (if applicable) 
☐My niece(s) and/or nephew(s)  
☐My child(ren)'s niece(s) and/or nephew(s) (If applicable)  
☐My child(ren)'s child(ren) (If applicable)  
☐My uncle(s) and/or aunt(s)  
☐My cousin(s)  
☐My grandparent(s) on my mother's side 
☐My grandparent(s) on my father's side 
☐Other biological family member 
☐I don't have any biological family members with any characteristics or traits of 
ASD 
☐I don't know or I am unsure 
11. To the best of your knowledge, other than your child with ASD, which of YOUR 
biological family members (including yourself) been diagnosed with ASD? (Please 
check all that apply) 
☐Myself  
☐My child(ren) not diagnosed with ASD 
☐My mother  
☐My father 
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☐My sibling(s) 
☐My half sibling(s) (if applicable) 
☐My niece(s) and/or nephew(s)  
☐My child(ren)'s niece(s) and/or nephew(s) (If applicable)  
☐My child(ren)'s child(ren) (If applicable)  
☐My uncle(s) and/or aunt(s)  
☐My cousin(s)  
☐My grandparent(s) on my mother's side 
☐My grandparent(s) on my father's side 
☐Other biological family member 
☐I don't have any biological family members with any characteristics or traits of 
ASD 
☐I don't know or I am unsure 
 
Information about Your Spouse 
1. Is your current spouse the biological parent of your child(ren) with ASD?  
☐Yes  
☐No  
☐N/A (e.g. divorced, widowed, never been married) 
2. Your spouse’s current age:  
  Years 
3. What is your spouse’s race/ethnicity?  
☐White/Caucasian  
☐Black/African American  
☐Hispanic/Latino  
☐Asian 
☐American Indian/Alaska Native  
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☐Native Hawaiian/Pacific Islander 
☐Multiple Race 
☐Other (Please specify): 
____________________________________________________________ 
4. What is the highest grade or level of schooling your spouse completed? 
☐Less than high school graduate 
☐High school graduate 
☐Some college or technical school 
☐College graduate 
☐Advanced graduate degree 
☐Other (Please specify): 
____________________________________________________________ 
5. What is your spouse’s current occupational status? 
☐Employed  
☐Unemployed  
☐Homemaker  
☐Student  
☐Retired  
☐Other (Please specify): 
____________________________________________________________ 
6. Which of the following best describes your spouse’s religious affiliation? 
☐Catholic 
☐Non-Catholic Christian 
☐Mormon 
☐Jewish  
☐Muslim 
☐Buddhist 
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☐Unaffiliated/None  
☐Other (Please specify): 
____________________________________________________________ 
7. To the best of your knowledge, other than your child with ASD, which of YOUR 
SPOUSE'S biological family members (including your spouse) have any 
characteristics or traits of ASD? (Please check all that apply)   
☐My spouse 
☐My child(ren) not diagnosed with ASD 
☐My spouse’s mother  
☐My spouse’s father 
☐My spouse’s sibling(s) 
☐My spouse’s half sibling(s) (if applicable) 
☐My spouse’s niece(s) and/or nephew(s)  
☐My spouse’s uncle(s) and/or aunt(s)  
☐My spouse’s cousin(s)  
☐My spouse’s grandparent(s) on his/her mother's side 
☐My spouse’s grandparent(s) on his/her father's side 
☐Other biological family member 
☐My spouse doesn't have any biological family members with any characteristics or 
traits of ASD 
☐I don't know or I am unsure 
8. To the best of your knowledge, other than your child with ASD, which of YOUR 
SPOUSE’S biological family members (including your spouse) been diagnosed 
with ASD? (Please check all that apply)   
☐My spouse 
☐My child(ren) not diagnosed with ASD 
☐My spouse’s mother  
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☐My spouse’s father 
☐My spouse’s sibling(s) 
☐My spouse’s half sibling(s) (if applicable) 
☐My spouse’s niece(s) and/or nephew(s)  
☐My spouse’s uncle(s) and/or aunt(s)  
☐My spouse’s cousin(s)  
☐My spouse’s grandparent(s) on his/her mother's side 
☐My spouse’s grandparent(s) on his/her father's side 
☐Other biological family member 
☐My spouse doesn't have any biological family members with any characteristics or 
traits of ASD 
☐I don't know or I am unsure 
 
Section II Perceived Severity of ASD 
 
The following questions ask about your perspective about the severity of ASD. 
Please mark your answer in the appropriate box. 
How much do you agree or disagree with the 
following statements? 
Strongly 
Disagree 
Disagree Agree 
Strongly 
Agree 
1. ASD is a severe disorder     
2. Individuals with ASD have problems living 
independently   
    
3. The public discriminates against individuals with 
ASD 
    
4. Individuals with ASD have fewer job 
opportunities 
    
5.  Compared to a child without ASD, it’s hard to 
raise a child with ASD 
    
6. Health problems associated with ASD are severe     
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Section III Perceived Genetic Cause of ASD 
 
The following questions ask about your perspective about the cause of your 
child(ren)’s ASD. Please mark your answer in the appropriate box. 
How much do you agree or disagree with the 
following statements? 
Strongly 
Disagree 
Disagree Agree 
Strongly 
Agree 
1. ASD has a genetic factor     
2. ASD is caused by genes     
3. ASD is associated with family history     
4. ASD is an inherited disorder     
 
 
Section IV Perceived Benefits of ASD Genetic Testing 
 
The following questions ask you about the benefits of ASD genetic testing. 
Please mark your answer in the appropriate box. 
How much do you agree or disagree with the 
following statements? 
Strongly 
Disagree 
Disagree Agree 
Strongly 
Agree 
1. ASD genetic testing identifies the cause of 
children’s ASD 
    
2. ASD genetic testing promotes early detection and 
intervention for children with ASD 
    
3. ASD genetic testing helps develop treatment plans 
targeting ASD-associated medical conditions for 
affected children 
    
4. ASD genetic testing helps children with ASD 
make informed family planning decisions 
    
5. ASD genetic testing helps children with ASD get 
more social support 
    
6. Taking children with ASD to undergo ASD 
genetic testing contributes to ASD research 
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Section V Perceived Barriers in Taking Your Child(ren) with 
ASD to Undergo ASD Genetic Testing 
 
The following questions ask about your barriers that prevent you from taking your 
child(ren) with ASD to undergo ASD genetic testing.  
Please mark your answer in the appropriate box. 
How much do you agree or disagree with the 
following statements? 
Strongly 
Disagree 
Disagree Agree 
Strongly 
Agree 
1. ASD is not caused by genes     
2. ASD genetic testing cannot improve the current 
situation of my child(ren) diagnosed with ASD 
    
3. My child(ren) has/have already been diagnosed 
with ASD, so there’s no need to undergo this 
testing 
    
4. Taking my child(ren) with ASD to undergo ASD 
genetic testing contradicts with my religious or 
cultural beliefs 
    
5. ASD genetic testing does more harm than good     
6. ASD genetic testing can cause family conflicts     
7. The procedure of undergoing ASD genetic testing 
is uncomfortable for my child (i.e., drawing 
blood) 
    
8. The results of ASD genetic testing can cause 
public discrimination against my child(ren) with 
ASD 
    
9. The results of ASD genetic testing can put the 
health insurance status of my child(ren) with ASD 
in jeopardy 
    
 
Section VI Previous Experience with Genetic Testing 
 
The following questions ask about your previous experience with genetic testing. 
Please mark your answer in the appropriate box. 
1. Preconception testing is a genetic test that a couple undergoes before becoming 
pregnant to help predict the chances of having a child with a genetic disorder [e.g., 
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cystic fibrosis carrier testing, sickle cell testing, and Huntington's disease genetic 
testing]. Have you or your spouse ever undergone preconception testing? 
☐Yes 
☐No (If no, please skip to question 2) 
1.1. Your or your spouse’s level of satisfaction with the preconception testing: 
☐Very Unsatisfied  
☐Not Satisfied 
☐Satisfied  
☐Very Satisfied 
2. Have you or your spouse ever undergone non-invasive prenatal genetic 
testing (e.g., ultrasound, quad screen, NIPD/verifi) for any of your children?  
☐Yes  
☐No (If no, please skip to question 3) 
2.1. Your or your spouse’s level of satisfaction with the non-invasive prenatal 
genetic testing: 
☐Very Unsatisfied  
☐Not Satisfied  
☐Satisfied  
☐Very Satisfied 
3. Have you or your spouse ever undergone invasive prenatal genetic testing (e.g., 
amniocentesis, chorionic villus sampling [CVS]) for any of your children?  
☐Yes  
☐No (If no, please skip to question 4) 
3.1. Your or your spouse’s level of satisfaction with invasive prenatal genetic 
testing: 
☐Very Unsatisfied 
☐Not Satisfied 
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☐Satisfied  
☐Very Satisfied 
4. Newborn screening begins within 24 to 48 hours of a child's birth when a few drops 
of blood are obtained from a heel stick. Have any of your children 
undergone newborn screening?  
☐Yes  
☐No (If no, please skip to question 5) 
4.1. Your level of satisfaction with newborn screening: 
☐Very Unsatisfied  
☐Not Satisfied  
☐Satisfied  
☐Very Satisfied 
5. Have you or your spouse ever undergone other types of genetic testing (e.g., 
BRCA1/2 genetic testing, Alzheimer's disease genetic testing) that are not mentioned 
above?   
☐Yes  
☐No (If no, please skip to Section VII) 
5.1. Your or your spouse’s level of satisfaction with other types of genetic testing: 
☐Very Unsatisfied 
☐Not Satisfied  
☐Satisfied  
☐Very Satisfied 
 
Section VII Attitudes toward ASD Genetic Testing 
 
The following questions ask about your attitudes toward ASD genetic testing. 
Please mark your answer in the appropriate box. 
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How much do you agree or disagree with the 
following statements? 
Attitudes (Agreement) 
Strongly 
Disagree 
Disagree Agree 
Strongly 
Agree 
1. Taking a child with ASD to undergo ASD genetic 
testing is a good thing 
    
2. Taking a child with ASD to undergo ASD genetic 
testing is beneficial 
    
3. Taking a child with ASD to undergo ASD genetic 
testing is necessary 
    
4. All children diagnosed with ASD should undergo 
ASD genetic testing 
    
5. All children with ASD characteristics or traits 
should undergo ASD genetic testing 
    
 
 Please rate how important each statement is to 
you. 
Attitudes (Importance) 
Not 
Important 
At all 
Not 
Important 
Important 
Extremely 
Important 
1. Taking a child with ASD to undergo ASD 
genetic testing is a good thing 
    
2. Taking a child with ASD to undergo ASD 
genetic testing is beneficial 
    
3. Taking a child with ASD to undergo ASD 
genetic testing is necessary 
    
4. All children diagnosed with ASD should 
undergo ASD genetic testing 
    
5. All children with ASD characteristics or traits 
should undergo ASD genetic testing 
    
 
Section VIII Subjective Norms 
 
The following questions ask about your subjective norms on ASD genetic testing. 
Please mark your answer in the appropriate box. 
 
1. How likely are the following people to suggest that I should take my 
child(ren) with ASD to undergo ASD genetic testing? 
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Extremely  
unlikely 
Unlikely Likely 
Extremely 
likely 
1-1. Spouse       
1-2. My family members on my side     
1-3. My family members on my spouse’s side      
1-4. Physicians     
1-5. Health care professionals other than physicians 
(e.g., nurses, social workers, occupational/ 
physical/ speech therapists, psychologists) 
    
1-6. School teachers      
1-7. My friends     
1-8. Other parents of children with ASD     
1-9. General public     
 
2. Generally speaking, how much do you care if the following people think you 
should take your child(ren) with ASD to undergo ASD genetic testing? 
 Not at all 
Just a 
little 
Quite a 
bit 
Very 
much 
2-1. Spouse       
2-2. Your family members on your side     
2-3. Your family members on your spouse’s side      
2-4. Physicians     
2-5. Health care professionals other than physicians 
(e.g., nurses, social workers, occupational/ 
physical/ speech therapists, psychologists) 
    
2-6. School teachers      
2-7. Your friends     
2-8. Other parents of children with ASD     
2-9. General public     
 
Section IX Self-Efficacy 
 
The following questions ask about your confidence in taking your child(ren) with 
ASD to undergo the genetic testing for ASD 
 
 
 
 
0 10 
“Not confident at all” “Extremely confident” 
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1. How confident are you in finding a time to take your child(ren) with ASD for 
ASD genetic testing?  
0 1 2 3 4 5 6 7 8 9 10 
2.  How confident are you that you are able to afford to take your child(ren) with 
ASD for ASD genetic testing?   
0 1 2 3 4 5 6 7 8 9 10 
3. How confident are you in finding a suitable hospital or doctor to take your 
child(ren) with ASD for ASD genetic testing?   
0 1 2 3 4 5 6 7 8 9 10 
4. How confident are you that you can make an appointment with an ASD genetic 
testing provider to take your child(ren) with ASD for ASD genetic testing?  
0 1 2 3 4 5 6 7 8 9 10 
5. How confident are you that you can figure out the health insurance for ASD 
genetic testing?   
0 1 2 3 4 5 6 7 8 9 10 
6. How confident are you that your family members will support you in taking 
your child(ren) with ASD to undergo genetic testing for ASD?   
0 1 2 3 4 5 6 7 8 9 10 
 
Section X Intentions 
 
The following questions ask about your intentions to take your child(ren) with ASD 
to undergo ASD genetic testing 
How Likely are you to… 
Extremely 
Unlikely 
Unlikely Likely 
Extremely 
Likely 
1. How likely are you to organize your time to take 
your child(ren) with ASD to undergo ASD 
genetic testing? 
    
2. How likely are you to pay out-of-pocket for ASD 
genetic testing for your child(ren) with ASD? 
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3. How likely are you to make an appointment with 
an ASD genetic testing provider to take your 
child(ren) with ASD for ASD genetic testing? 
    
4. How likely are you to contact the health insurance 
company about the cost of ASD genetic testing 
for your child(ren) with ASD? 
    
5. How likely are you to obtain your family 
members’ support to take your child(ren) with 
ASD to undergo ASD genetic testing? 
    
6. How likely are you to take your child(ren) with 
ASD to undergo ASD genetic testing? 
    
 
 
Part XI Perspectives about Prenatal Genetic Testing for ASD 
 
We would like to know your perspectives about prenatal genetic testing for ASD in 
a hypothetical scenario. 
1. Suppose that you plan to have another child, the chance of having another child with 
ASD is _____%            (Percentage is from 1% – 100%) 
2. Compared to other parents (same age and gender as you) without children with 
ASD, your chance of having another child with ASD is: 
☐Much Lower  
☐Lower  
☐About the same  
☐Higher 
☐Much Higher 
3. Suppose that you plan to have another child, how likely are you or your spouse to 
undergo prenatal genetic testing for ASD to detect if the fetus might have ASD? 
☐Extremely unlikely  
☐Unlikely  
☐Likely  
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☐Extremely likely  
☐It depends  
☐I prefer not to answer this question 
3.1 If you choose ‘Extremely unlikely’ or ‘Unlikely’, please state your reasons: 
(Please check all that apply) 
☐The test result would not make any difference in my decision to keep or abort 
the fetus 
☐Undergoing prenatal genetic testing for ASD is contradicted by my religion 
☐Undergoing prenatal genetic testing makes me anxious 
☐Prenatal genetic testing for ASD cannot indicate the severity of ASD 
☐I am unsure about the value of prenatal genetic testing for ASD 
☐Other (Please specify): 
________________________________________________________ 
3.2 If you choose ‘Likely’ or ‘Extremely likely’, please state your reasons: (Please 
check all that apply) 
☐The test result would better prepare me or my family for the birth of a child 
with ASD 
☐If my child develops ASD once he/she is born, my child would then receive 
earlier and better medical treatment, which would facilitate a better health 
outcome 
☐Undergoing prenatal genetic testing would reduce the unnecessary medical 
examinations and doctor visits  to find out that my child has ASD 
☐Undergoing prenatal genetic testing would allow me or my spouse to abort the 
pregnancy 
☐Undergoing prenatal genetic testing for ASD contributes to research 
☐Curiosity about prenatal genetic testing for ASD 
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☐Other (Please specify): 
________________________________________________________ 
3.3 If you choose ‘It depends’, please state your reasons: (Please check all that 
apply) 
☐My decision depends on the condition of pregnancy 
☐My decision depends on the month of pregnancy 
☐My decision depends on the cost of prenatal genetic testing for ASD 
☐My decision depends on the procedures involved in prenatal genetic testing for 
ASD 
☐My decision depends on the accuracy of prenatal genetic testing for ASD 
☐Other (Please specify): 
________________________________________________________ 
4. Suppose that you underwent prenatal genetic testing for ASD and the results indicate 
that you have a high risk of having another child with ASD. What would you plan to 
do? 
☐Give birth to the child 
☐Terminate the pregnancy 
☐It depends 
☐I prefer not to answer this question 
4.1 If you choose ‘Give birth to the child’, please state your reasons: (Please check 
all that apply) 
☐The prenatal genetic testing for ASD would give me or my family time to find 
resources and prepare for the birth of the child 
☐Bonding with the fetus during pregnancy 
☐Concerns about the limitations of prenatal genetic testing for ASD (e.g., low 
diagnosis rate of the test and the inability to identify the severity and types of 
ASD) 
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☐Religious beliefs  
☐Fetus might have the high chance of having ASD, which does not mean she/he 
must develop this disease 
☐Not all types of ASD are severe 
☐ASD does not directly relate to a child's happiness and success 
☐ASD does not directly relate to a family's happiness and success 
☐I already have the experience of raising a child with ASD 
☐A fetus is a living independent creature 
☐I will chose to have my baby regardless of medical conditions known or 
unknown 
☐Other (Please specify): 
________________________________________________________ 
4.2 If you choose ‘Terminate the pregnancy’, please state your reasons: (Please 
check all that apply) 
☐The social stigma of ASD 
☐My family cannot afford to raise another child with ASD (e.g., money, time) 
☐ASD is a severe condition 
☐I do not want to give birth to another child with ASD 
☐Other (Please specify): 
________________________________________________________ 
4.3 If you choose “It depends”, please state your reasons: (Please check all that 
apply) 
☐It depends on the doctor's recommendations  
☐It depends on the month of pregnancy 
☐Other (Please specify) 
________________________________________________________ 
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Part XII ASD Genetic Testing Education 
 
The following questions ask about the education needs regarding ASD genetic 
testing 
1. Are you interested in receiving information regarding ASD genetic testing? 
☐Yes  
☐No 
2. How much are you aware of ASD genetic testing? 
☐Not at all aware 
☐Very little aware  
☐Somewhat aware  
☐Very much aware 
3. We are planning to develop an education program for parents of children with ASD. 
This program is intended to let parents get more information about ASD genetic 
testing and then make their informed decision about if taking their children with 
ASD to undergo ASD genetic testing. If this education program is available for you 
to take, what kind of information do you want to learn about ASD genetic 
testing? (Please check all that apply) 
☐ Cost of ASD genetic testing  
☐ Benefits of ASD genetic testing 
☐ Accuracy of ASD genetic testing 
☐ Procedure of undergoing ASD genetic testing 
☐ Potential physical harm caused by ASD genetic testing 
☐ Confidentiality of ASD genetic testing results 
☐ Previous utilization of ASD genetic testing by affected individuals 
☐ Eligibility of ASD genetic testing 
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☐Other (Please specify): 
____________________________________________________________ 
4. With what kind of delivery method would you prefer to receive information 
regarding ASD genetic testing? (Please check all that apply)   
☐Web-based approach/education (e.g., online courses, webinar, emails with 
links to online resources) 
☐Workshops/seminars 
☐Brochures/flyers 
☐Video/CD 
☐Other (Please specify): 
____________________________________________________________ 
 
Part XIII Knowledge 
 
The following questions ask about your knowledge of ASD genetic testing. 
Please circle the single best answer to the best of your knowledge. 
1. Among the following individuals, who can benefit from the ASD genetic testing? 
☐  A. Biological parents of children with ASD 
☐  B. Siblings of the children with ASD 
☐  C. Children with ASD themselves 
☐  D. All of the above 
☐  E. Don’t know or not sure  
2. Which of the following is NOT a type of ASD genetic testing? 
☐  A. Fragile X  
☐  B. R-banded Karyotype 
☐  C. Chromosomal Microarray Analysis (CMA) 
☐  D. Gene Sequencing and Deletion/Duplication Analysis 
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☐  E. Don’t know or not sure 
3. Which of the following is the diagnosis rate/yield of an individual ASD genetic test 
in a clinical setting? 
☐  A. <25% 
☐  B. 25% - 50% 
☐  C. 50% - 75% 
☐  D. 75% - 100% 
☐  E. Don’t know or not sure 
4. Which of the following is TRUE? 
☐  A. Undergoing ASD genetic testing can help identify the cause of ASD-affected 
children 
☐  B. Undergoing ASD genetic testing can help ASD-affected children get early 
diagnosis 
☐  C. Undergoing ASD genetic testing can help ASD-affected children get early 
treatment  
☐  D. All of the above 
☐  E. Don’t know or not sure 
5. Which of the following is FALSE? 
☐  A. Undergoing ASD genetic testing can help ASD-affected children make 
informed family planning decisions in the future 
☐  B. Undergoing ASD genetic testing can confirm ASD diagnosis for children who 
have been diagnosed with ASD 
☐  C. Undergoing ASD genetic testing can prevent children with ASD from getting 
ASD 
☐  D. Undergoing ASD genetic testing can develop treatment plans targeting ASD-
associated medical conditions 
☐  E. Don’t know or not sure 
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6. Which of the following is TRUE? 
☐  A. ASD genetic testing can identify the severity level of children’s ASD 
☐  B. ASD genetic testing can identify all genetic causes of children’s ASD 
☐  C. ASD genetic testing can identify the complications/disease related to ASD 
☐  D. All of the above 
☐  E. Don’t know or not sure 
7. Which of the following is FALSE? 
☐  A. It is illegal for health insurance providers to use or require genetic information 
to make decisions about ASD-affected children’s insurance eligibility or 
coverage 
☐  B. It is illegal for long-term disabilities providers to use or require genetic 
information to make decisions about ASD-affected children’s insurance 
eligibility or coverage  
☐  C. It is illegal for employers to use ASD-affected children’s genetic information 
when making decisions about hiring, promotion, and several other terms of 
employment 
☐  D. It is illegal for health insurance providers to ask or require that ASD-affected 
children have ASD genetic testing 
☐  E. Don’t know or not sure 
 
Section XIV Experience 
 
The following questions ask about your experience regarding taking your 
child(ren) with ASD to undergo ASD genetic testing 
1. I have taken my child(ren) with ASD to undergo ASD genetic testing. 
☐Yes (If ‘Yes’, please continue this survey) 
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☐No (If ‘No’, then you have completed this survey, and please return it to us. 
Thank you) 
1.1 Please select the type of ASD genetic testing that your child(ren) with 
ASD  has/have undergone: (Please check all that apply) 
☐  Fragile X 
☐  G-banded Karyotype 
☐  Chromosomal Microarray Analysis (CMA) 
☐  Gene Sequencing and Deletion/Duplication Analysis 
☐  I don't know/I am not sure 
☐  Other (Please specify): 
________________________________________________ 
1.2 In which year have you take your child(ren) with ASD to undergo ASD genetic 
testing: ________ 
1.3 Your level of satisfaction with ASD genetic testing: 
☐  Very Unsatisfied 
☐  Not Satisfied 
☐  Satisfied 
☐  Very Satisfied 
1.4 If you choose “Very Unsatisfied”, please state your reason(s): (Please check all 
that apply) 
☐  The process of ASD genetic testing took long time (e.g., long waiting time to 
receive genetic testing results, too much paperwork to fill out) 
☐  The ASD genetic testing providers were unfriendly 
☐  The ASD genetic testing providers could not explain the genetic testing 
results well to me 
☐  The ASD genetic testing was too hard for me to understand 
☐  The ASD genetic testing result made me confused 
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☐  The ASD genetic testing didn't provide any new treatment options that could 
improve my child(ren)'s condition 
☐  The ASD genetic testing didn't make any change to my family’s day-to-day 
experience 
☐  The ASD genetic testing merely confirmed what I already knew to be true 
about my child(ren) 
☐  The ASD genetic testing result made me feel guilty about my child(ren) 
☐  The ASD genetic testing result caused some family conflicts 
☐  The ASD genetic testing result was inaccurate 
☐  The ASD genetic testing was too expensive 
☐  Other (Please specify): 
________________________________________________ 
1.5 If you choose “Satisfied” or Very satisfied, please state your reason(s): (Please 
check all that apply) 
☐  The ASD genetic testing result offered an explanation for our child(ren)’s 
condition, which made me feel comforted 
☐  The ASD genetic testing result reduced our feelings of guilt for my child(ren) 
with ASD 
☐  The ASD genetic testing result  helped me to explain to others (e.g., medical 
providers, teachers, caretakers, and relatives) that our child(ren)’s behavior 
was the result of a medical condition 
☐  The ASD genetic testing result helped me to access additional services or 
resources for my child(ren) with ASD 
☐  The ASD genetic testing result helped me to examine our child(ren)’s 
problems, and enabled me to improve my understanding of my child(ren)’s 
behaviors, capabilities, potential 
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☐  The ASD genetic testing result helped me gain a better understanding of my 
child(ren)’s strengths and weaknesses, and also helped me develop more 
realistic expectations for my child(ren) with ASD 
☐  The ASD genetic testing result informed medical care for our child(ren) with 
ASD 
☐  The ASD genetic testing result helped me in treatment planning for my 
child(ren) with ASD 
☐  The ASD genetic testing results helped me abandon approaches that could be 
futile or harmful(e.g., avoiding vaccinations and restrictive diets) 
☐  The ASD genetic testing results played a potential role in future reproductive 
decisions of my child(ren) or other family members 
☐  The ASD genetic testing results helped me get connected with other families 
with children with ASD, or with ASD organizations 
☐  The ASD genetic testing results can contribute to scientific knowledge and 
research, which would eventually lead to benefits for other and my own 
child(ren) with ASD 
☐  Other (Please specify): 
________________________________________________ 
1.6 How helpful has the ASD genetic testing result been for your family? 
☐  Not at all helpful 
☐  Just a little helpful 
☐  Quite a bit helpful 
☐  Extremely helpful 
1.7 Will you recommend this ASD genetic testing to other parents of children with 
ASD? 
☐  No, I won't (Please state your reason) 
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_________________________________________________________________
_________________________________________________________________
__________________________ 
☐  Yes, I will (Please state your reason) 
_________________________________________________________________
_________________________________________________________________
__________________________ 
 
☐  It depends (Please state your reason) 
_________________________________________________________________
_________________________________________________________________
__________________________ 
 
☐  I don't know or I am not sure (Please state your reason) 
_________________________________________________________________
_________________________________________________________________
__________________________ 
 
Thank you very much! 
 
Thank you so much for participating in our Autism Spectrum Disorders (ASD) research. 
Your feedback is important and valuable for this study. In thanks for your participation, 
we would like to send you a $10 Amazon electronic gift card and a summary of study 
findings. You will be redirected to a separate web link below where you can fill out your 
name and preferred e-mail address. As this will be done through a separate web link, 
there will be no way to trace your responses and your identity. Please note that we will 
need both your name and email address to process the payment so that you can receive 
your $10 Amazon electronic gift card. 
 
Please click the 'Next Page' button below to enter your full name and email 
address.  
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APPENDIX F 
 
FORMAL TEST INVITATION EMAIL 
 
 
IAN Subject Recruitment ID#: SR00557 
Study Title: Autism Spectrum Disorder (ASD) Genetic Testing: Perspectives among 
Parents of Children Diagnosed with ASD (SR00557) 
Email Subject Line: Perspectives regarding ASD Genetic Testing (SR00557) 
Link: https://tamucehd.qualtrics.com/jfe/form/SV_3EHxmq7Bmv5vDq5 
 
Dear @@RecipientFirstName @@RecipientLastName,  
 
When you joined the Interactive Autism Network (IAN) Research Project, we promised 
to inform you about research projects that might be of interest to you. Here is an 
invitation from a team of researchers seeking IAN Research Project participants. 
 
This is an IAN 1-Click study! Please click on the appropriate link below to indicate 
whether or not you are interested in the study. Once you have clicked on either the 
"Interested" or "Not Interested/Don’t Qualify" link below, IAN will no longer send 
you notifications about this study.  
 
Researchers at Texas A&M University are conducting an online study on perspectives 
regarding genetic testing for Autism Spectrum Disorders (ASD) among parents of 
children diagnosed with ASD. The purpose of this study is to understand the value of 
ASD genetic testing and help develop relevant laws and policies.  
 
Who qualifies? All biological parents of children with ASD are invited to participate. 
There are no age requirements for children with ASD. Participants should reside in the 
United States.  
 
What is involved? Biological parents of children with ASD are asked to complete an 
anonymous online survey regarding the views of ASD genetic testing. The survey takes 
about 20 minutes to complete and can be accessed using any computers and other smart 
devices (e.g., iPads, smart phones). 
 
Compensation. Study participants will be compensated for their time with a $10 
Amazon electronic gift card and a summary report of the study findings.   
 
Questions? Please contact the Principal Investigator, Dr. Lei-Shih Chen, at 
lace@hlkn.tamu.edu or the Graduate Assistant, Shixi Zhao, at shixizhao@tamu.edu   
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Please click on the appropriate link to indicate whether or not you are interested in 
this study: 
 
Interested? Please click on this link when you are ready to start the 20 minute 
survey: @@URLLink 
 
Not Interested/Don’t Qualify? @@NotInterestedLink 
 
IAN Subject Recruitment ID: SR00557. You do not have to participate in this study and 
your non-participation will neither affect the care you receive from any health provider 
nor your standing as a participant in IAN Research. IAN Research is serving as a 
resource linking the autism community and researchers. This study is not endorsed by or 
performed under the auspices of the IAN Research project at Kennedy Krieger Institute. 
Please email ResearchTeam@IANproject.org if you are no longer interested in receiving 
information about subject recruitment opportunities from IAN, or if you have any 
questions or concerns that you would like to share. 
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APPENDIX G 
DATASET USE AGREEMENT 
 
